Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.8997995991983969,2.126126352763188,0.0,0.11949850423128405,0.094,4/4,10.74%,DKK1;FOS;DDIT4;EGR1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.6920032472595257,2.071205630507059,0.0018832391713747645,0.09745984566403904,0.154,5/7,10.74%,DKK1;FOS;SLC6A6;DDIT4;EGR1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.6436496880214324,2.0569951818478414,0.005555555555555556,0.07738017896943804,0.178,5/8,12.72%,DKK1;LTF;RELN;EGR1;EFNA1
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.6511764172252819,1.975407509633794,0.001869158878504673,0.13566018718059705,0.337,5/7,20.08%,DKK1;FOS;DDIT4;EGR1;GPNMB
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.8196392785571142,-1.960195234027437,0.002066115702479339,0.7096021447518417,0.408,4/4,18.89%,FABP5;FABP3;SLC10A4;CETP
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.86,-1.8276007133449035,0.002028397565922921,1.0,0.785,3/3,14.71%,TCIM;PSMB9;PSMB8
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.86,-1.8143734353045078,0.00202020202020202,0.6251135440637627,0.807,3/3,14.71%,PSMB9;AP2M1;PSMB8
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.86,-1.8143734353045078,0.00202020202020202,0.6251135440637627,0.807,3/3,14.71%,PSMB9;AP2M1;PSMB8
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.7726575597813412,1.8095118464487876,0.0,0.4938618510935527,0.79,3/4,4.97%,SLC6A6;LRP2;KCNJ13
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.878,1.8090724366792441,0.003787878787878788,0.41285753715972323,0.79,3/3,12.72%,OPHN1;RELN;EFNA1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.86,-1.8058417442800503,0.005964214711729622,0.5319463559938267,0.827,3/3,14.71%,CHI3L1;PSMB9;PSMB8
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.7014883504875847,1.8056366964853217,0.009074410163339383,0.365212056257203,0.799,4/5,15.11%,COL2A1;FCGR3A;FCGR3B;HLA-DRA
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.8560000000000001,1.7836188999616984,0.009124087591240875,0.38347265907006317,0.841,3/3,14.91%,SLC6A6;LRP2;SLC1A3
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.4943851235075063,1.777938453770706,0.01876172607879925,0.3547951947121913,0.851,5/11,6.56%,DKK1;LTF;CYP26B1;KANK1;DDIT4
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.755511022044088,1.7758732400622002,0.011342155009451797,0.32538855004616857,0.856,4/4,25.05%,LRP2;SOX8;CHODL;VEGFA
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.6271179211044534,-1.7699033180570893,0.006109979633401222,0.5891229316860614,0.897,5/6,26.04%,FABP5;FABP3;CETP;LIPG;FABP7
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.7294589178356713,-1.7504621709969401,0.01616161616161616,0.5923318211381766,0.926,4/4,27.83%,ACAT2;CETP;HMGCR;MSMO1
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.7334669338677354,-1.7477780580447289,0.016877637130801686,0.5307977194285809,0.928,4/4,27.44%,CBLN1;CBLN2;DCTN1;ERC2
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.7474949899799599,-1.7430916020473741,0.015873015873015872,0.44077013797031667,0.933,4/4,26.04%,FABP5;FABP3;LIPG;FABP7
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.7474949899799599,-1.7430916020473741,0.015873015873015872,0.44077013797031667,0.933,4/4,26.04%,FABP5;FABP3;LIPG;FABP7
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.4297436486753834,1.7426051968756673,0.025878003696857672,0.3834281365275031,0.915,10/14,33.60%,OPHN1;BBS5;EXOC8;MAK;TMEM237;CEP19;EXOC5;MYLK;EXOC6;SSX2IP
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.7374749498997996,-1.7416756130170534,0.014256619144602852,0.4045985283156675,0.934,4/4,27.04%,TRH;LIF;SYT4;HMGCR
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.9660678642714571,1.737416848932651,0.001937984496124031,0.3165171154229093,0.925,2/2,3.78%,LTF;CYP26B1
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.9660678642714571,1.737416848932651,0.001937984496124031,0.3165171154229093,0.925,2/2,3.78%,LTF;CYP26B1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.9660678642714571,1.737416848932651,0.001937984496124031,0.3165171154229093,0.925,2/2,3.78%,LTF;CYP26B1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.5786290322580645,-1.730402018720159,0.015086206896551725,0.4071278492371178,0.942,7/7,43.14%,PSMB9;PSMB8;CDC7;DCTN1;DCTN3;PPP2R1A;OFD1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.804,-1.7209104268776942,0.004098360655737705,0.3318283410710051,0.954,3/3,20.28%,FABP3;CETP;LIPG
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.804,-1.7209104268776942,0.004098360655737705,0.3318283410710051,0.954,3/3,20.28%,FABP3;CETP;LIPG
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.804,-1.7209104268776942,0.004098360655737705,0.3318283410710051,0.954,3/3,20.28%,FABP3;CETP;LIPG
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.804,-1.7209104268776942,0.004098360655737705,0.3318283410710051,0.954,3/3,20.28%,FABP3;CETP;LIPG
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.572389225943263,1.7036850022467345,0.02376599634369287,0.396108156648617,0.965,4/7,11.53%,SLC6A6;LRP2;LRP1B;SLC3A1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.9860279441117763,1.70285397401998,0.0018656716417910447,0.29933395814000335,0.965,2/2,1.79%,LTF;DEFA4
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),0.9860279441117763,1.70285397401998,0.0018656716417910447,0.29933395814000335,0.965,2/2,1.79%,LTF;DEFA4
prerank,GO_Biological_Process_2021__antifungal humoral response (GO:0019732),0.9860279441117763,1.70285397401998,0.0018656716417910447,0.29933395814000335,0.965,2/2,1.79%,LTF;DEFA4
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.9860279441117763,1.70285397401998,0.0018656716417910447,0.29933395814000335,0.965,2/2,1.79%,LTF;DEFA4
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.9860279441117763,1.70285397401998,0.0018656716417910447,0.29933395814000335,0.965,2/2,1.79%,LTF;DEFA4
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.721573088837587,1.6998965515672029,0.013157894736842105,0.29207635967849366,0.967,3/4,12.13%,OPHN1;KANK1;KBTBD7
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.806,-1.6949329135476316,0.025210084033613446,0.3993951978501691,0.978,3/3,20.08%,CBLN1;CBLN2;DCTN1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.9880239520958083,-1.690466181039931,0.0020325203252032522,0.3707879438688155,0.982,2/2,1.79%,FABP5;FABP3
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.9880239520958083,-1.690466181039931,0.0020325203252032522,0.3707879438688155,0.982,2/2,1.79%,FABP5;FABP3
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.802,1.671629957797435,0.014953271028037384,0.34559171840230585,0.984,3/3,20.28%,FOS;EGR1;JUN
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.802,1.671629957797435,0.014953271028037384,0.34559171840230585,0.984,3/3,20.28%,FOS;EGR1;JUN
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.9361277445109779,-1.6665924287126044,0.00808080808080808,0.4433737141848738,0.991,2/2,6.96%,CXCL8;RBPMS2
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.9461077844311376,-1.66541174356104,0.003913894324853229,0.40780078783089824,0.993,2/2,5.96%,ISG15;NLRC5
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.9461077844311376,-1.66541174356104,0.003913894324853229,0.40780078783089824,0.993,2/2,5.96%,ISG15;NLRC5
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.656067795408179,-1.660202822968008,0.019120458891013385,0.3921530317939135,0.995,3/5,8.95%,CHI3L1;MIF;PHB2
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.656067795408179,-1.660202822968008,0.019120458891013385,0.3921530317939135,0.995,3/5,8.95%,CHI3L1;MIF;PHB2
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.9381237524950099,-1.6548156728457397,0.004149377593360996,0.39758140311707507,0.997,2/2,6.76%,EDNRB;CXCL8
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.9461077844311376,1.6526240896936912,0.009689922480620155,0.3957571706047683,0.991,2/2,5.77%,DKK1;CNDP1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.9281437125748502,-1.6464505040074247,0.0020242914979757085,0.378867743266785,0.998,2/2,7.75%,HBA1;GPX1
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.9281437125748502,-1.6464505040074247,0.0020242914979757085,0.378867743266785,0.998,2/2,7.75%,HBA1;GPX1
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.9281437125748502,-1.6464505040074247,0.0020242914979757085,0.378867743266785,0.998,2/2,7.75%,HBA1;GPX1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.9441117764471059,1.6452536879058004,0.0,0.40641245389872444,0.994,2/2,5.96%,RELN;CASQ1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.57200763084771,-1.6342242600330454,0.032520325203252036,0.4073126873050884,0.998,4/6,11.13%,ISG15;NLRC5;PHB2;IFITM3
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.9201596806387224,-1.6301083253228568,0.009633911368015413,0.3940770323488413,0.998,2/2,8.55%,MIF;TCIM
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),-0.9201596806387224,-1.6301083253228568,0.009633911368015413,0.3940770323488413,0.998,2/2,8.55%,MIF;TCIM
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.7819999999999999,1.6265727789510989,0.021621621621621623,0.44276844084481537,0.997,3/3,22.27%,COL2A1;LRP2;MYO3B
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.7819999999999999,1.6265727789510989,0.021621621621621623,0.44276844084481537,0.997,3/3,22.27%,COL2A1;LRP2;MYO3B
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.9161676646706586,-1.6160198675547213,0.02268041237113402,0.41422077671409013,0.998,2/2,8.95%,TCIM;PHB2
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.9161676646706586,-1.6160198675547213,0.02268041237113402,0.41422077671409013,0.998,2/2,8.95%,TCIM;PHB2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.7709176310701666,1.6100364608593454,0.027131782945736434,0.49405075388127184,0.999,2/3,6.56%,DKK1;DDIT4
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.9361277445109779,1.6050380342932011,0.005671077504725898,0.49606402816418005,1.0,2/2,6.76%,KCNJ13;KCNJ14
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.6256592992477275,1.6040961601384465,0.03787878787878788,0.48315269552309875,1.0,4/5,17.50%,LTF;DEFA4;LCN2;S100A12
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.7853244332430611,-1.6016672361796092,0.037037037037037035,0.4496048798656189,0.998,2/3,4.57%,CHI3L1;SDC1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.9261477045908183,-1.598015771789028,0.014373716632443531,0.44944872535217373,0.998,2/2,7.95%,DTX3L;BDNF
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.6025279688934649,1.5883637155109596,0.04423076923076923,0.5278535197482368,1.0,4/5,25.05%,RELN;DDIT4;SPOCK1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),0.8962075848303392,1.586727789722939,0.025390625,0.5022142800778256,1.0,2/2,10.74%,DKK1;EGR1
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.8962075848303392,1.586727789722939,0.025390625,0.5022142800778256,1.0,2/2,10.74%,DKK1;EGR1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.8842315369261476,-1.582235894536817,0.021825396825396824,0.48095103172777953,0.998,2/2,12.13%,DTX3L;LIF
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.8842315369261476,-1.582235894536817,0.021825396825396824,0.48095103172777953,0.998,2/2,12.13%,DTX3L;LIF
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.75,-1.574356916402957,0.041916167664670656,0.4969364508589668,0.999,3/3,25.65%,EDNRB;CXCL8;FIS1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.5553319919517103,-1.5667982512172212,0.041928721174004195,0.5128351379281988,0.999,6/6,45.33%,COPE;DCTN1;CNIH3;DCTN3;ANK1;COG3
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.6613226452905813,1.565729253476441,0.042884990253411304,0.570181869755442,1.0,4/4,34.39%,DKK1;IFIT1;JUN;CFHR1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7419127819568965,1.5625258456535849,0.03968253968253968,0.5671281471304382,1.0,2/3,4.77%,OPHN1;RELN
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.6646230033756899,1.561967423388065,0.03676470588235294,0.5536600780060107,1.0,3/4,17.50%,LTF;DEFA4;S100A12
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.37871698835067047,-1.560069334827133,0.05895691609977324,0.5255905669994667,0.999,11/14,41.55%,RIT2;SLC18A2;GABRA2;CBLN1;CBLN2;PCDHB16;ERC2;CDH8;GABRA4;NTSR1;BSN
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.87624750499002,1.557048906463351,0.02111324376199616,0.558842140966417,1.0,2/2,12.72%,RELN;EFNA1
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.8742514970059879,-1.5529571194124674,0.024742268041237112,0.5256501259324794,0.999,2/2,13.12%,CXCL8;AP2M1
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.8742514970059879,-1.5529571194124674,0.024742268041237112,0.5256501259324794,0.999,2/2,13.12%,CXCL8;AP2M1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.6788413518716181,1.5511243636716583,0.04819277108433735,0.5520840941597491,1.0,3/4,15.71%,COL2A1;EFEMP1;GUCY2F
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.6788413518716181,1.5511243636716583,0.04819277108433735,0.5520840941597491,1.0,3/4,15.71%,COL2A1;EFEMP1;GUCY2F
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.2996351644470386,-1.5479302717329118,0.05122950819672131,0.5306404126121518,0.999,10/24,15.31%,ISG15;SDC1;MIF;CXCL8;PSMB9;IRF9;IFITM3;LIF;PSMB8;PLP2
prerank,GO_Biological_Process_2021__iron coordination entity transport (GO:1901678),0.8842315369261478,1.545743032935858,0.023575638506876228,0.5590228182573738,1.0,2/2,11.93%,LTF;LCN2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.5120967741935484,-1.541262343497501,0.06352459016393443,0.5415531345395187,0.999,7/7,49.70%,PSMB9;PSMB8;DCTN1;DCTN3;PPP2R1A;OFD1;ANLN
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.5181451612903224,1.5384113112836786,0.05555555555555555,0.5740562891190573,1.0,7/7,48.91%,LTF;DHX33;S100A12;CAPN3;IRAK3;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.7409363621615659,-1.537020230382961,0.060291060291060294,0.5338108095490083,1.0,2/3,6.76%,CHI3L1;CXCL8
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.7409363621615659,-1.537020230382961,0.060291060291060294,0.5338108095490083,1.0,2/3,6.76%,CHI3L1;CXCL8
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.47469111599256414,-1.5345285574616758,0.042682926829268296,0.5308601748446581,1.0,4/8,14.71%,CHI3L1;CXCL8;PSMB9;PSMB8
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.6446274877047282,-1.5344164879288251,0.05473684210526316,0.5201621956763051,1.0,2/4,6.76%,CHI3L1;CXCL8
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.4221510499608334,1.5321021004876323,0.06902985074626866,0.5859018192432766,1.0,8/11,33.60%,BBS5;EXOC8;MAK;TMEM237;CEP19;EXOC5;EXOC6;SSX2IP
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.8882235528942115,1.531935457608035,0.04208416833667335,0.5733923653278464,1.0,2/2,11.53%,SLC6A6;SLC3A1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.87624750499002,1.5259988556730164,0.021153846153846155,0.5833788751648714,1.0,2/2,12.72%,OPHN1;EFNA1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.8582834331337325,-1.5248410466418658,0.03522504892367906,0.4149449591950406,1.0,2/2,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.754,1.5211524229216402,0.03898635477582846,0.5898742194294713,1.0,3/3,25.05%,KIAA1217;SOX8;VEGFA
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.508978304725135,-1.5162191155446212,0.07554671968190854,0.43238999974729264,1.0,3/7,11.13%,CHI3L1;ISG15;IFITM3
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.872255489021956,-1.513850905315012,0.04183266932270916,0.4316553007414572,1.0,2/2,13.32%,DTX3L;STMN1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.728,-1.5127190257898266,0.0486815415821501,0.41561037305067206,1.0,3/3,27.83%,ACAT2;HMGCR;MSMO1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.728,-1.5127190257898266,0.0486815415821501,0.41561037305067206,1.0,3/3,27.83%,ACAT2;HMGCR;MSMO1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.728,-1.5127190257898266,0.0486815415821501,0.41561037305067206,1.0,3/3,27.83%,ACAT2;HMGCR;MSMO1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.724370683273651,-1.5120436255785685,0.056133056133056136,0.41114625398283483,1.0,2/3,6.76%,EDNRB;CXCL8
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.38649050333321766,-1.509558147862709,0.07453416149068323,0.4126607183260482,1.0,6/13,18.09%,CHI3L1;RIT2;MIF;PHB2;LIF;DIRAS2
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.8343313373253491,1.5089247582944063,0.043151969981238276,0.6270690397553607,1.0,2/2,16.90%,LTF;IFIT1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.872255489021956,-1.5086084075181583,0.026422764227642278,0.40899970141751835,1.0,2/2,13.32%,CXCL8;STMN1
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.5718233111482693,-1.5057981953626167,0.07056451612903226,0.411117481873177,1.0,4/5,21.07%,PSMB9;SERPINH1;PSMB8;GAPDH
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.8542914171656688,1.5055452640848739,0.04291044776119403,0.6023700111250441,1.0,2/2,14.91%,SLC6A6;SLC1A3
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.8542914171656688,1.5055452640848739,0.04291044776119403,0.6023700111250441,1.0,2/2,14.91%,SLC6A6;SLC1A3
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.8542914171656688,1.5055452640848739,0.04291044776119403,0.6023700111250441,1.0,2/2,14.91%,SLC6A6;SLC1A3
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.7171346920137001,-1.5042928448253048,0.047151277013752456,0.40884563004640434,1.0,2/3,5.96%,ISG15;NLRC5
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.6415690894478033,-1.5010584002349632,0.07234042553191489,0.4105550404110512,1.0,3/4,14.71%,PSMB9;AP2M1;PSMB8
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.8502994011976047,1.4986944818626118,0.04339250493096647,0.6038688476438497,1.0,2/2,15.31%,RELN;EFEMP1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.8502994011976047,1.4986944818626118,0.04339250493096647,0.6038688476438497,1.0,2/2,15.31%,RELN;EFEMP1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.529215310502797,-1.489503043027367,0.0823293172690763,0.4265701391510184,1.0,4/6,14.71%,ISG15;IRF9;IFITM3;PSMB8
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.529215310502797,-1.489503043027367,0.0823293172690763,0.4265701391510184,1.0,4/6,14.71%,ISG15;IRF9;IFITM3;PSMB8
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.4952028969481961,1.487950037986257,0.11531190926275993,0.6319255706102014,1.0,3/7,4.77%,OPHN1;CNTNAP4;RELN
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.5589418421947565,-1.470789595745064,0.0640495867768595,0.4695469200220128,1.0,2/5,6.76%,CHI3L1;CXCL8
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.706,-1.4659757253655943,0.08203125,0.4760234258355311,1.0,3/3,30.02%,SYT4;RAB15;RIMS3
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.8463073852295409,-1.4602084676902014,0.05353728489483748,0.48598813075549246,1.0,2/2,15.90%,MIF;NUAK1
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.5602081133759758,-1.457701418419881,0.081419624217119,0.4869210631427106,1.0,3/5,11.53%,IRX3;BDNF;CLSTN2
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.5251509054325956,-1.456893688662402,0.07822410147991543,0.48351062440785253,1.0,6/6,48.31%,PRPF8;DDX41;GPATCH1;LSM7;GTF2H4;RBM4B
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.3294277981711931,1.4563954615136443,0.08704061895551257,0.7466716003638012,1.0,4/18,2.98%,DKK1;LTF;CITED2;LRP2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.8463073852295409,-1.4563917305369953,0.050200803212851405,0.47921055995410844,1.0,2/2,15.90%,ATP6V0D1;NUAK1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.715428259604026,1.4531567235595104,0.07434944237918216,0.7205067161591457,1.0,2/3,6.76%,KCNJ13;KCNJ14
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.715428259604026,1.4531567235595104,0.07434944237918216,0.7205067161591457,1.0,2/3,6.76%,KCNJ13;KCNJ14
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.715428259604026,1.4531567235595104,0.07434944237918216,0.7205067161591457,1.0,2/3,6.76%,KCNJ13;KCNJ14
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.6900000000000001,-1.444708217118403,0.07630522088353414,0.5050111324109202,1.0,3/3,31.61%,PSMB9;PSMB8;PTPN3
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.3999054034296392,1.441140562198764,0.09041591320072333,0.7549164206765228,1.0,7/11,30.82%,SLC6A6;KCNJ14;SLC1A3;RYR3;KCNH8;SLC6A16;SLC40A1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.8143712574850299,-1.4389080202865683,0.04897959183673469,0.5159705480798199,1.0,2/2,19.09%,IFITM3;LGALS1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.5970798282204794,-1.438779855194265,0.0835117773019272,0.5104576512589959,1.0,3/4,19.48%,PSMB9;PSMB8;CDC7
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.6097984300402807,1.433743563806726,0.08718861209964412,0.7707450868586169,1.0,2/4,3.78%,LRP2;CYP26B1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.602772954579214,-1.428611859843521,0.07539682539682539,0.5353027805931655,1.0,2/4,4.77%,ISG15;DTX3L
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.6821842442988859,-1.4279026782877882,0.09148936170212765,0.5315866819178406,1.0,2/3,7.95%,GPX1;BDNF
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.4737151922929487,1.427218380051252,0.09796672828096119,0.7864190254842909,1.0,4/7,16.50%,OPHN1;RELN;EFNA1;ANOS1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.5580811404176573,1.4254661528496728,0.11278195488721804,0.7809357850972589,1.0,3/5,14.91%,SLC6A6;LRP2;SLC1A3
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.6131125552599491,1.4231567431462424,0.1,0.7782657219943396,1.0,2/4,2.39%,LTF;SLC6A6
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.5464747923296376,1.4190386802812809,0.0777988614800759,0.7813375890754384,1.0,3/5,20.08%,DKK1;EFNA1;GPNMB
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.6012470640910834,-1.4177513127376409,0.08964143426294821,0.5555328406694355,1.0,2/4,8.95%,CHI3L1;PHB2
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.8123752495009979,-1.4117493447426437,0.07414829659318638,0.561320036363189,1.0,2/2,19.28%,INSM1;PLPP3
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.8123752495009979,-1.4117493447426437,0.07414829659318638,0.561320036363189,1.0,2/2,19.28%,INSM1;PLPP3
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.41379310344827586,1.411211245735091,0.1042830540037244,0.8011032954750381,1.0,10/10,59.44%,EFEMP1;SPIN4;ZNF217;CCNA2;ESRRG;NFIL3;ZNF146;RBM4B;NAB1;PPP2R1A
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.36399460232518427,1.4104970164562292,0.11338289962825279,0.791754113652282,1.0,11/13,48.91%,LTF;RELN;DHX33;S100A12;VEGFA;CAPN3;ABRA;ZIC2;IRAK3;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.6703022171158506,-1.4049940340037277,0.07966457023060797,0.5768153186342974,1.0,2/3,7.75%,PCSK1;GPX1
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.8023952095808382,-1.4043480748539168,0.0826271186440678,0.5433024907431954,1.0,2/2,20.28%,CETP;LIPG
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.8023952095808382,-1.4043480748539168,0.0826271186440678,0.5433024907431954,1.0,2/2,20.28%,CETP;LIPG
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),-0.8023952095808382,-1.4043480748539168,0.0826271186440678,0.5433024907431954,1.0,2/2,20.28%,CETP;LIPG
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.8023952095808382,-1.4043480748539168,0.0826271186440678,0.5433024907431954,1.0,2/2,20.28%,CETP;LIPG
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.8023952095808382,-1.4043480748539168,0.0826271186440678,0.5433024907431954,1.0,2/2,20.28%,CETP;LIPG
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.8023952095808382,-1.4043480748539168,0.0826271186440678,0.5433024907431954,1.0,2/2,20.28%,CETP;LIPG
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.6799999999999999,1.403780750755432,0.09784735812133072,0.7940447057117017,1.0,3/3,32.41%,EXOC8;EXOC5;EXOC6
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.6799999999999999,1.403780750755432,0.09784735812133072,0.7940447057117017,1.0,3/3,32.41%,EXOC8;EXOC5;EXOC6
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.674213455931466,-1.4034701797999107,0.10492505353319058,0.5408157382260276,1.0,2/3,8.95%,TCIM;PHB2
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.3522206401350261,-1.4031339068506412,0.12419700214132762,0.5365817426660185,1.0,5/14,12.13%,CHI3L1;MIF;BDNF;KNDC1;LIF
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.6740000000000002,1.4004196268638702,0.08070866141732283,0.7961693834641216,1.0,3/3,33.00%,KANK1;SPOCK1;CORO2B
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.8003992015968063,1.397322060344011,0.06593406593406594,0.7742495592652704,1.0,2/2,20.28%,FOS;JUN
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.8003992015968063,1.397322060344011,0.06593406593406594,0.7742495592652704,1.0,2/2,20.28%,FOS;JUN
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.8003992015968063,1.397322060344011,0.06593406593406594,0.7742495592652704,1.0,2/2,20.28%,FOS;JUN
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.5023065651501631,1.3946648540774476,0.12021857923497267,0.7729878423670142,1.0,3/6,13.72%,OPHN1;RELN;ARHGAP11B
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.3750825081239128,-1.3937518538864055,0.12022900763358779,0.557784992392227,1.0,3/11,5.17%,CHI3L1;ISG15;MIF
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.7984031936127743,-1.387605987663086,0.07707509881422925,0.5695235382677498,1.0,2/2,20.68%,FABP3;ACADVL
prerank,GO_Biological_Process_2021__positive regulation of gliogenesis (GO:0014015),0.7924151696606787,1.3875012509009437,0.09023941068139964,0.7887799150539709,1.0,2/2,21.07%,LRP2;SOX8
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.782435129740519,1.3866728367481984,0.08171206225680934,0.7704662089382568,1.0,2/2,22.07%,CASQ1;RYR3
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.782435129740519,1.3866728367481984,0.08171206225680934,0.7704662089382568,1.0,2/2,22.07%,CASQ1;RYR3
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.7684630738522954,-1.3853823230800508,0.09959349593495935,0.5710123901136424,1.0,2/2,23.66%,CETP;AQP9
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.7924151696606787,1.3813500204055937,0.09315589353612168,0.768620771715414,1.0,2/2,21.07%,LTF;SOX8
prerank,GO_Biological_Process_2021__positive regulation of osteoblast proliferation (GO:0033690),0.7924151696606787,1.3813500204055937,0.09315589353612168,0.768620771715414,1.0,2/2,21.07%,LTF;SOX8
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.4893751943792381,1.3808286898033946,0.13193116634799235,0.7610301803428572,1.0,5/6,39.17%,FOS;JUN;RYR3;CAPN3;NLGN1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.7724550898203593,-1.3807446319788215,0.094,0.5788931940707955,1.0,2/2,23.26%,CORO1A;FAT1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.3865543384555438,-1.3804390982644168,0.13276231263383298,0.574430107558346,1.0,8/10,41.55%,RIT2;SLC18A2;GABRA2;CBLN1;PCDHB16;GABRA4;NTSR1;BSN
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.4641013216113701,1.3762472166936237,0.11560693641618497,0.767372277907241,1.0,3/7,12.52%,DKK1;DDIT4;DNAJC3
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.666,-1.3760111163971196,0.13305613305613306,0.5815520441365168,1.0,3/3,34.00%,RAB3C;RAB15;ANK1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.6600000000000001,1.3747488053136574,0.11776447105788423,0.7634364909252007,1.0,3/3,34.39%,DKK1;IFIT1;CFHR1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.666,-1.3738012043791143,0.12,0.5825483888536265,1.0,3/3,34.00%,MICAL2;CNTNAP1;ANK1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.7944111776447105,-1.3730108142802087,0.09375,0.5396127349082258,1.0,2/2,21.07%,ALDOC;GAPDH
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.7944111776447105,-1.3730108142802087,0.09375,0.5396127349082258,1.0,2/2,21.07%,ALDOC;GAPDH
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.7944111776447105,-1.3730108142802087,0.09375,0.5396127349082258,1.0,2/2,21.07%,ALDOC;GAPDH
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.7944111776447105,-1.3730108142802087,0.09375,0.5396127349082258,1.0,2/2,21.07%,ALDOC;GAPDH
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.7944111776447105,-1.3730108142802087,0.09375,0.5396127349082258,1.0,2/2,21.07%,ALDOC;GAPDH
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.7944111776447105,-1.3730108142802087,0.09375,0.5396127349082258,1.0,2/2,21.07%,ALDOC;GAPDH
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.7944111776447105,-1.3730108142802087,0.09375,0.5396127349082258,1.0,2/2,21.07%,ALDOC;GAPDH
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.7944111776447105,-1.3730108142802087,0.09375,0.5396127349082258,1.0,2/2,21.07%,ALDOC;GAPDH
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.7944111776447105,-1.3730108142802087,0.09375,0.5396127349082258,1.0,2/2,21.07%,ALDOC;GAPDH
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.6670106272704737,-1.3718356838110801,0.12301587301587301,0.5386396456085922,1.0,2/3,5.96%,MIF;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.7844311377245509,-1.3696679298600658,0.11627906976744186,0.5394308805055976,1.0,2/2,22.07%,BDNF;SYT4
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.7984031936127743,-1.3693021037026991,0.10633946830265849,0.5270353809269906,1.0,2/2,20.68%,ACAT2;ACADVL
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.7984031936127743,-1.3693021037026991,0.10633946830265849,0.5270353809269906,1.0,2/2,20.68%,ACAT2;ACADVL
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.7984031936127743,-1.3693021037026991,0.10633946830265849,0.5270353809269906,1.0,2/2,20.68%,ACAT2;ACADVL
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.6701167771273139,1.369212333276412,0.12092130518234165,0.7734099913198517,1.0,2/3,5.17%,OPHN1;RAD23B
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.65,-1.3666454891711912,0.10805084745762712,0.5174970185081748,1.0,3/3,35.59%,RPLP2;LYAR;IMP4
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.65,-1.3666454891711912,0.10805084745762712,0.5174970185081748,1.0,3/3,35.59%,RPLP2;LYAR;IMP4
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.65,-1.3666454891711912,0.10805084745762712,0.5174970185081748,1.0,3/3,35.59%,RPLP2;LYAR;IMP4
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.65,-1.3666454891711912,0.10805084745762712,0.5174970185081748,1.0,3/3,35.59%,RPLP2;LYAR;IMP4
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.41295546558704455,1.3633705234593463,0.12476370510396975,0.7857008514393291,1.0,9/9,59.44%,SPOCK1;CYP27B1;TAF9B;HSPA1B;HSPA1A;CDKN2AIP;PSRC1;EIF4G1;PPP2R1A
prerank,GO_Biological_Process_2021__amine transport (GO:0015837),-0.7684630738522954,-1.3619174031478167,0.1228813559322034,0.5254394412714819,1.0,2/2,23.66%,SLC18A2;AQP9
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.7684630738522954,-1.3608423563137642,0.12448132780082988,0.5244294692851316,1.0,2/2,23.66%,SLC2A13;AQP9
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.49046585828876116,1.357424171103593,0.1256931608133087,0.7963540863745746,1.0,2/6,2.98%,DKK1;LRP2
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.5773069710423844,-1.3571238235000758,0.11641221374045801,0.5302553077172149,1.0,3/4,24.85%,ISG15;NLRC5;NPLOC4
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.5705525816605629,-1.35293178871236,0.11788617886178862,0.5395208276075405,1.0,2/4,5.96%,ISG15;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5795664647074104,1.3504191988607261,0.12310606060606061,0.817902709140589,1.0,3/4,25.05%,DKK1;S100A12;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.646,-1.3492682991136051,0.13814432989690723,0.5485259921595282,1.0,3/3,35.98%,DTX3L;LIF;CCT7
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.656,-1.3475791191470614,0.1364562118126273,0.5503167470661545,1.0,3/3,34.99%,CMPK2;NMNAT2;GUK1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.7684630738522954,-1.3471468131056223,0.11226611226611227,0.548166496581843,1.0,2/2,23.66%,SLC10A4;AQP9
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.7524950099800398,1.345312017040481,0.1104868913857678,0.8234910423699151,1.0,2/2,25.05%,EFEMP1;VEGFA
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.7524950099800398,1.345312017040481,0.1104868913857678,0.8234910423699151,1.0,2/2,25.05%,EFEMP1;VEGFA
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.45735708616469156,-1.3443673048567513,0.15866388308977036,0.5549382792213029,1.0,5/7,27.63%,ISG15;NLRC5;GAPDH;NPLOC4;DDX41
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),-0.7644710578842314,-1.343423044162977,0.11873840445269017,0.555886761221039,1.0,2/2,24.06%,ATP6V0D1;IRS4
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.7544910179640718,-1.3431473128634928,0.11328125,0.5529262264925382,1.0,2/2,25.05%,CORO1A;PLEKHM2
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.5160642570281126,1.3426149885983787,0.1417910447761194,0.8295533316513128,1.0,5/5,48.91%,HSPA1L;RANBP2;IER5;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.748502994011976,-1.3421120802764086,0.12524461839530332,0.548990520306671,1.0,2/2,25.65%,PHB2;FIS1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.748502994011976,-1.3421120802764086,0.12524461839530332,0.548990520306671,1.0,2/2,25.65%,PHB2;FIS1
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,"GO_Biological_Process_2021__positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.9999999999999999,1.33989312969014,0.003968253968253968,0.7292934943479087,1.0,1/1,0.20%,DKK1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.3956552857393561,1.3385709203987326,0.1564245810055866,0.7299281301308087,1.0,8/10,43.54%,FOS;DEFA4;EGR1;JUN;RYR3;GNB1;AANAT;HCN1
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.7611454217490551,1.33790267769057,0.10831721470019343,0.7274485849431422,1.0,1/2,0.20%,DKK1
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.6394145934948432,-1.3369066463257935,0.13721413721413722,0.5643689414390378,1.0,2/3,8.95%,BDNF;PHB2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.6394145934948432,-1.3369066463257935,0.13721413721413722,0.5643689414390378,1.0,2/3,8.95%,BDNF;PHB2
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.75249500998004,1.3363579322119867,0.11742424242424243,0.7294201631427806,1.0,2/2,25.05%,RELN;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.4776893712105317,-1.3361121484794072,0.15151515151515152,0.5644582404882122,1.0,3/6,12.13%,MIF;BDNF;LIF
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.35104920285412666,1.3360896267957023,0.14500941619585686,0.7250247757115762,1.0,8/12,36.78%,CITED2;ID3;ZNF217;JUN;SOX8;CAPN3;ZIC2;NFIL3
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.632,-1.3360059182949273,0.1407563025210084,0.5609908399225949,1.0,3/3,37.38%,TMSB10;FGF9;CCL21
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.7664670658682634,-1.3359182138764585,0.09771309771309772,0.5575147542787344,1.0,2/2,23.86%,STMN1;MICAL2
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.5082389825833535,-1.3359091331693924,0.147117296222664,0.5536231896353881,1.0,3/5,11.13%,ISG15;NLRC5;IFITM3
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.2921775438363971,1.3357389756347628,0.14003944773175542,0.7220657471911249,1.0,4/20,2.98%,DKK1;LTF;CITED2;LRP2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.6287941039495731,1.3340055747604915,0.13009708737864079,0.7295951051720742,1.0,2/3,12.72%,RELN;EFNA1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.75249500998004,1.3299598984641183,0.122568093385214,0.7601346174240182,1.0,2/2,25.05%,DKK1;VEGFA
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),0.75249500998004,1.3293881331937916,0.1261595547309833,0.7461176727305159,1.0,2/2,25.05%,LRP2;VEGFA
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.75249500998004,1.3293881331937916,0.1261595547309833,0.7461176727305159,1.0,2/2,25.05%,LRP2;VEGFA
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.75249500998004,1.3293881331937916,0.1261595547309833,0.7461176727305159,1.0,2/2,25.05%,LRP2;VEGFA
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.99800796812749,-1.328932961152322,0.007751937984496124,0.5722796882714505,1.0,1/1,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__chitin metabolic process (GO:0006030),-0.99800796812749,-1.328932961152322,0.007751937984496124,0.5722796882714505,1.0,1/1,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.99800796812749,-1.328932961152322,0.007751937984496124,0.5722796882714505,1.0,1/1,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.99800796812749,-1.328932961152322,0.007751937984496124,0.5722796882714505,1.0,1/1,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__chitin catabolic process (GO:0006032),-0.99800796812749,-1.328932961152322,0.007751937984496124,0.5722796882714505,1.0,1/1,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.99800796812749,-1.328932961152322,0.007751937984496124,0.5722796882714505,1.0,1/1,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.7664670658682635,1.3256939531414351,0.12375249500998003,0.7765726160367686,1.0,2/2,23.66%,RANBP2;KPNA5
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),0.9900398406374502,1.3256586483390609,0.024539877300613498,0.7499702276958677,1.0,1/1,1.19%,HSD17B2
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.9900398406374502,1.3256586483390609,0.024539877300613498,0.7499702276958677,1.0,1/1,1.19%,HSD17B2
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.9900398406374502,1.3256586483390609,0.024539877300613498,0.7499702276958677,1.0,1/1,1.19%,HSD17B2
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),0.9900398406374502,1.3256586483390609,0.024539877300613498,0.7499702276958677,1.0,1/1,1.19%,HSD17B2
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.5650418184898577,-1.3255788666709567,0.16498993963782696,0.5932137795421367,1.0,3/4,22.47%,BDNF;GABRA2;PCDHB16
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.9880478087649402,1.3250720182821847,0.01606425702811245,0.6596830926891073,1.0,1/1,1.39%,LTF
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.5077862951606565,-1.3235678211940645,0.15384615384615385,0.6065003914222302,1.0,3/5,14.71%,DTX3L;PSMB9;PSMB8
prerank,GO_Biological_Process_2021__spleen development (GO:0048536),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__positive regulation of gonad development (GO:1905941),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__left/right axis specification (GO:0070986),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__regulation of male gonad development (GO:2000018),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__positive regulation of male gonad development (GO:2000020),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__determination of left/right asymmetry in lateral mesoderm (GO:0003140),0.9760956175298805,1.3227994204144145,0.04897959183673469,0.5979141584800026,1.0,1/1,2.58%,CITED2
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.7564870259481037,-1.32210043233203,0.10588235294117647,0.6135264208178624,1.0,2/2,24.85%,ISG15;NPLOC4
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.5240963855421686,-1.3209245703577621,0.1600877192982456,0.6133023115039625,1.0,5/5,48.31%,PRPF8;DDX41;GPATCH1;LSM7;RBM4B
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.5240963855421686,-1.3209245703577621,0.1600877192982456,0.6133023115039625,1.0,5/5,48.31%,PRPF8;DDX41;GPATCH1;LSM7;RBM4B
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.9920318725099602,-1.3207745350846336,0.02574257425742574,0.606493196325163,1.0,1/1,1.19%,FABP5
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.9920318725099602,-1.3207745350846336,0.02574257425742574,0.606493196325163,1.0,1/1,1.19%,FABP5
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.6194837489555346,-1.3205973933390975,0.15020576131687244,0.6005543695702796,1.0,1/3,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.6194837489555346,-1.3205973933390975,0.15020576131687244,0.6005543695702796,1.0,1/3,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.750499001996008,1.3194592324361105,0.11623246492985972,0.623326726476913,1.0,2/2,25.25%,CEP120;CHMP4C
prerank,GO_Biological_Process_2021__oxygen transport (GO:0015671),-0.9840637450199203,-1.3187930012626576,0.023166023166023165,0.6141537371721721,1.0,1/1,1.99%,HBA1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.624,1.3187887987173879,0.14258188824662812,0.6255009833878501,1.0,3/3,37.97%,GUCY2F;PTGS2;ADGRA2
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.5751503006012023,-1.3180335511467989,0.1511879049676026,0.6153884211446817,1.0,4/4,43.14%,DCTN1;DCTN3;PPP2R1A;OFD1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.9860557768924303,1.3165996481528024,0.03346456692913386,0.6153363819094168,1.0,1/1,1.59%,OPHN1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.9860557768924303,1.3165996481528024,0.03346456692913386,0.6153363819094168,1.0,1/1,1.59%,OPHN1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.9860557768924303,1.3165996481528024,0.03346456692913386,0.6153363819094168,1.0,1/1,1.59%,OPHN1
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.9860557768924303,1.3165996481528024,0.03346456692913386,0.6153363819094168,1.0,1/1,1.59%,OPHN1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.9860557768924303,1.3165996481528024,0.03346456692913386,0.6153363819094168,1.0,1/1,1.59%,OPHN1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.9860557768924303,1.3165996481528024,0.03346456692913386,0.6153363819094168,1.0,1/1,1.59%,OPHN1
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.9860557768924303,1.3165996481528024,0.03346456692913386,0.6153363819094168,1.0,1/1,1.59%,OPHN1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.9860557768924303,1.3165996481528024,0.03346456692913386,0.6153363819094168,1.0,1/1,1.59%,OPHN1
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.99800796812749,1.3161016262294445,0.003629764065335753,0.6078369538497721,1.0,1/1,0.40%,FOS
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.99800796812749,1.3161016262294445,0.003629764065335753,0.6078369538497721,1.0,1/1,0.40%,FOS
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.99800796812749,1.3161016262294445,0.003629764065335753,0.6078369538497721,1.0,1/1,0.40%,FOS
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.9701195219123506,-1.314581601338382,0.06273764258555133,0.6092368342063653,1.0,1/1,3.38%,TRH
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.9701195219123506,-1.314581601338382,0.06273764258555133,0.6092368342063653,1.0,1/1,3.38%,TRH
prerank,GO_Biological_Process_2021__histamine metabolic process (GO:0001692),-0.9701195219123506,-1.314581601338382,0.06273764258555133,0.6092368342063653,1.0,1/1,3.38%,TRH
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.9701195219123506,-1.314581601338382,0.06273764258555133,0.6092368342063653,1.0,1/1,3.38%,TRH
prerank,GO_Biological_Process_2021__negative regulation of anion transport (GO:1903792),-0.9701195219123506,-1.314581601338382,0.06273764258555133,0.6092368342063653,1.0,1/1,3.38%,TRH
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.9701195219123506,-1.314581601338382,0.06273764258555133,0.6092368342063653,1.0,1/1,3.38%,TRH
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),-0.9701195219123506,-1.314581601338382,0.06273764258555133,0.6092368342063653,1.0,1/1,3.38%,TRH
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.9701195219123506,-1.314581601338382,0.06273764258555133,0.6092368342063653,1.0,1/1,3.38%,TRH
prerank,GO_Biological_Process_2021__positive regulation of amino acid transport (GO:0051957),-0.9701195219123506,-1.314581601338382,0.06273764258555133,0.6092368342063653,1.0,1/1,3.38%,TRH
prerank,GO_Biological_Process_2021__positive regulation of anion transport (GO:1903793),-0.9701195219123506,-1.314581601338382,0.06273764258555133,0.6092368342063653,1.0,1/1,3.38%,TRH
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.9960159362549801,1.3111955532473945,0.01568627450980392,0.6387721163650086,1.0,1/1,0.60%,COL2A1
prerank,GO_Biological_Process_2021__embryonic skeletal joint morphogenesis (GO:0060272),0.9960159362549801,1.3111955532473945,0.01568627450980392,0.6387721163650086,1.0,1/1,0.60%,COL2A1
prerank,GO_Biological_Process_2021__embryonic skeletal joint development (GO:0072498),0.9960159362549801,1.3111955532473945,0.01568627450980392,0.6387721163650086,1.0,1/1,0.60%,COL2A1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.4203017529566996,-1.3107921673527787,0.14663951120162932,0.639970437805012,1.0,2/7,3.98%,ADGRG7;GPR26
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.5176663264740646,-1.310683414427051,0.16043956043956045,0.6371460314940118,1.0,3/5,12.52%,NLRC5;PHB2;EOMES
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.9860557768924303,-1.3101533785146005,0.044921875,0.6264072104983577,1.0,1/1,1.79%,FABP3
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.9860557768924303,-1.3101533785146005,0.044921875,0.6264072104983577,1.0,1/1,1.79%,FABP3
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.9860557768924303,-1.3101533785146005,0.044921875,0.6264072104983577,1.0,1/1,1.79%,FABP3
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.9860557768924303,-1.3101533785146005,0.044921875,0.6264072104983577,1.0,1/1,1.79%,FABP3
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.9741035856573705,-1.3098503053418296,0.059670781893004114,0.625867764934602,1.0,1/1,2.98%,AHNAK2
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.7475464482706952,1.3086758292667224,0.12830188679245283,0.6570493722845705,1.0,1/2,0.20%,DKK1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.75249500998004,1.3071493130136145,0.13060428849902533,0.653824926982567,1.0,2/2,25.05%,PTGS2;VEGFA
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.75249500998004,1.3071493130136145,0.13060428849902533,0.653824926982567,1.0,2/2,25.05%,PTGS2;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.75249500998004,1.3071493130136145,0.13060428849902533,0.653824926982567,1.0,2/2,25.05%,PTGS2;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.75249500998004,1.3071493130136145,0.13060428849902533,0.653824926982567,1.0,2/2,25.05%,PTGS2;VEGFA
prerank,GO_Biological_Process_2021__proximal/distal pattern formation (GO:0009954),0.9641434262948207,1.3066783255000534,0.0728744939271255,0.6312167304053168,1.0,1/1,3.78%,CYP26B1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.9641434262948207,1.3066783255000534,0.0728744939271255,0.6312167304053168,1.0,1/1,3.78%,CYP26B1
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),0.9641434262948207,1.3066783255000534,0.0728744939271255,0.6312167304053168,1.0,1/1,3.78%,CYP26B1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.9641434262948207,1.3066783255000534,0.0728744939271255,0.6312167304053168,1.0,1/1,3.78%,CYP26B1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.9641434262948207,1.3066783255000534,0.0728744939271255,0.6312167304053168,1.0,1/1,3.78%,CYP26B1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.9641434262948207,1.3066783255000534,0.0728744939271255,0.6312167304053168,1.0,1/1,3.78%,CYP26B1
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.9641434262948207,1.3066783255000534,0.0728744939271255,0.6312167304053168,1.0,1/1,3.78%,CYP26B1
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.505056935253337,1.3061065439782213,0.14669051878354203,0.6319218033181385,1.0,3/5,17.50%,LTF;DEFA4;S100A12
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.4251999335260123,-1.3046805335134688,0.1625,0.6641040911412072,1.0,2/7,3.98%,ADGRG7;GPR26
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.9681274900398407,-1.300815568221179,0.060784313725490195,0.6894768976728686,1.0,1/1,3.58%,RIT2
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.9681274900398407,-1.300815568221179,0.060784313725490195,0.6894768976728686,1.0,1/1,3.58%,RIT2
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.7265469061876247,-1.3007502918153173,0.14836223506743737,0.6824331733941599,1.0,2/2,27.83%,HMGCR;MSMO1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.7265469061876247,-1.3007502918153173,0.14836223506743737,0.6824331733941599,1.0,2/2,27.83%,HMGCR;MSMO1
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.9621513944223108,-1.300498251154135,0.07766990291262135,0.6765524858986828,1.0,1/1,4.17%,SHISA2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.9621513944223108,-1.300498251154135,0.07766990291262135,0.6765524858986828,1.0,1/1,4.17%,SHISA2
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.6180008859769545,-1.2982887042220579,0.162,0.6910694284222544,1.0,2/3,11.53%,BDNF;CLSTN2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.7365269461077845,1.2966005225000907,0.12686567164179105,0.6931903388045757,1.0,2/2,26.64%,FOLH1;FOLH1B
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),0.7365269461077845,1.2966005225000907,0.12686567164179105,0.6931903388045757,1.0,2/2,26.64%,FOLH1;FOLH1B
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),0.7365269461077845,1.2966005225000907,0.12686567164179105,0.6931903388045757,1.0,2/2,26.64%,FOLH1;FOLH1B
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.7365269461077845,1.2966005225000907,0.12686567164179105,0.6931903388045757,1.0,2/2,26.64%,FOLH1;FOLH1B
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.30391494798963725,1.296533183487522,0.1423290203327172,0.6902640227576856,1.0,10/16,34.00%,BBS5;EXOC8;MAK;CHMP4C;TMEM237;CEP19;EXOC5;EXOC6;SSX2IP;CAPN3
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.75249500998004,1.2960997737148325,0.14534883720930233,0.6815416086284762,1.0,2/2,25.05%,SOX8;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.75249500998004,1.2960997737148325,0.14534883720930233,0.6815416086284762,1.0,2/2,25.05%,SOX8;VEGFA
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.75249500998004,1.2960997737148325,0.14534883720930233,0.6815416086284762,1.0,2/2,25.05%,SOX8;VEGFA
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.9840637450199203,1.2954459505184996,0.04554079696394687,0.6834290376436765,1.0,1/1,1.79%,DEFA4
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.5006195540333539,1.2941616044161242,0.18095238095238095,0.6908539496132172,1.0,2/5,2.78%,NXPH4;NXPH2
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.5120481927710845,1.2932736634735793,0.19038461538461537,0.6931241453476907,1.0,5/5,49.30%,RMI1;ZFYVE26;RPA4;SMC5;XRCC2
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.9780876494023905,1.2925891657303996,0.05439330543933055,0.6738239469011096,1.0,1/1,2.39%,SLC6A6
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.9780876494023905,1.2925891657303996,0.05439330543933055,0.6738239469011096,1.0,1/1,2.39%,SLC6A6
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.9780876494023905,1.2925891657303996,0.05439330543933055,0.6738239469011096,1.0,1/1,2.39%,SLC6A6
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),0.9780876494023905,1.2925891657303996,0.05439330543933055,0.6738239469011096,1.0,1/1,2.39%,SLC6A6
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.9780876494023905,1.2925891657303996,0.05439330543933055,0.6738239469011096,1.0,1/1,2.39%,SLC6A6
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.9780876494023905,1.2925891657303996,0.05439330543933055,0.6738239469011096,1.0,1/1,2.39%,SLC6A6
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.9780876494023905,1.2925891657303996,0.05439330543933055,0.6738239469011096,1.0,1/1,2.39%,SLC6A6
prerank,GO_Biological_Process_2021__female genitalia development (GO:0030540),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__pulmonary artery morphogenesis (GO:0061156),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__folate transmembrane transport (GO:0098838),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__heart field specification (GO:0003128),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__secondary heart field specification (GO:0003139),0.9721115537848606,1.2896773667915926,0.055876685934489405,0.6382987774431002,1.0,1/1,2.98%,LRP2
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.9721115537848606,-1.2881141045958804,0.07086614173228346,0.72750628930853,1.0,1/1,3.18%,ISG15
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.9721115537848606,-1.2881141045958804,0.07086614173228346,0.72750628930853,1.0,1/1,3.18%,ISG15
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.9721115537848606,-1.2881141045958804,0.07086614173228346,0.72750628930853,1.0,1/1,3.18%,ISG15
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.9721115537848606,-1.2881141045958804,0.07086614173228346,0.72750628930853,1.0,1/1,3.18%,ISG15
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.9721115537848606,-1.2881141045958804,0.07086614173228346,0.72750628930853,1.0,1/1,3.18%,ISG15
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.9721115537848606,-1.2881141045958804,0.07086614173228346,0.72750628930853,1.0,1/1,3.18%,ISG15
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.9721115537848606,-1.2881141045958804,0.07086614173228346,0.72750628930853,1.0,1/1,3.18%,ISG15
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.9721115537848606,-1.2881141045958804,0.07086614173228346,0.72750628930853,1.0,1/1,3.18%,ISG15
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.9721115537848606,-1.2881141045958804,0.07086614173228346,0.72750628930853,1.0,1/1,3.18%,ISG15
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.9721115537848606,-1.2881141045958804,0.07086614173228346,0.72750628930853,1.0,1/1,3.18%,ISG15
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.9721115537848606,-1.2881141045958804,0.07086614173228346,0.72750628930853,1.0,1/1,3.18%,ISG15
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.5456705662655514,1.2876936013669034,0.166044776119403,0.6461997704713953,1.0,2/4,6.76%,KCNJ13;KCNJ14
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.5551102204408818,-1.2874339995435073,0.17718940936863545,0.7281876415277984,1.0,4/4,45.13%,PCSK1;RPLP2;GGT5;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.5350701402805611,-1.2865714534055144,0.18816067653276955,0.7310639871067371,1.0,4/4,47.12%,GPX1;DCTN1;CCL21;PSRC1
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.9760956175298805,-1.2860267314702296,0.04526748971193416,0.6909045915633858,1.0,1/1,2.78%,EDNRB
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.9760956175298805,-1.2860267314702296,0.04526748971193416,0.6909045915633858,1.0,1/1,2.78%,EDNRB
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),-0.9760956175298805,-1.2860267314702296,0.04526748971193416,0.6909045915633858,1.0,1/1,2.78%,EDNRB
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.9760956175298805,-1.2860267314702296,0.04526748971193416,0.6909045915633858,1.0,1/1,2.78%,EDNRB
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.9760956175298805,-1.2860267314702296,0.04526748971193416,0.6909045915633858,1.0,1/1,2.78%,EDNRB
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.9760956175298805,-1.2860267314702296,0.04526748971193416,0.6909045915633858,1.0,1/1,2.78%,EDNRB
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.9760956175298805,-1.2860267314702296,0.04526748971193416,0.6909045915633858,1.0,1/1,2.78%,EDNRB
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.9760956175298805,-1.2860267314702296,0.04526748971193416,0.6909045915633858,1.0,1/1,2.78%,EDNRB
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),-0.9760956175298805,-1.2860267314702296,0.04526748971193416,0.6909045915633858,1.0,1/1,2.78%,EDNRB
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.9760956175298805,-1.2860267314702296,0.04526748971193416,0.6909045915633858,1.0,1/1,2.78%,EDNRB
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.9760956175298805,-1.2860267314702296,0.04526748971193416,0.6909045915633858,1.0,1/1,2.78%,EDNRB
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.9760956175298805,-1.2860267314702296,0.04526748971193416,0.6909045915633858,1.0,1/1,2.78%,EDNRB
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.9760956175298805,-1.2860267314702296,0.04526748971193416,0.6909045915633858,1.0,1/1,2.78%,EDNRB
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3170195918415327,1.2837789411620357,0.18625678119349007,0.6709998544421519,1.0,9/14,36.78%,FOS;CITED2;EGR1;JUN;SOX8;CAPN3;ESRRG;ZIC2;NFIL3
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.6093371694070043,-1.2817339742484137,0.1740041928721174,0.7177365143899974,1.0,2/3,9.34%,BDNF;EGR2
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.45242551063739067,-1.280799288294923,0.18811881188118812,0.7228800718701758,1.0,2/6,6.76%,CHI3L1;CXCL8
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.43538396602507357,1.2779802293244458,0.177007299270073,0.7064759799708412,1.0,4/7,24.25%,KCNJ13;KCNJ14;SLC1A3;KCNH8
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.43538396602507357,1.2779802293244458,0.177007299270073,0.7064759799708412,1.0,4/7,24.25%,KCNJ13;KCNJ14;SLC1A3;KCNH8
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.9422310756972111,-1.2761581229723964,0.11336032388663968,0.7416628085740017,1.0,1/1,6.16%,CORO1A
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.9422310756972111,-1.2761581229723964,0.11336032388663968,0.7416628085740017,1.0,1/1,6.16%,CORO1A
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.9422310756972111,-1.2761581229723964,0.11336032388663968,0.7416628085740017,1.0,1/1,6.16%,CORO1A
prerank,GO_Biological_Process_2021__natural killer cell activation involved in immune response (GO:0002323),-0.9422310756972111,-1.2761581229723964,0.11336032388663968,0.7416628085740017,1.0,1/1,6.16%,CORO1A
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.954183266932271,1.2755104678879625,0.062135922330097085,0.6829070999828444,1.0,1/1,4.77%,RELN
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.954183266932271,1.2755104678879625,0.062135922330097085,0.6829070999828444,1.0,1/1,4.77%,RELN
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.954183266932271,1.2755104678879625,0.062135922330097085,0.6829070999828444,1.0,1/1,4.77%,RELN
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.954183266932271,1.2755104678879625,0.062135922330097085,0.6829070999828444,1.0,1/1,4.77%,RELN
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.954183266932271,1.2755104678879625,0.062135922330097085,0.6829070999828444,1.0,1/1,4.77%,RELN
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.954183266932271,1.2755104678879625,0.062135922330097085,0.6829070999828444,1.0,1/1,4.77%,RELN
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.954183266932271,1.2755104678879625,0.062135922330097085,0.6829070999828444,1.0,1/1,4.77%,RELN
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.954183266932271,1.2755104678879625,0.062135922330097085,0.6829070999828444,1.0,1/1,4.77%,RELN
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.954183266932271,1.2755104678879625,0.062135922330097085,0.6829070999828444,1.0,1/1,4.77%,RELN
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.954183266932271,1.2755104678879625,0.062135922330097085,0.6829070999828444,1.0,1/1,4.77%,RELN
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.954183266932271,1.2755104678879625,0.062135922330097085,0.6829070999828444,1.0,1/1,4.77%,RELN
prerank,GO_Biological_Process_2021__positive regulation of AMPA receptor activity (GO:2000969),0.954183266932271,1.2755104678879625,0.062135922330097085,0.6829070999828444,1.0,1/1,4.77%,RELN
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.954183266932271,1.2755104678879625,0.062135922330097085,0.6829070999828444,1.0,1/1,4.77%,RELN
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.7405189620758482,-1.274706450304907,0.18255578093306288,0.7505315430950952,1.0,2/2,26.44%,SDC1;SDC3
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.9581673306772909,1.2743707628769578,0.09803921568627451,0.6583905648023165,1.0,1/1,4.37%,KANK1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.9581673306772909,1.2743707628769578,0.09803921568627451,0.6583905648023165,1.0,1/1,4.37%,KANK1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.9581673306772909,1.2743707628769578,0.09803921568627451,0.6583905648023165,1.0,1/1,4.37%,KANK1
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.9581673306772909,1.2743707628769578,0.09803921568627451,0.6583905648023165,1.0,1/1,4.37%,KANK1
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.9581673306772909,1.2743707628769578,0.09803921568627451,0.6583905648023165,1.0,1/1,4.37%,KANK1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.9581673306772909,1.2743707628769578,0.09803921568627451,0.6583905648023165,1.0,1/1,4.37%,KANK1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.9581673306772909,1.2743707628769578,0.09803921568627451,0.6583905648023165,1.0,1/1,4.37%,KANK1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.9581673306772909,1.2743707628769578,0.09803921568627451,0.6583905648023165,1.0,1/1,4.37%,KANK1
prerank,GO_Biological_Process_2021__negative regulation of lamellipodium organization (GO:1902744),0.9581673306772909,1.2743707628769578,0.09803921568627451,0.6583905648023165,1.0,1/1,4.37%,KANK1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.9581673306772909,1.2743707628769578,0.09803921568627451,0.6583905648023165,1.0,1/1,4.37%,KANK1
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.9581673306772909,1.2743707628769578,0.09803921568627451,0.6583905648023165,1.0,1/1,4.37%,KANK1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.9581673306772909,-1.2740650423595206,0.08333333333333333,0.7412994548926785,1.0,1/1,4.57%,SDC1
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),-0.9581673306772909,-1.2740650423595206,0.08333333333333333,0.7412994548926785,1.0,1/1,4.57%,SDC1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.9581673306772909,-1.2740650423595206,0.08333333333333333,0.7412994548926785,1.0,1/1,4.57%,SDC1
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.9581673306772909,-1.2740650423595206,0.08333333333333333,0.7412994548926785,1.0,1/1,4.57%,SDC1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.5375063216320305,1.2738523788832181,0.1781818181818182,0.6531485951316598,1.0,3/4,27.24%,LRP2;SOX8;MAMLD1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.5375063216320305,1.2738523788832181,0.1781818181818182,0.6531485951316598,1.0,3/4,27.24%,LRP2;SOX8;MAMLD1
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.5375063216320305,1.2738523788832181,0.1781818181818182,0.6531485951316598,1.0,3/4,27.24%,LRP2;SOX8;MAMLD1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.3594630843268942,1.2710052423594735,0.18878504672897195,0.6671398374706847,1.0,5/11,16.50%,OPHN1;RELN;DDIT4;SPOCK1;ANOS1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.7085828343313373,-1.2688520455928642,0.1752988047808765,0.774127247348788,1.0,2/2,29.62%,SDC1;RAB15
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.412121212121212,1.2679008244868728,0.2060491493383743,0.6827837096438139,1.0,8/8,59.44%,EFEMP1;SPIN4;ZNF217;ESRRG;NFIL3;ZNF146;NAB1;PPP2R1A
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.9402390438247011,-1.2656021319819137,0.09979633401221996,0.7913513383934417,1.0,1/1,6.36%,SLC10A4
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.24624138731344794,-1.2653182613420126,0.1945031712473573,0.7894224595475885,1.0,7/25,12.13%,CHI3L1;RIT2;MIF;TCIM;PHB2;VWF;LIF
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.37801321534107724,1.2635841920634423,0.1828358208955224,0.7036163820804963,1.0,5/9,25.05%,OPHN1;RELN;EFNA1;ANOS1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.9561752988047809,-1.2633349426110791,0.09467455621301775,0.7376403372633108,1.0,1/1,4.77%,DTX3L
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.9422310756972111,1.2631040087817438,0.12845849802371542,0.687215879385916,1.0,1/1,5.96%,CASQ1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.9422310756972111,1.2631040087817438,0.12845849802371542,0.687215879385916,1.0,1/1,5.96%,CASQ1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.9422310756972111,1.2631040087817438,0.12845849802371542,0.687215879385916,1.0,1/1,5.96%,CASQ1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.9422310756972111,1.2631040087817438,0.12845849802371542,0.687215879385916,1.0,1/1,5.96%,CASQ1
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.9422310756972111,1.2631040087817438,0.12845849802371542,0.687215879385916,1.0,1/1,5.96%,CASQ1
prerank,GO_Biological_Process_2021__positive regulation of store-operated calcium channel activity (GO:1901341),0.9422310756972111,1.2631040087817438,0.12845849802371542,0.687215879385916,1.0,1/1,5.96%,CASQ1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.9422310756972111,1.2631040087817438,0.12845849802371542,0.687215879385916,1.0,1/1,5.96%,CASQ1
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.7125748502994012,1.2607293175579706,0.16666666666666666,0.6893805418596122,1.0,2/2,29.03%,VEGFA;VIP
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.7125748502994012,1.2607293175579706,0.16666666666666666,0.6893805418596122,1.0,2/2,29.03%,VEGFA;VIP
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.7125748502994012,1.2607293175579706,0.16666666666666666,0.6893805418596122,1.0,2/2,29.03%,VEGFA;VIP
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.7125748502994012,1.2607293175579706,0.16666666666666666,0.6893805418596122,1.0,2/2,29.03%,VEGFA;VIP
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.950199203187251,1.2584117949490277,0.11811023622047244,0.6959411735546551,1.0,1/1,5.17%,RAD23B
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.950199203187251,1.2584117949490277,0.11811023622047244,0.6959411735546551,1.0,1/1,5.17%,RAD23B
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.950199203187251,1.2584117949490277,0.11811023622047244,0.6959411735546551,1.0,1/1,5.17%,RAD23B
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.3279205972469944,-1.2573710884475935,0.17872340425531916,0.772684808365828,1.0,5/12,11.13%,ISG15;NLRC5;CORO1A;PHB2;IFITM3
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__negative regulation of macrophage migration (GO:1905522),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__negative regulation of macrophage chemotaxis (GO:0010760),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.9521912350597609,-1.2573062565042632,0.11978221415607986,0.7231392658435596,1.0,1/1,5.17%,MIF
prerank,GO_Biological_Process_2021__positive regulation of gap junction assembly (GO:1903598),-0.946215139442231,-1.2569017066038148,0.11752577319587629,0.7147492602468757,1.0,1/1,5.77%,IRX3
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),-0.946215139442231,-1.2569017066038148,0.11752577319587629,0.7147492602468757,1.0,1/1,5.77%,IRX3
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.946215139442231,-1.2569017066038148,0.11752577319587629,0.7147492602468757,1.0,1/1,5.77%,IRX3
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.946215139442231,-1.2569017066038148,0.11752577319587629,0.7147492602468757,1.0,1/1,5.77%,IRX3
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.9442231075697212,1.256627783669143,0.13203883495145632,0.7033448660930365,1.0,1/1,5.77%,CNDP1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.606,1.2564012228788008,0.17086330935251798,0.6966930815087918,1.0,3/3,39.76%,FOS;JUN;ARHGEF18
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.606,1.2564012228788008,0.17086330935251798,0.6966930815087918,1.0,3/3,39.76%,FOS;JUN;ARHGEF18
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.606,1.2564012228788008,0.17086330935251798,0.6966930815087918,1.0,3/3,39.76%,FOS;JUN;ARHGEF18
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.944223107569721,-1.2536391350871174,0.11450381679389313,0.7148301645443473,1.0,1/1,5.96%,NLRC5
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.944223107569721,-1.2536391350871174,0.11450381679389313,0.7148301645443473,1.0,1/1,5.96%,NLRC5
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.944223107569721,-1.2536391350871174,0.11450381679389313,0.7148301645443473,1.0,1/1,5.96%,NLRC5
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.944223107569721,-1.2536391350871174,0.11450381679389313,0.7148301645443473,1.0,1/1,5.96%,NLRC5
prerank,GO_Biological_Process_2021__positive regulation of MHC class I biosynthetic process (GO:0045345),-0.944223107569721,-1.2536391350871174,0.11450381679389313,0.7148301645443473,1.0,1/1,5.96%,NLRC5
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.944223107569721,-1.2536391350871174,0.11450381679389313,0.7148301645443473,1.0,1/1,5.96%,NLRC5
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.944223107569721,-1.2536391350871174,0.11450381679389313,0.7148301645443473,1.0,1/1,5.96%,NLRC5
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.3093698969645491,1.252054381893154,0.18882466281310212,0.7116618419415671,1.0,7/15,17.50%,LTF;DEFA4;CEACAM8;LCN2;DNAJC3;FCGR3B;S100A12
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.3093698969645491,1.252054381893154,0.18882466281310212,0.7116618419415671,1.0,7/15,17.50%,LTF;DEFA4;CEACAM8;LCN2;DNAJC3;FCGR3B;S100A12
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.3093698969645491,1.252054381893154,0.18882466281310212,0.7116618419415671,1.0,7/15,17.50%,LTF;DEFA4;CEACAM8;LCN2;DNAJC3;FCGR3B;S100A12
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.7085828343313373,-1.250437184674438,0.18712273641851107,0.7249099270397382,1.0,2/2,29.62%,RAB3C;RAB15
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.7085828343313373,-1.250437184674438,0.18712273641851107,0.7249099270397382,1.0,2/2,29.62%,RAB3C;RAB15
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.7085828343313373,-1.250437184674438,0.18712273641851107,0.7249099270397382,1.0,2/2,29.62%,RAB3C;RAB15
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.9243027888446215,-1.2493735003998925,0.13861386138613863,0.6955816736873983,1.0,1/1,7.95%,BDNF
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.7165668662674651,1.2491926990459814,0.16255144032921812,0.7213411396931343,1.0,2/2,28.63%,JUN;TAF11
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.7165668662674651,1.2491926990459814,0.16255144032921812,0.7213411396931343,1.0,2/2,28.63%,JUN;TAF11
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.7125748502994012,1.2485130612399278,0.18055555555555555,0.7219459114245568,1.0,2/2,29.03%,LPAR1;VIP
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.24742954992608773,1.2466239729198325,0.20795660036166366,0.7288486459015002,1.0,4/25,2.98%,DKK1;LTF;CITED2;LRP2
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.9362549800796813,1.2436147146374628,0.12103174603174603,0.7322873113896935,1.0,1/1,6.56%,DDIT4
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.9362549800796813,1.2436147146374628,0.12103174603174603,0.7322873113896935,1.0,1/1,6.56%,DDIT4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.9362549800796813,1.2436147146374628,0.12103174603174603,0.7322873113896935,1.0,1/1,6.56%,DDIT4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.9362549800796813,1.2436147146374628,0.12103174603174603,0.7322873113896935,1.0,1/1,6.56%,DDIT4
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.9362549800796813,1.2436147146374628,0.12103174603174603,0.7322873113896935,1.0,1/1,6.56%,DDIT4
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.9342629482071713,-1.2422063223624298,0.13359528487229863,0.7212437315617652,1.0,1/1,6.96%,RBPMS2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),-0.9342629482071713,-1.2422063223624298,0.13359528487229863,0.7212437315617652,1.0,1/1,6.96%,RBPMS2
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),-0.9342629482071713,-1.2422063223624298,0.13359528487229863,0.7212437315617652,1.0,1/1,6.96%,RBPMS2
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),-0.9342629482071713,-1.2422063223624298,0.13359528487229863,0.7212437315617652,1.0,1/1,6.96%,RBPMS2
prerank,GO_Biological_Process_2021__negative regulation of muscle cell differentiation (GO:0051148),-0.9342629482071713,-1.2422063223624298,0.13359528487229863,0.7212437315617652,1.0,1/1,6.96%,RBPMS2
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.9262948207171314,-1.2416420632163947,0.12398373983739837,0.6909736475101781,1.0,1/1,7.75%,GPX1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.5358284742106043,1.2410304398453793,0.18336886993603413,0.7409590469469572,1.0,2/4,4.37%,CITED2;KANK1
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.5358284742106043,1.2410304398453793,0.18336886993603413,0.7409590469469572,1.0,2/4,4.37%,CITED2;KANK1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.7105788423153692,1.2394802461207348,0.1765834932821497,0.746490525342253,1.0,2/2,29.22%,LTF;CCNA2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.7085828343313373,1.2386642144298552,0.18679245283018867,0.7480372393410907,1.0,2/2,29.42%,LHPP;AK3
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.9183266932270916,-1.236670059072105,0.15463917525773196,0.705892040517035,1.0,1/1,8.55%,TCIM
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.9183266932270916,-1.236670059072105,0.15463917525773196,0.705892040517035,1.0,1/1,8.55%,TCIM
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),-0.9183266932270916,-1.236670059072105,0.15463917525773196,0.705892040517035,1.0,1/1,8.55%,TCIM
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),-0.9183266932270916,-1.236670059072105,0.15463917525773196,0.705892040517035,1.0,1/1,8.55%,TCIM
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.4799196787148594,-1.235969479295638,0.21063829787234042,0.7080430782604605,1.0,5/5,52.68%,DCTN1;DCTN3;PPP2R1A;OFD1;RAB3IP
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.41960210120153796,-1.2354817314029631,0.19162995594713655,0.708293571449663,1.0,6/7,43.14%,CDC7;DCTN1;DCTN3;ABCB1;PPP2R1A;OFD1
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.9143426294820717,1.2353133718845961,0.16795366795366795,0.7613580525878672,1.0,1/1,8.75%,OTUD1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.5195728351832293,-1.2340702265611825,0.20773930753564154,0.7119147169322735,1.0,2/4,7.95%,FABP5;BDNF
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.3632526844196943,1.233605580719828,0.19573643410852712,0.7674230372108237,1.0,3/9,10.74%,DKK1;CITED2;EGR1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.9163346613545816,1.2314948683132767,0.15811088295687886,0.7698259884806288,1.0,1/1,8.55%,MAN2A1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.9163346613545816,1.2314948683132767,0.15811088295687886,0.7698259884806288,1.0,1/1,8.55%,MAN2A1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.9163346613545816,1.2314948683132767,0.15811088295687886,0.7698259884806288,1.0,1/1,8.55%,MAN2A1
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),-0.9362549800796812,-1.2310439017089216,0.13877551020408163,0.7056710990552206,1.0,1/1,6.76%,CXCL8
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.9362549800796812,-1.2310439017089216,0.13877551020408163,0.7056710990552206,1.0,1/1,6.76%,CXCL8
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.9362549800796812,-1.2310439017089216,0.13877551020408163,0.7056710990552206,1.0,1/1,6.76%,CXCL8
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.9362549800796812,-1.2310439017089216,0.13877551020408163,0.7056710990552206,1.0,1/1,6.76%,CXCL8
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.9362549800796812,-1.2310439017089216,0.13877551020408163,0.7056710990552206,1.0,1/1,6.76%,CXCL8
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.9362549800796812,-1.2310439017089216,0.13877551020408163,0.7056710990552206,1.0,1/1,6.76%,CXCL8
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.9362549800796812,-1.2310439017089216,0.13877551020408163,0.7056710990552206,1.0,1/1,6.76%,CXCL8
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.9362549800796812,-1.2310439017089216,0.13877551020408163,0.7056710990552206,1.0,1/1,6.76%,CXCL8
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.9362549800796812,-1.2310439017089216,0.13877551020408163,0.7056710990552206,1.0,1/1,6.76%,CXCL8
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.9362549800796812,-1.2310439017089216,0.13877551020408163,0.7056710990552206,1.0,1/1,6.76%,CXCL8
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.18783186515855202,1.226987534784166,0.22743055555555555,0.7919343269238707,1.0,35/56,47.51%,DKK1;FOS;CITED2;NKX2-3;EGR1;ID3;EFNA1;ZNF217;EPC2;ZNF420;JUN;ZNF521;SOX8;ZNF397;VEGFA;IER5;ZNF232;MAMLD1;ZNF462;ZNF813;ABRA;TET1;ESRRG;ZIC2;STAT4;NFIL3;ZNF146;ZNF528;ZNF816;ZNF468;TAF9B;ZNF222;ZNF850;BMI1;TBK1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.3952942817810308,-1.2258890505113664,0.21174004192872117,0.7275600969060503,1.0,5/7,31.61%,RIT2;PSMB9;PSMB8;FGF9;PTPN3
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.42454728370221334,-1.2258535484057744,0.24034334763948498,0.7234445689751673,1.0,6/6,58.25%,PPP2R1A;PSRC1;CDKN2AIP;HSPA1A;HSPA1B;CYP27B1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.42454728370221334,-1.2258535484057744,0.24034334763948498,0.7234445689751673,1.0,6/6,58.25%,PPP2R1A;PSRC1;CDKN2AIP;HSPA1A;HSPA1B;CYP27B1
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.9063745019920318,-1.2244679653192205,0.18200836820083682,0.7282178457824112,1.0,1/1,9.74%,TMSB10
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__activation of protein kinase C activity (GO:1990051),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__regulation of cytochrome-c oxidase activity (GO:1904959),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.9143426294820717,-1.221836185181969,0.1689059500959693,0.7051601632453739,1.0,1/1,8.95%,PHB2
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.7045908183632734,-1.2217889589196038,0.24110671936758893,0.7032274129449763,1.0,2/2,30.02%,SYT4;RIMS3
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.7025948103792414,-1.219161023438713,0.25048923679060664,0.7139078909621346,1.0,2/2,30.22%,INSM1;FAM110C
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.6906187624750498,1.2179780020148951,0.1980952380952381,0.8356248711372697,1.0,2/2,31.21%,CHMP4C;LEMD3
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.5897252577431048,-1.2165689916332896,0.24435318275154005,0.720885320681395,1.0,1/3,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.5897252577431048,-1.2165689916332896,0.24435318275154005,0.720885320681395,1.0,1/3,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.5897252577431048,-1.2165689916332896,0.24435318275154005,0.720885320681395,1.0,1/3,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.9103585657370518,-1.2161098422478345,0.18363273453093812,0.7084932141419378,1.0,1/1,9.34%,EGR2
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.9103585657370518,-1.2161098422478345,0.18363273453093812,0.7084932141419378,1.0,1/1,9.34%,EGR2
prerank,GO_Biological_Process_2021__skeletal muscle cell differentiation (GO:0035914),-0.9103585657370518,-1.2161098422478345,0.18363273453093812,0.7084932141419378,1.0,1/1,9.34%,EGR2
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.9103585657370518,-1.2161098422478345,0.18363273453093812,0.7084932141419378,1.0,1/1,9.34%,EGR2
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.9103585657370518,-1.2161098422478345,0.18363273453093812,0.7084932141419378,1.0,1/1,9.34%,EGR2
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.9103585657370518,-1.2161098422478345,0.18363273453093812,0.7084932141419378,1.0,1/1,9.34%,EGR2
prerank,GO_Biological_Process_2021__Schwann cell differentiation (GO:0014037),-0.9103585657370518,-1.2161098422478345,0.18363273453093812,0.7084932141419378,1.0,1/1,9.34%,EGR2
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.9083665338645417,1.2124516684116151,0.16764132553606237,0.8619126664129405,1.0,1/1,9.34%,KIAA1217
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.898406374501992,1.2109471459457724,0.20481927710843373,0.8646709314728943,1.0,1/1,10.34%,DHX33
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.898406374501992,1.2109471459457724,0.20481927710843373,0.8646709314728943,1.0,1/1,10.34%,DHX33
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.5150300601202408,1.2107368973358192,0.21455223880597016,0.8624594984068454,1.0,4/4,48.91%,VEGFA;IRAK3;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.5190380761523046,-1.2103037770492127,0.24242424242424243,0.7314478051518625,1.0,4/4,48.71%,ISG15;PLPP3;MYH9;ITGB6
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2897667101452714,1.209867963253048,0.2237093690248566,0.8641013540476452,1.0,9/15,36.78%,CITED2;ID3;ZNF217;JUN;SOX8;TOB1;CAPN3;ZIC2;NFIL3
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.688622754491018,-1.209697181026087,0.2198443579766537,0.7325410304121093,1.0,2/2,31.61%,PHB2;PTPN3
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.896414342629482,-1.2062412482496505,0.208955223880597,0.7458972319582858,1.0,1/1,10.74%,VWF
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.688622754491018,-1.2057281848399815,0.2332695984703633,0.7461369219492199,1.0,2/2,31.61%,GLRX;PTPN3
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.6826347305389222,1.2051928282242224,0.20415879017013233,0.887327354178836,1.0,2/2,32.01%,KANK1;MYLK
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.6826347305389222,1.2044408416589256,0.21135029354207435,0.8885446267870235,1.0,2/2,32.01%,CASQ1;MYLK
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.6726546906187626,1.2034426849629523,0.20594059405940593,0.8906773484317551,1.0,2/2,33.00%,CEP120;CORO2B
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.8944223107569721,1.2033694411494817,0.20041753653444677,0.8595916862012367,1.0,1/1,10.74%,EGR1
prerank,GO_Biological_Process_2021__regulation of hormone biosynthetic process (GO:0046885),0.8944223107569721,1.2033694411494817,0.20041753653444677,0.8595916862012367,1.0,1/1,10.74%,EGR1
prerank,GO_Biological_Process_2021__cellular response to heparin (GO:0071504),0.8944223107569721,1.2033694411494817,0.20041753653444677,0.8595916862012367,1.0,1/1,10.74%,EGR1
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),0.8944223107569721,1.2033694411494817,0.20041753653444677,0.8595916862012367,1.0,1/1,10.74%,EGR1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.8944223107569721,1.2033694411494817,0.20041753653444677,0.8595916862012367,1.0,1/1,10.74%,EGR1
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.8944223107569721,1.2033694411494817,0.20041753653444677,0.8595916862012367,1.0,1/1,10.74%,EGR1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.8944223107569721,1.2033694411494817,0.20041753653444677,0.8595916862012367,1.0,1/1,10.74%,EGR1
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.8944223107569721,1.2033694411494817,0.20041753653444677,0.8595916862012367,1.0,1/1,10.74%,EGR1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.8944223107569721,1.2033694411494817,0.20041753653444677,0.8595916862012367,1.0,1/1,10.74%,EGR1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.8944223107569721,1.2033694411494817,0.20041753653444677,0.8595916862012367,1.0,1/1,10.74%,EGR1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.8944223107569721,1.2033694411494817,0.20041753653444677,0.8595916862012367,1.0,1/1,10.74%,EGR1
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.569677222254615,1.2011675107373305,0.23745173745173745,0.8680798533975281,1.0,2/3,20.28%,CITED2;JUN
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.4572488040323366,-1.2011374503805357,0.2334047109207709,0.7650919555153868,1.0,3/5,13.12%,HBA1;CXCL8;AP2M1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.9043824701195219,1.199761703514364,0.1811175337186898,0.861381164445203,1.0,1/1,9.74%,PLOD2
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.9043824701195219,1.199761703514364,0.1811175337186898,0.861381164445203,1.0,1/1,9.74%,PLOD2
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.9043824701195219,1.199761703514364,0.1811175337186898,0.861381164445203,1.0,1/1,9.74%,PLOD2
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.9043824701195219,1.199761703514364,0.1811175337186898,0.861381164445203,1.0,1/1,9.74%,PLOD2
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.9043824701195219,1.199761703514364,0.1811175337186898,0.861381164445203,1.0,1/1,9.74%,PLOD2
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.4014317538435719,1.1987160744749135,0.25851703406813625,0.8642966753302057,1.0,2/7,4.37%,DKK1;KANK1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.9083665338645418,-1.1960655737704924,0.21951219512195122,0.7823526047728586,1.0,1/1,9.54%,KNDC1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.9083665338645418,-1.1960655737704924,0.21951219512195122,0.7823526047728586,1.0,1/1,9.54%,KNDC1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.39517033248753375,1.1957340503580614,0.24045801526717558,0.8754190857758366,1.0,3/7,12.72%,KANK1;SPOCK1;EFNA1
prerank,GO_Biological_Process_2021__norepinephrine biosynthetic process (GO:0042421),-0.900398406374502,-1.195274637537442,0.2153846153846154,0.7610028733707561,1.0,1/1,10.34%,INSM1
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.900398406374502,-1.195274637537442,0.2153846153846154,0.7610028733707561,1.0,1/1,10.34%,INSM1
prerank,GO_Biological_Process_2021__glandular epithelial cell differentiation (GO:0002067),-0.900398406374502,-1.195274637537442,0.2153846153846154,0.7610028733707561,1.0,1/1,10.34%,INSM1
prerank,GO_Biological_Process_2021__enteroendocrine cell differentiation (GO:0035883),-0.900398406374502,-1.195274637537442,0.2153846153846154,0.7610028733707561,1.0,1/1,10.34%,INSM1
prerank,GO_Biological_Process_2021__norepinephrine metabolic process (GO:0042415),-0.900398406374502,-1.195274637537442,0.2153846153846154,0.7610028733707561,1.0,1/1,10.34%,INSM1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.900398406374502,-1.195274637537442,0.2153846153846154,0.7610028733707561,1.0,1/1,10.34%,INSM1
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),-0.900398406374502,-1.195274637537442,0.2153846153846154,0.7610028733707561,1.0,1/1,10.34%,INSM1
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),-0.900398406374502,-1.195274637537442,0.2153846153846154,0.7610028733707561,1.0,1/1,10.34%,INSM1
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.900398406374502,-1.195274637537442,0.2153846153846154,0.7610028733707561,1.0,1/1,10.34%,INSM1
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),-0.900398406374502,-1.195274637537442,0.2153846153846154,0.7610028733707561,1.0,1/1,10.34%,INSM1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.900398406374502,-1.195274637537442,0.2153846153846154,0.7610028733707561,1.0,1/1,10.34%,INSM1
prerank,GO_Biological_Process_2021__noradrenergic neuron differentiation (GO:0003357),-0.900398406374502,-1.195274637537442,0.2153846153846154,0.7610028733707561,1.0,1/1,10.34%,INSM1
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.3438959229795969,-1.195157142277776,0.23395445134575568,0.7596101535292793,1.0,4/10,14.71%,ISG15;DTX3L;PSMB9;PSMB8
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.5820000000000001,1.1944672360990232,0.2619047619047619,0.8787957456107578,1.0,3/3,42.15%,LRP2;RYR3;CYP27B1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.8824701195219123,-1.19401180068982,0.19919517102615694,0.7408367245487294,1.0,1/1,12.13%,LIF
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698),-0.8824701195219123,-1.19401180068982,0.19919517102615694,0.7408367245487294,1.0,1/1,12.13%,LIF
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),-0.8824701195219123,-1.19401180068982,0.19919517102615694,0.7408367245487294,1.0,1/1,12.13%,LIF
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.8824701195219123,-1.19401180068982,0.19919517102615694,0.7408367245487294,1.0,1/1,12.13%,LIF
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.8824701195219123,-1.19401180068982,0.19919517102615694,0.7408367245487294,1.0,1/1,12.13%,LIF
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.8824701195219123,-1.19401180068982,0.19919517102615694,0.7408367245487294,1.0,1/1,12.13%,LIF
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),-0.8824701195219123,-1.19401180068982,0.19919517102615694,0.7408367245487294,1.0,1/1,12.13%,LIF
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.8824701195219123,-1.19401180068982,0.19919517102615694,0.7408367245487294,1.0,1/1,12.13%,LIF
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.8824701195219123,-1.19401180068982,0.19919517102615694,0.7408367245487294,1.0,1/1,12.13%,LIF
prerank,GO_Biological_Process_2021__regulation of nephron tubule epithelial cell differentiation (GO:0072182),-0.8824701195219123,-1.19401180068982,0.19919517102615694,0.7408367245487294,1.0,1/1,12.13%,LIF
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),-0.8824701195219123,-1.19401180068982,0.19919517102615694,0.7408367245487294,1.0,1/1,12.13%,LIF
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.8824701195219123,-1.19401180068982,0.19919517102615694,0.7408367245487294,1.0,1/1,12.13%,LIF
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.568,1.1938677674662652,0.2438095238095238,0.8762080898368456,1.0,3/3,43.54%,SLC6A6;SLC6A16;HCN1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.568,1.1938677674662652,0.2438095238095238,0.8762080898368456,1.0,3/3,43.54%,SLC6A6;SLC6A16;HCN1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.6626746506986028,1.1911570108386318,0.2176360225140713,0.8728660857571799,1.0,2/2,34.00%,CASQ1;CAPN3
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6626746506986028,1.1911570108386318,0.2176360225140713,0.8728660857571799,1.0,2/2,34.00%,CASQ1;CAPN3
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.6626746506986028,1.1911570108386318,0.2176360225140713,0.8728660857571799,1.0,2/2,34.00%,CASQ1;CAPN3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.6626746506986028,1.1911570108386318,0.2176360225140713,0.8728660857571799,1.0,2/2,34.00%,CASQ1;CAPN3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.6626746506986028,1.1911570108386318,0.2176360225140713,0.8728660857571799,1.0,2/2,34.00%,CASQ1;CAPN3
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.6626746506986028,1.1911570108386318,0.2176360225140713,0.8728660857571799,1.0,2/2,34.00%,CASQ1;CAPN3
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.5150300601202404,-1.1896091918079459,0.246,0.7585456884389559,1.0,4/4,49.11%,ATP6V0D1;IRS4;RAB15;EPRS1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.6666666666666666,-1.187805698775734,0.22478991596638656,0.7649336460290623,1.0,2/2,33.80%,CDH8;CNTNAP1
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.6626746506986029,1.1875937471784839,0.2222222222222222,0.8878876053723498,1.0,2/2,34.00%,EGR1;CAPN3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5050100200400802,1.1867220544261756,0.2514506769825919,0.8895435686576976,1.0,4/4,49.90%,CITED2;LEMD3;HSPA1A;ZNF451
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.8804780876494024,-1.1849308625717232,0.23196881091617932,0.7741739366762411,1.0,1/1,12.33%,CNTN6
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.5752203658789032,1.1844019893158162,0.25475285171102663,0.8971974373318816,1.0,2/3,11.53%,SLC6A6;SLC3A1
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),0.8864541832669323,1.1835350864508667,0.23883495145631067,0.8988804525931959,1.0,1/1,11.53%,SLC3A1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6694322728479658,1.1829737449398439,0.21442495126705652,0.8988902269278163,1.0,1/2,0.20%,DKK1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.6726546906187626,1.1818100218355063,0.22672064777327935,0.9004685569791682,1.0,2/2,33.00%,SPOCK1;CORO2B
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.6726546906187626,1.1818100218355063,0.22672064777327935,0.9004685569791682,1.0,2/2,33.00%,SPOCK1;CORO2B
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.3818978678308625,1.1809195475450038,0.25903614457831325,0.9012594315639216,1.0,3/8,10.14%,LRP2;LRP1B;RAB20
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.5069631146345285,1.1804978310894718,0.25572519083969464,0.900533944512114,1.0,3/4,27.63%,KANK1;SPOCK1;LPAR1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.5048551135560452,-1.1799335055164435,0.27586206896551724,0.792649470827188,1.0,3/4,27.04%,PSMB9;PSMB8;HMGCR
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.6706586826347305,-1.1794457301764947,0.246,0.7921290940766043,1.0,2/2,33.40%,FIS1;TNFRSF12A
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8924302788844621,-1.1792866049257724,0.22267206477732793,0.7813262167939884,1.0,1/1,11.13%,IFITM3
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.8924302788844621,-1.1792866049257724,0.22267206477732793,0.7813262167939884,1.0,1/1,11.13%,IFITM3
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.8924302788844621,-1.1792866049257724,0.22267206477732793,0.7813262167939884,1.0,1/1,11.13%,IFITM3
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.8924302788844621,-1.1792866049257724,0.22267206477732793,0.7813262167939884,1.0,1/1,11.13%,IFITM3
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.8924302788844621,-1.1792866049257724,0.22267206477732793,0.7813262167939884,1.0,1/1,11.13%,IFITM3
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.8924302788844621,-1.1792866049257724,0.22267206477732793,0.7813262167939884,1.0,1/1,11.13%,IFITM3
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.8924302788844621,1.1789352257160821,0.21135029354207435,0.8950201735550297,1.0,1/1,10.93%,BBS5
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.8924302788844621,1.1789352257160821,0.21135029354207435,0.8950201735550297,1.0,1/1,10.93%,BBS5
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.8924302788844621,1.1789352257160821,0.21135029354207435,0.8950201735550297,1.0,1/1,10.93%,BBS5
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.8924302788844621,1.1789352257160821,0.21135029354207435,0.8950201735550297,1.0,1/1,10.93%,BBS5
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.8924302788844621,1.1789352257160821,0.21135029354207435,0.8950201735550297,1.0,1/1,10.93%,BBS5
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.8685258964143426,-1.1788494718680314,0.22568093385214008,0.7808150845439117,1.0,1/1,13.52%,ACO2
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.32957964213345026,1.1787282948568703,0.24158415841584158,0.8930647553134111,1.0,3/10,10.74%,DKK1;CITED2;EGR1
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.4597958853723929,1.1777795615617626,0.25842696629213485,0.8950874444059712,1.0,3/5,21.07%,EFNA1;EFEMP1;SOX8
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.900398406374502,1.177595483439633,0.23421588594704684,0.8933402733516368,1.0,1/1,10.14%,RAB20
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.3952868613566087,1.176044011254716,0.2629558541266795,0.8974773885145725,1.0,4/7,25.05%,SLC6A6;RELN;SOX8;VEGFA
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5050100200400801,-1.1755706976863116,0.26260504201680673,0.7913964127560108,1.0,4/4,50.10%,RPLP2;PPP2R1A;EIF4G1;PAN2
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.655070148639797,1.1738395220533944,0.22828282828282828,0.9000720828341269,1.0,1/2,1.59%,OPHN1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.655070148639797,1.1738395220533944,0.22828282828282828,0.9000720828341269,1.0,1/2,1.59%,OPHN1
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.655070148639797,1.1738395220533944,0.22828282828282828,0.9000720828341269,1.0,1/2,1.59%,OPHN1
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.8904382470119522,1.1736344262538243,0.2297551789077213,0.8957027252193367,1.0,1/1,11.13%,NAA25
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.8904382470119522,1.1736344262538243,0.2297551789077213,0.8957027252193367,1.0,1/1,11.13%,NAA25
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.4989979959919839,-1.173563676186555,0.2604166666666667,0.7949656283274543,1.0,4/4,50.70%,CLSTN2;RIMS3;WLS;CDKN2AIP
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.4989979959919839,-1.173563676186555,0.2604166666666667,0.7949656283274543,1.0,4/4,50.70%,CLSTN2;RIMS3;WLS;CDKN2AIP
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.5580514220181473,-1.1732657021779074,0.2595573440643863,0.794265918772311,1.0,2/3,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.8745019920318725,1.1725125498777187,0.22088353413654618,0.8687236044515961,1.0,1/1,12.72%,EFNA1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.8745019920318725,1.1725125498777187,0.22088353413654618,0.8687236044515961,1.0,1/1,12.72%,EFNA1
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.8745019920318725,1.1725125498777187,0.22088353413654618,0.8687236044515961,1.0,1/1,12.72%,EFNA1
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.8745019920318725,1.1725125498777187,0.22088353413654618,0.8687236044515961,1.0,1/1,12.72%,EFNA1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.8745019920318725,1.1725125498777187,0.22088353413654618,0.8687236044515961,1.0,1/1,12.72%,EFNA1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.8745019920318725,1.1725125498777187,0.22088353413654618,0.8687236044515961,1.0,1/1,12.72%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.8745019920318725,1.1725125498777187,0.22088353413654618,0.8687236044515961,1.0,1/1,12.72%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.8745019920318725,1.1725125498777187,0.22088353413654618,0.8687236044515961,1.0,1/1,12.72%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.8745019920318725,1.1725125498777187,0.22088353413654618,0.8687236044515961,1.0,1/1,12.72%,EFNA1
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.8745019920318725,1.1725125498777187,0.22088353413654618,0.8687236044515961,1.0,1/1,12.72%,EFNA1
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.8745019920318725,1.1725125498777187,0.22088353413654618,0.8687236044515961,1.0,1/1,12.72%,EFNA1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.8745019920318725,1.1725125498777187,0.22088353413654618,0.8687236044515961,1.0,1/1,12.72%,EFNA1
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.8745019920318725,1.1725125498777187,0.22088353413654618,0.8687236044515961,1.0,1/1,12.72%,EFNA1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.8804780876494023,1.1719696969696975,0.226890756302521,0.8689289239618619,1.0,1/1,12.13%,KBTBD7
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.5028656021189848,-1.1713182452280364,0.28542094455852157,0.7996682325269088,1.0,3/4,20.68%,ATP6V0D1;DCTN1;ACADVL
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.8725099601593626,-1.171314741035857,0.24489795918367346,0.7843489117410736,1.0,1/1,13.12%,AP2M1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.8725099601593626,-1.171314741035857,0.24489795918367346,0.7843489117410736,1.0,1/1,13.12%,AP2M1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.8725099601593626,-1.171314741035857,0.24489795918367346,0.7843489117410736,1.0,1/1,13.12%,AP2M1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.8725099601593626,-1.171314741035857,0.24489795918367346,0.7843489117410736,1.0,1/1,13.12%,AP2M1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.8725099601593626,-1.171314741035857,0.24489795918367346,0.7843489117410736,1.0,1/1,13.12%,AP2M1
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.8725099601593626,-1.171314741035857,0.24489795918367346,0.7843489117410736,1.0,1/1,13.12%,AP2M1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.8725099601593626,-1.171314741035857,0.24489795918367346,0.7843489117410736,1.0,1/1,13.12%,AP2M1
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.8725099601593626,-1.171314741035857,0.24489795918367346,0.7843489117410736,1.0,1/1,13.12%,AP2M1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.6506986027944112,-1.1712180394508094,0.2729124236252546,0.7828608536616803,1.0,2/2,35.39%,FIS1;ALDH1A1
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.8764940239043824,1.1691410092604118,0.2765957446808511,0.8782418893661648,1.0,1/1,12.52%,DNAJC3
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.6686626746506985,-1.1681798654913567,0.2785977859778598,0.7927937699705979,1.0,2/2,33.60%,MIF;THAP4
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.56,-1.1678446808422018,0.2959830866807611,0.7924206643387062,1.0,3/3,44.53%,NLRC5;CCL21;ABCB10
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.6642287887624947,1.1675702642698786,0.2737864077669903,0.8825204715251015,1.0,1/2,1.39%,LTF
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.8685258964143426,1.1674300836552507,0.2543689320388349,0.8739784757129601,1.0,1/1,13.32%,FCGR3A
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.8685258964143426,1.1674300836552507,0.2543689320388349,0.8739784757129601,1.0,1/1,13.32%,FCGR3A
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.8685258964143426,1.1674300836552507,0.2543689320388349,0.8739784757129601,1.0,1/1,13.32%,FCGR3A
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.8685258964143426,1.1674300836552507,0.2543689320388349,0.8739784757129601,1.0,1/1,13.32%,FCGR3A
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.3670501413037034,1.1670493984616033,0.2594059405940594,0.8733715225509833,1.0,2/8,4.37%,DKK1;KANK1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.3290990883363429,1.1669894412732156,0.27984344422700586,0.8714108038770236,1.0,3/11,4.77%,CITED2;KANK1;RELN
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.8705179282868526,1.166370106761566,0.23958333333333334,0.8714354168955089,1.0,1/1,13.12%,FANCL
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.8625498007968128,-1.1662478165323718,0.26359832635983266,0.7928494817600097,1.0,1/1,14.12%,CYP27C1
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.8625498007968128,-1.1662478165323718,0.26359832635983266,0.7928494817600097,1.0,1/1,14.12%,CYP27C1
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.8625498007968128,-1.1662478165323718,0.26359832635983266,0.7928494817600097,1.0,1/1,14.12%,CYP27C1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.6626746506986028,1.1640005456324147,0.23694779116465864,0.8802097115059188,1.0,2/2,34.00%,CHODL;CAPN3
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.2615641536308622,1.1635886538340696,0.2640449438202247,0.8791840289610239,1.0,3/18,2.58%,DKK1;SLC6A6;CITED2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.4889779559118236,-1.163541215314267,0.26292134831460673,0.8004889159930823,1.0,4/4,51.69%,DCTN1;PSRC1;HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.5560315797729132,1.1633518185626828,0.26356589147286824,0.8781690407013623,1.0,2/3,12.72%,RELN;EFNA1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.554,-1.1630348461868885,0.2680851063829787,0.8003759646060891,1.0,3/3,45.13%,PHB2;CDC7;EIF4G1
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.8725099601593626,1.1627904492281393,0.23943661971830985,0.8787511322119453,1.0,1/1,12.92%,RMI1
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.6626746506986029,1.1625947531223304,0.24703557312252963,0.8770957417908095,1.0,2/2,34.00%,MYLK;CAPN3
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.6416328682194178,-1.1622950305244384,0.2637795275590551,0.7998957986197812,1.0,1/2,2.98%,AHNAK2
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.6416328682194178,-1.1622950305244384,0.2637795275590551,0.7998957986197812,1.0,1/2,2.98%,AHNAK2
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.4538152610441767,-1.1621293643238515,0.2788844621513944,0.7985588581848955,1.0,5/5,55.27%,BDNF;SYT4;EIF4G1;CDKN2AIP;TAF9B
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.8705179282868526,-1.1614602597567283,0.2624254473161034,0.7866134843740088,1.0,1/1,13.32%,STMN1
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.8705179282868526,-1.1614602597567283,0.2624254473161034,0.7866134843740088,1.0,1/1,13.32%,STMN1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.8705179282868526,-1.1614602597567283,0.2624254473161034,0.7866134843740088,1.0,1/1,13.32%,STMN1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.8705179282868526,-1.1614602597567283,0.2624254473161034,0.7866134843740088,1.0,1/1,13.32%,STMN1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.8705179282868526,-1.1614602597567283,0.2624254473161034,0.7866134843740088,1.0,1/1,13.32%,STMN1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.8705179282868526,-1.1614602597567283,0.2624254473161034,0.7866134843740088,1.0,1/1,13.32%,STMN1
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.8705179282868526,-1.1614602597567283,0.2624254473161034,0.7866134843740088,1.0,1/1,13.32%,STMN1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.8705179282868526,-1.1614602597567283,0.2624254473161034,0.7866134843740088,1.0,1/1,13.32%,STMN1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.40692735488072646,-1.1614035482753746,0.2710843373493976,0.7851639147119006,1.0,4/6,29.42%,SDC1;SDC3;CHSY3;DSEL
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.41152889213416105,-1.1602675548765107,0.2962962962962963,0.7870940277319851,1.0,3/6,14.71%,CXCL8;PSMB9;PSMB8
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.8745019920318725,-1.16017157610132,0.24807692307692308,0.7732390141902122,1.0,1/1,12.92%,ATP6V0D1
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.8745019920318725,-1.16017157610132,0.24807692307692308,0.7732390141902122,1.0,1/1,12.92%,ATP6V0D1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.8745019920318725,-1.16017157610132,0.24807692307692308,0.7732390141902122,1.0,1/1,12.92%,ATP6V0D1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.8745019920318725,-1.16017157610132,0.24807692307692308,0.7732390141902122,1.0,1/1,12.92%,ATP6V0D1
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.8745019920318725,-1.16017157610132,0.24807692307692308,0.7732390141902122,1.0,1/1,12.92%,ATP6V0D1
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.8745019920318725,-1.16017157610132,0.24807692307692308,0.7732390141902122,1.0,1/1,12.92%,ATP6V0D1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.8745019920318725,-1.16017157610132,0.24807692307692308,0.7732390141902122,1.0,1/1,12.92%,ATP6V0D1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.8745019920318725,-1.16017157610132,0.24807692307692308,0.7732390141902122,1.0,1/1,12.92%,ATP6V0D1
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.40738569790108126,-1.1598790421618774,0.298989898989899,0.7727151985610515,1.0,3/6,11.13%,ISG15;CXCL8;IFITM3
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.546,-1.1597267645103353,0.24066390041493776,0.7714142894395326,1.0,3/3,45.92%,EGR2;NXF1;XPO4
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.8625498007968126,1.159208243296466,0.2504970178926441,0.8826003934349238,1.0,1/1,13.92%,METTL21C
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.8625498007968126,1.159208243296466,0.2504970178926441,0.8826003934349238,1.0,1/1,13.92%,METTL21C
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.8625498007968126,1.159208243296466,0.2504970178926441,0.8826003934349238,1.0,1/1,13.92%,METTL21C
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.8625498007968126,1.159208243296466,0.2504970178926441,0.8826003934349238,1.0,1/1,13.92%,METTL21C
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.652694610778443,-1.15691628184376,0.2784552845528455,0.78021557956615,1.0,2/2,35.19%,SDC1;PLD3
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.6626746506986028,1.1565013233417571,0.248046875,0.8914977137077733,1.0,2/2,34.00%,TRHDE;CAPN3
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),-0.8784860557768924,-1.155674657111084,0.27111984282907664,0.7731533175225458,1.0,1/1,12.52%,EOMES
prerank,GO_Biological_Process_2021__endodermal cell fate specification (GO:0001714),-0.8784860557768924,-1.155674657111084,0.27111984282907664,0.7731533175225458,1.0,1/1,12.52%,EOMES
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.8784860557768924,-1.155674657111084,0.27111984282907664,0.7731533175225458,1.0,1/1,12.52%,EOMES
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.8784860557768924,-1.155674657111084,0.27111984282907664,0.7731533175225458,1.0,1/1,12.52%,EOMES
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),-0.8784860557768924,-1.155674657111084,0.27111984282907664,0.7731533175225458,1.0,1/1,12.52%,EOMES
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.8784860557768924,-1.155674657111084,0.27111984282907664,0.7731533175225458,1.0,1/1,12.52%,EOMES
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),-0.8784860557768924,-1.155674657111084,0.27111984282907664,0.7731533175225458,1.0,1/1,12.52%,EOMES
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.6666666666666666,-1.155443969096326,0.26195426195426197,0.7723507109011112,1.0,2/2,33.80%,BDNF;CNTNAP1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.6566866267465069,-1.152064225435716,0.27655310621242485,0.7832843102142458,1.0,2/2,34.79%,CCK;GAP43
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.8665338645418327,-1.1518484570730223,0.2670940170940171,0.7722438700945363,1.0,1/1,13.72%,SLC18A2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.8665338645418327,-1.1518484570730223,0.2670940170940171,0.7722438700945363,1.0,1/1,13.72%,SLC18A2
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),-0.8665338645418327,-1.1518484570730223,0.2670940170940171,0.7722438700945363,1.0,1/1,13.72%,SLC18A2
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),-0.8665338645418327,-1.1518484570730223,0.2670940170940171,0.7722438700945363,1.0,1/1,13.72%,SLC18A2
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.8665338645418327,-1.1518484570730223,0.2670940170940171,0.7722438700945363,1.0,1/1,13.72%,SLC18A2
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.8665338645418327,-1.1518484570730223,0.2670940170940171,0.7722438700945363,1.0,1/1,13.72%,SLC18A2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.8665338645418327,-1.1518484570730223,0.2670940170940171,0.7722438700945363,1.0,1/1,13.72%,SLC18A2
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.654690618762475,1.1517880177036262,0.241635687732342,0.9072121971462378,1.0,2/2,34.79%,LPAR1;ABRA
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.654690618762475,1.1517880177036262,0.241635687732342,0.9072121971462378,1.0,2/2,34.79%,LPAR1;ABRA
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.6586826347305389,-1.1514673365342827,0.29690721649484536,0.7722869175352122,1.0,2/2,34.59%,THAP4;ASRGL1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.6496909832641383,1.151293562755779,0.24660194174757283,0.907453374169195,1.0,1/2,2.58%,CITED2
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.8645418326693227,1.1508790396858333,0.2633587786259542,0.900058564087845,1.0,1/1,13.72%,ARHGAP11B
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.8645418326693227,1.1508790396858333,0.2633587786259542,0.900058564087845,1.0,1/1,13.72%,ARHGAP11B
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.8645418326693227,1.1508790396858333,0.2633587786259542,0.900058564087845,1.0,1/1,13.72%,ARHGAP11B
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.8645418326693227,1.1508790396858333,0.2633587786259542,0.900058564087845,1.0,1/1,13.72%,ARHGAP11B
prerank,GO_Biological_Process_2021__L-aspartate transmembrane transport (GO:0070778),0.8525896414342629,1.1499368862888628,0.2830188679245283,0.8875915145796262,1.0,1/1,14.91%,SLC1A3
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.8525896414342629,1.1499368862888628,0.2830188679245283,0.8875915145796262,1.0,1/1,14.91%,SLC1A3
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.8525896414342629,1.1499368862888628,0.2830188679245283,0.8875915145796262,1.0,1/1,14.91%,SLC1A3
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.8525896414342629,1.1499368862888628,0.2830188679245283,0.8875915145796262,1.0,1/1,14.91%,SLC1A3
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.8525896414342629,1.1499368862888628,0.2830188679245283,0.8875915145796262,1.0,1/1,14.91%,SLC1A3
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.8525896414342629,1.1499368862888628,0.2830188679245283,0.8875915145796262,1.0,1/1,14.91%,SLC1A3
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.8525896414342629,1.1499368862888628,0.2830188679245283,0.8875915145796262,1.0,1/1,14.91%,SLC1A3
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.654690618762475,-1.1476871188929192,0.2975708502024291,0.7831695428654853,1.0,2/2,34.99%,GPX1;GUK1
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.4417670682730923,1.14753013770638,0.28790786948176583,0.8954171894253226,1.0,5/5,56.26%,VEGFA;CDHR1;PCARE;TOPORS;RP1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.8545816733067729,-1.1467694405230306,0.27710843373493976,0.781735434868128,1.0,1/1,14.91%,ITM2C
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.8545816733067729,-1.1467694405230306,0.27710843373493976,0.781735434868128,1.0,1/1,14.91%,ITM2C
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.8545816733067729,-1.1467694405230306,0.27710843373493976,0.781735434868128,1.0,1/1,14.91%,ITM2C
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.652694610778443,1.1465560532423789,0.26908396946564883,0.8970115498853971,1.0,2/2,34.99%,PLOD2;TET1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.4853512048855254,1.1446768264096656,0.28982725527831094,0.9031173471821848,1.0,2/4,12.33%,LTF;SPOCK1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.5537968575531731,-1.1425734102224965,0.30148619957537154,0.7940273387505441,1.0,2/3,12.13%,BDNF;LIF
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.8565737051792829,1.1424075370286157,0.2865384615384615,0.9056901865530209,1.0,1/1,14.51%,GPR137C
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.8565737051792829,1.1424075370286157,0.2865384615384615,0.9056901865530209,1.0,1/1,14.51%,GPR137C
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.8565737051792829,1.1424075370286157,0.2865384615384615,0.9056901865530209,1.0,1/1,14.51%,GPR137C
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.49098196392785565,-1.1416105711606481,0.2928870292887029,0.7955552029816748,1.0,4/4,51.49%,PSMB9;PSMB8;EIF4G1;HSPA1A
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.6506986027944112,-1.1408720804075996,0.3040816326530612,0.7945657090829337,1.0,2/2,35.39%,ACSS2;ALDH1A1
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.6506986027944112,-1.1408720804075996,0.3040816326530612,0.7945657090829337,1.0,2/2,35.39%,ACSS2;ALDH1A1
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__regulation of T-helper cell differentiation (GO:0045622),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)",0.850597609561753,1.1408168664823275,0.26601941747572816,0.8690798197656643,1.0,1/1,15.11%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.8545816733067729,1.1403388724254266,0.299009900990099,0.8647105360666658,1.0,1/1,14.71%,HSPA1L
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.8545816733067729,1.1403388724254266,0.299009900990099,0.8647105360666658,1.0,1/1,14.71%,HSPA1L
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.8545816733067729,1.1403388724254266,0.299009900990099,0.8647105360666658,1.0,1/1,14.71%,HSPA1L
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.5499595449772036,-1.1402278370614163,0.29504950495049503,0.7953756062715008,1.0,1/3,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.5491463165140478,1.1367414035326624,0.30708661417322836,0.8757268492277558,1.0,1/3,0.20%,DKK1
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.8565737051792829,-1.1364830958118863,0.2776735459662289,0.8065873964746955,1.0,1/1,14.71%,PSMB8
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.654690618762475,-1.1363556535259811,0.28790786948176583,0.8054251368158681,1.0,2/2,34.99%,GLRX;GUK1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.554,-1.1350887322183343,0.3075313807531381,0.8084073174130679,1.0,3/3,45.13%,RPLP2;PPP2R1A;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.4735662597143955,-1.1347499087982358,0.31865828092243187,0.8078131022906023,1.0,2/4,7.95%,RIT2;BDNF
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.6400563471681093,1.1337135317806712,0.27479338842975204,0.8854551508291276,1.0,1/2,2.58%,CITED2
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.552,-1.1335149270582174,0.3004032258064516,0.8102652499623818,1.0,3/3,45.33%,COPE;PLPP3;COG3
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.848605577689243,-1.1327997472486966,0.30495049504950494,0.8080186574146401,1.0,1/1,15.51%,STAG3
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.848605577689243,-1.1327997472486966,0.30495049504950494,0.8080186574146401,1.0,1/1,15.51%,STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.848605577689243,-1.1327997472486966,0.30495049504950494,0.8080186574146401,1.0,1/1,15.51%,STAG3
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.848605577689243,1.1313711106708573,0.28225806451612906,0.8797340495172967,1.0,1/1,15.31%,EFEMP1
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.848605577689243,1.1313711106708573,0.28225806451612906,0.8797340495172967,1.0,1/1,15.31%,EFEMP1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.848605577689243,1.1313711106708573,0.28225806451612906,0.8797340495172967,1.0,1/1,15.31%,EFEMP1
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.848605577689243,1.1313711106708573,0.28225806451612906,0.8797340495172967,1.0,1/1,15.31%,EFEMP1
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.848605577689243,1.1313711106708573,0.28225806451612906,0.8797340495172967,1.0,1/1,15.31%,EFEMP1
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.848605577689243,1.1313711106708573,0.28225806451612906,0.8797340495172967,1.0,1/1,15.31%,EFEMP1
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.848605577689243,1.1313711106708573,0.28225806451612906,0.8797340495172967,1.0,1/1,15.31%,EFEMP1
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.6334580829001231,-1.1308993172845483,0.3203285420944558,0.8126398020390138,1.0,1/2,2.39%,PCSK1
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.8585657370517928,-1.1275591611753497,0.3069306930693069,0.8188858857511607,1.0,1/1,14.51%,ALDOC
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.8585657370517928,-1.1275591611753497,0.3069306930693069,0.8188858857511607,1.0,1/1,14.51%,ALDOC
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.8585657370517928,-1.1275591611753497,0.3069306930693069,0.8188858857511607,1.0,1/1,14.51%,ALDOC
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.552,-1.1244067779764997,0.3155818540433925,0.8287214056001179,1.0,3/3,45.33%,NPLOC4;PLEKHM2;COG3
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.534,-1.1238974723215203,0.31422505307855625,0.8287346264664136,1.0,3/3,47.12%,DCTN1;CCL21;PSRC1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.47544885424691646,-1.1227351442788482,0.305668016194332,0.8305772770965852,1.0,2/4,11.53%,BDNF;CLSTN2
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.8326693227091634,1.1225389781919826,0.30265848670756645,0.9043990115785551,1.0,1/1,16.90%,IFIT1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),0.8326693227091634,1.1225389781919826,0.30265848670756645,0.9043990115785551,1.0,1/1,16.90%,IFIT1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.8326693227091634,1.1225389781919826,0.30265848670756645,0.9043990115785551,1.0,1/1,16.90%,IFIT1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.8326693227091634,1.1225389781919826,0.30265848670756645,0.9043990115785551,1.0,1/1,16.90%,IFIT1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.8326693227091634,-1.1212803705553018,0.2891089108910891,0.8288205961355708,1.0,1/1,17.10%,CMPK2
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.8326693227091634,-1.1212803705553018,0.2891089108910891,0.8288205961355708,1.0,1/1,17.10%,CMPK2
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.8326693227091634,-1.1212803705553018,0.2891089108910891,0.8288205961355708,1.0,1/1,17.10%,CMPK2
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.8326693227091634,-1.1212803705553018,0.2891089108910891,0.8288205961355708,1.0,1/1,17.10%,CMPK2
prerank,GO_Biological_Process_2021__immunological synapse formation (GO:0001771),-0.6307385229540917,-1.1202456083594143,0.3114406779661017,0.8306114581045234,1.0,2/2,37.38%,CORO1A;CCL21
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.3129232061586129,-1.11985296641023,0.30278884462151395,0.8303860141109132,1.0,3/10,9.34%,ISG15;DTX3L;EGR2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.6398646117012022,1.1195476575884973,0.298,0.9138407030140023,1.0,1/2,2.58%,CITED2
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.6347305389221556,-1.119338921582038,0.31837606837606836,0.8290993017448818,1.0,2/2,36.98%,LIPG;PLBD2
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.6347305389221556,-1.119338921582038,0.31837606837606836,0.8290993017448818,1.0,2/2,36.98%,LIPG;PLBD2
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic depression (GO:1900454),-0.8346613545816733,-1.1191766831644279,0.3333333333333333,0.8230685222674361,1.0,1/1,16.90%,CBLN1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.8346613545816733,-1.1191766831644279,0.3333333333333333,0.8230685222674361,1.0,1/1,16.90%,CBLN1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),-0.8346613545816733,-1.1191766831644279,0.3333333333333333,0.8230685222674361,1.0,1/1,16.90%,CBLN1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),-0.8346613545816733,-1.1191766831644279,0.3333333333333333,0.8230685222674361,1.0,1/1,16.90%,CBLN1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.6307977734572471,1.118404392281629,0.2970873786407767,0.9168527189399525,1.0,1/2,2.58%,CITED2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.6307385229540917,-1.1183398599616656,0.3230452674897119,0.8239695050268908,1.0,2/2,37.38%,LIF;CCL21
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.6467065868263473,-1.1179181518323815,0.3391472868217054,0.8236737079836319,1.0,2/2,35.79%,SYT4;TRAK2
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.6365369965661936,-1.116246089219923,0.30677290836653387,0.8255190964666853,1.0,1/2,1.99%,HBA1
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),-0.6365369965661936,-1.116246089219923,0.30677290836653387,0.8255190964666853,1.0,1/2,1.99%,HBA1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.8446215139442231,-1.116140534871527,0.33665338645418325,0.819284674599547,1.0,1/1,15.90%,NUAK1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.8446215139442231,-1.116140534871527,0.33665338645418325,0.819284674599547,1.0,1/1,15.90%,NUAK1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.8446215139442231,-1.116140534871527,0.33665338645418325,0.819284674599547,1.0,1/1,15.90%,NUAK1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.8446215139442231,-1.116140534871527,0.33665338645418325,0.819284674599547,1.0,1/1,15.90%,NUAK1
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),0.8446215139442231,1.1156584579583915,0.3144016227180527,0.9193540034030582,1.0,1/1,15.71%,GUCY2F
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),0.8446215139442231,1.1156584579583915,0.3144016227180527,0.9193540034030582,1.0,1/1,15.71%,GUCY2F
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.8446215139442231,1.1156584579583915,0.3144016227180527,0.9193540034030582,1.0,1/1,15.71%,GUCY2F
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.8446215139442231,1.1156584579583915,0.3144016227180527,0.9193540034030582,1.0,1/1,15.71%,GUCY2F
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.5297454869739865,-1.1140913335062421,0.3305439330543933,0.8249563257848229,1.0,2/3,12.92%,CORO1A;ATP6V0D1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.8346613545816733,1.1139615036207613,0.3185483870967742,0.9193632126429213,1.0,1/1,16.70%,LHPP
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.8346613545816733,1.1139615036207613,0.3185483870967742,0.9193632126429213,1.0,1/1,16.70%,LHPP
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.8346613545816733,1.1139615036207613,0.3185483870967742,0.9193632126429213,1.0,1/1,16.70%,LHPP
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.48096192384769537,1.113801581023218,0.32375478927203066,0.9157523477711567,1.0,4/4,52.29%,TAF11;ESRRG;TAF9B;GTF2H4
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.48096192384769537,1.113801581023218,0.32375478927203066,0.9157523477711567,1.0,4/4,52.29%,TAF11;ESRRG;TAF9B;GTF2H4
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.5345254406923177,-1.1128303990065072,0.3286852589641434,0.8274849605815977,1.0,2/3,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.6307385229540917,-1.1127748734696912,0.30785123966942146,0.8181564307996263,1.0,2/2,37.38%,CXCL8;CCL21
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.6307385229540917,-1.1127748734696912,0.30785123966942146,0.8181564307996263,1.0,2/2,37.38%,CXCL8;CCL21
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.6307385229540917,-1.1127748734696912,0.30785123966942146,0.8181564307996263,1.0,2/2,37.38%,CXCL8;CCL21
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.6307385229540917,-1.1127748734696912,0.30785123966942146,0.8181564307996263,1.0,2/2,37.38%,CXCL8;CCL21
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.6307385229540917,-1.1127748734696912,0.30785123966942146,0.8181564307996263,1.0,2/2,37.38%,CXCL8;CCL21
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.6307385229540917,-1.1127748734696912,0.30785123966942146,0.8181564307996263,1.0,2/2,37.38%,CXCL8;CCL21
prerank,GO_Biological_Process_2021__quinone catabolic process (GO:1901662),-0.8426294820717132,-1.1124288813392822,0.32879377431906615,0.8174849631659094,1.0,1/1,16.10%,NQO2
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.6316770230896978,-1.1122640628784322,0.29646017699115046,0.8164862132402514,1.0,1/2,2.98%,AHNAK2
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.39400259781031494,-1.1087090134318671,0.33954451345755693,0.8260874634777271,1.0,2/6,6.76%,FABP3;CXCL8
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.628025273861322,1.1073684235272545,0.3037475345167653,0.9378085892721362,1.0,1/2,2.98%,LRP2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.3960963802276722,-1.1065852436440216,0.3200836820083682,0.8305625235818629,1.0,3/6,12.13%,BDNF;INSM1;LIF
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.8266932270916335,1.106324025629857,0.33858267716535434,0.9376896628628765,1.0,1/1,17.50%,S100A12
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.8266932270916335,1.106324025629857,0.33858267716535434,0.9376896628628765,1.0,1/1,17.50%,S100A12
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",-0.6287425149700598,-1.105603024759145,0.32983193277310924,0.8308529610064894,1.0,2/2,37.57%,GABRA2;GABRA4
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.6287425149700598,-1.105603024759145,0.32983193277310924,0.8308529610064894,1.0,2/2,37.57%,GABRA2;GABRA4
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.534,-1.1054423724869142,0.3232104121475054,0.8296982358648542,1.0,3/3,47.12%,STMN1;DCTN1;PSRC1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.39538195555793193,1.1052738522803678,0.31547619047619047,0.9396976974611997,1.0,5/6,45.73%,GPNMB;VEGFA;MYLK;ELP5;CAPN7
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.8406374501992032,-1.1047995059564975,0.3387096774193548,0.8303278755088535,1.0,1/1,16.30%,GABRA2
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.21157029613916262,1.1040216569165537,0.3301707779886148,0.9415760672101161,1.0,19/27,49.90%,DKK1;LTF;CITED2;EGR1;EFEMP1;SPIN4;ZNF217;TOB1;VEGFA;ZNF462;ESRRG;NFIL3;ZC3H7A;ZNF146;BMI1;HSPA1B;HSPA1A;TDRD7;ZNF451
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.4236947791164658,-1.1030230156451868,0.3114754098360656,0.8352387190433177,1.0,5/5,58.25%,IFITM3;GAPDH;CCL21;EPRS1;CYP27B1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.8366533864541833,-1.1029253987554546,0.3443579766536965,0.8307575363239553,1.0,1/1,16.70%,GLRX
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.8366533864541833,-1.1029253987554546,0.3443579766536965,0.8307575363239553,1.0,1/1,16.70%,GLRX
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.8366533864541833,-1.1029253987554546,0.3443579766536965,0.8307575363239553,1.0,1/1,16.70%,GLRX
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),-0.526,-1.1007261568566886,0.34845360824742266,0.8361805002071757,1.0,3/3,47.91%,CHSY3;DSEL;CHST9
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.6287425149700598,1.1001632313593432,0.305019305019305,0.9538503646969367,1.0,2/2,37.38%,IMMP2L;NDUFB6
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.2620602965340287,-1.099467729759815,0.31808278867102396,0.8390324704998382,1.0,4/16,10.34%,FABP3;MIF;CXCL8;INSM1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.46032902719438595,-1.0983816124700772,0.3236607142857143,0.8409255214129631,1.0,2/4,6.96%,SHISA2;RBPMS2
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.8306772908366534,-1.097270440185508,0.37524950099800397,0.8414842296387537,1.0,1/1,17.30%,NMNAT2
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.8306772908366534,-1.097270440185508,0.37524950099800397,0.8414842296387537,1.0,1/1,17.30%,NMNAT2
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.6367265469061876,-1.0958897240836367,0.332,0.843773562844134,1.0,2/2,36.78%,EOMES;COL4A2
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.5180702063250552,-1.0954075538668706,0.35129740518962077,0.8424036993593665,1.0,2/3,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.5180702063250552,-1.0954075538668706,0.35129740518962077,0.8424036993593665,1.0,2/3,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.6107784431137725,1.0938058390939167,0.33468559837728196,0.9761042168407451,1.0,2/2,39.17%,EFNA1;NLGN1
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.526,-1.0932690653383095,0.36767676767676766,0.8476582676323665,1.0,3/3,47.91%,SDC1;SDC3;CHST9
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.6203599362291727,-1.0918131857050486,0.32688588007736946,0.8497126867174973,1.0,1/2,3.18%,ISG15
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.6203599362291727,-1.0918131857050486,0.32688588007736946,0.8497126867174973,1.0,1/2,3.18%,ISG15
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.514,1.0915084608939032,0.35294117647058826,0.9807064050992018,1.0,3/3,48.91%,CHMP4C;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.514,1.0915084608939032,0.35294117647058826,0.9807064050992018,1.0,3/3,48.91%,CHMP4C;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.6227544910179641,1.0900795905389327,0.345679012345679,0.983827911813795,1.0,2/2,37.97%,GPNMB;ADGRA2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.8087649402390438,-1.089701935301597,0.3726315789473684,0.8457095224717691,1.0,1/1,19.48%,CDC7
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.8087649402390438,-1.089701935301597,0.3726315789473684,0.8457095224717691,1.0,1/1,19.48%,CDC7
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.8087649402390438,-1.089701935301597,0.3726315789473684,0.8457095224717691,1.0,1/1,19.48%,CDC7
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.8087649402390438,-1.089701935301597,0.3726315789473684,0.8457095224717691,1.0,1/1,19.48%,CDC7
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.8087649402390438,-1.089701935301597,0.3726315789473684,0.8457095224717691,1.0,1/1,19.48%,CDC7
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.8087649402390438,-1.089701935301597,0.3726315789473684,0.8457095224717691,1.0,1/1,19.48%,CDC7
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.8087649402390438,-1.089701935301597,0.3726315789473684,0.8457095224717691,1.0,1/1,19.48%,CDC7
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6107784431137726,1.088194349802027,0.3333333333333333,0.982339224741907,1.0,2/2,39.17%,RELN;NLGN1
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.6107784431137726,1.088194349802027,0.3333333333333333,0.982339224741907,1.0,2/2,39.17%,RELN;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.6107784431137726,1.088194349802027,0.3333333333333333,0.982339224741907,1.0,2/2,39.17%,RELN;NLGN1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.6107784431137726,1.088194349802027,0.3333333333333333,0.982339224741907,1.0,2/2,39.17%,RELN;NLGN1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.38563670650902043,-1.0880749680688255,0.3474747474747475,0.8495995780196128,1.0,2/6,6.76%,CHI3L1;CXCL8
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.624750499001996,-1.087246778752988,0.35546875,0.8511717174422805,1.0,2/2,37.97%,GPX1;GGT5
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.8247011952191234,1.0867847322955682,0.36907216494845363,0.9809168360064504,1.0,1/1,17.69%,NAP1L3
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.8247011952191234,1.0867847322955682,0.36907216494845363,0.9809168360064504,1.0,1/1,17.69%,NAP1L3
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.8247011952191234,1.0867847322955682,0.36907216494845363,0.9809168360064504,1.0,1/1,17.69%,NAP1L3
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.6227544910179641,1.086712518709733,0.3587174348697395,0.9790659648724372,1.0,2/2,37.97%,VEGFA;ADGRA2
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.38894912118246533,-1.086259512945961,0.3487394957983193,0.8512728701010697,1.0,5/6,43.14%,DCTN1;DCTN3;ABCB1;PPP2R1A;OFD1
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.38894912118246533,-1.086259512945961,0.3487394957983193,0.8512728701010697,1.0,5/6,43.14%,DCTN1;DCTN3;ABCB1;PPP2R1A;OFD1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.8027888446215139,-1.0848976347985715,0.3783783783783784,0.8327158164418895,1.0,1/1,20.08%,DCTN1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),-0.8107569721115537,-1.084760638154672,0.3797979797979798,0.8302159373800411,1.0,1/1,19.28%,PLPP3
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.8107569721115537,-1.084760638154672,0.3797979797979798,0.8302159373800411,1.0,1/1,19.28%,PLPP3
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6327345309381237,-1.0847225083897387,0.36182902584493043,0.8292412633940738,1.0,2/2,37.18%,GLRX;ABCB1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.45544874397270096,-1.0843490775174933,0.33752620545073375,0.8288779604120404,1.0,3/4,28.83%,LIPG;HMGCR;ACSS2
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),-0.8127490039840637,-1.0828594553118125,0.3702970297029703,0.824898447746981,1.0,1/1,19.09%,LGALS1
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),-0.8127490039840637,-1.0828594553118125,0.3702970297029703,0.824898447746981,1.0,1/1,19.09%,LGALS1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.8127490039840637,-1.0828594553118125,0.3702970297029703,0.824898447746981,1.0,1/1,19.09%,LGALS1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.8127490039840637,-1.0828594553118125,0.3702970297029703,0.824898447746981,1.0,1/1,19.09%,LGALS1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.8127490039840637,-1.0828594553118125,0.3702970297029703,0.824898447746981,1.0,1/1,19.09%,LGALS1
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.8127490039840637,-1.0828594553118125,0.3702970297029703,0.824898447746981,1.0,1/1,19.09%,LGALS1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.39330325773629504,1.082290708775577,0.3517110266159696,0.9936023521570652,1.0,2/6,3.78%,LRP2;CYP26B1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.631910453105788,-1.0819709410439613,0.3727810650887574,0.8262287221408807,1.0,1/2,3.38%,TRH
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.6327345309381236,1.081840013455843,0.3761814744801512,0.9930731283945576,1.0,2/2,36.98%,NAA25;AANAT
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.8147410358565736,-1.0816085673696858,0.36983471074380164,0.8065929560592064,1.0,1/1,18.89%,CETP
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.6107784431137725,1.0804846097896144,0.3460764587525151,0.9955346612707966,1.0,2/2,39.17%,KANK1;NLGN1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.8047808764940239,1.0802023276250088,0.3587174348697395,0.9858224490222867,1.0,1/1,19.68%,CEP120
prerank,GO_Biological_Process_2021__positive regulation of centriole replication (GO:0046601),0.8047808764940239,1.0802023276250088,0.3587174348697395,0.9858224490222867,1.0,1/1,19.68%,CEP120
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.8047808764940239,1.0802023276250088,0.3587174348697395,0.9858224490222867,1.0,1/1,19.68%,CEP120
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.8047808764940239,1.0802023276250088,0.3587174348697395,0.9858224490222867,1.0,1/1,19.68%,CEP120
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.8047808764940239,1.0802023276250088,0.3587174348697395,0.9858224490222867,1.0,1/1,19.68%,CEP120
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.3860739640738857,-1.0801068903247744,0.36863543788187375,0.8093517551586409,1.0,2/6,5.96%,ISG15;NLRC5
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.3550116324144277,-1.0790710689262426,0.3481781376518219,0.8113771358774853,1.0,2/7,4.77%,ISG15;DTX3L
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.6107784431137725,1.07764373358096,0.35051546391752575,0.9935175441163242,1.0,2/2,39.17%,CNTNAP4;NLGN1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.8007968127490039,-1.0774479513521182,0.39307535641547864,0.8124066112945089,1.0,1/1,20.28%,LIPG
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.8007968127490039,-1.0774479513521182,0.39307535641547864,0.8124066112945089,1.0,1/1,20.28%,LIPG
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein particle clearance (GO:0010986),-0.8007968127490039,-1.0774479513521182,0.39307535641547864,0.8124066112945089,1.0,1/1,20.28%,LIPG
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.6147704590818363,1.0746287112174113,0.38181818181818183,1.0,1.0,2/2,38.77%,SOX8;LIN7C
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.514,1.0741926953935128,0.360377358490566,0.9976247736100934,1.0,3/3,48.91%,HSPA1L;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.514,1.0741926953935128,0.360377358490566,0.9976247736100934,1.0,3/3,48.91%,HSPA1L;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.514,1.0741926953935128,0.360377358490566,0.9976247736100934,1.0,3/3,48.91%,HSPA1L;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.6053194502794175,-1.072363825943074,0.36964980544747084,0.8251331226866133,1.0,1/2,4.77%,DTX3L
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.514,1.0717897305443884,0.3610586011342155,1.0,1.0,3/3,48.91%,RAD23B;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.5098832378871319,-1.0711472501053856,0.38556701030927837,0.8272548610252173,1.0,2/3,23.66%,HBA1;AQP9
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5139999999999999,1.0709857272618601,0.3711967545638945,1.0,1.0,3/3,48.91%,EGR1;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.798804780876494,1.0706226853845497,0.3850806451612903,0.996770865679433,1.0,1/1,20.28%,JUN
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.798804780876494,1.0706226853845497,0.3850806451612903,0.996770865679433,1.0,1/1,20.28%,JUN
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.798804780876494,1.0706226853845497,0.3850806451612903,0.996770865679433,1.0,1/1,20.28%,JUN
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.798804780876494,1.0706226853845497,0.3850806451612903,0.996770865679433,1.0,1/1,20.28%,JUN
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.798804780876494,1.0706226853845497,0.3850806451612903,0.996770865679433,1.0,1/1,20.28%,JUN
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.45681432314251946,1.069853885520072,0.377431906614786,0.9972151783831698,1.0,2/4,12.33%,OPHN1;SPOCK1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.514,-1.06878178014301,0.37422037422037424,0.8330764345630882,1.0,3/3,49.11%,RAB15;ADCY3;EPRS1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4414867358110373,1.0682439905919479,0.3483992467043315,1.0,1.0,1/4,0.20%,DKK1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.6082633023803506,1.068201046300905,0.374749498997996,0.9991638149290865,1.0,1/2,2.58%,CITED2
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.7928286852589641,-1.067546066352749,0.3907815631262525,0.8339842246433328,1.0,1/1,21.07%,GAPDH
prerank,GO_Biological_Process_2021__peptidyl-cysteine S-nitrosylation (GO:0018119),-0.7928286852589641,-1.067546066352749,0.3907815631262525,0.8339842246433328,1.0,1/1,21.07%,GAPDH
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.6102449709242546,-1.0671953577256936,0.36645962732919257,0.8336362992403032,1.0,1/2,3.18%,ISG15
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.8007968127490039,1.0645752699124056,0.402834008097166,0.9932422490315455,1.0,1/1,20.08%,GPNMB
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.8007968127490039,1.0645752699124056,0.402834008097166,0.9932422490315455,1.0,1/1,20.08%,GPNMB
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.8007968127490039,1.0645752699124056,0.402834008097166,0.9932422490315455,1.0,1/1,20.08%,GPNMB
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.8007968127490039,1.0645752699124056,0.402834008097166,0.9932422490315455,1.0,1/1,20.08%,GPNMB
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.8007968127490039,1.0645752699124056,0.402834008097166,0.9932422490315455,1.0,1/1,20.08%,GPNMB
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.8007968127490039,1.0645752699124056,0.402834008097166,0.9932422490315455,1.0,1/1,20.08%,GPNMB
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.8007968127490039,1.0645752699124056,0.402834008097166,0.9932422490315455,1.0,1/1,20.08%,GPNMB
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.8007968127490039,1.0645752699124056,0.402834008097166,0.9932422490315455,1.0,1/1,20.08%,GPNMB
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.8007968127490039,1.0645752699124056,0.402834008097166,0.9932422490315455,1.0,1/1,20.08%,GPNMB
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.6180103727380823,1.0627450214170926,0.37407407407407406,0.9954572233961179,1.0,1/2,2.98%,LRP2
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.6180103727380823,1.0627450214170926,0.37407407407407406,0.9954572233961179,1.0,1/2,2.98%,LRP2
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.45090180360721455,1.0620450495039782,0.3794466403162055,0.9958020071185003,1.0,4/4,55.27%,GPNMB;HSPA1B;HSPA1A;EIF4G1
prerank,GO_Biological_Process_2021__fat-soluble vitamin catabolic process (GO:0042363),0.6056134737733317,1.0617819973266553,0.3713733075435203,0.9944999446507501,1.0,1/2,3.78%,CYP26B1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.7948207171314741,1.0611412375694225,0.4024640657084189,0.9923360612694295,1.0,1/1,20.68%,IMMP2L
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.7948207171314741,1.0611412375694225,0.4024640657084189,0.9923360612694295,1.0,1/1,20.68%,IMMP2L
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.315828506227528,-1.0610883891095488,0.3760330578512397,0.8499935897123292,1.0,4/9,14.91%,RIT2;BDNF;KNDC1;ITM2C
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.378982180902651,1.0601733427063047,0.38104448742746616,0.9943238787572308,1.0,3/6,14.91%,SLC6A6;LRP2;SLC1A3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.4000554384893032,-1.0593907035648302,0.37681159420289856,0.8524140653801602,1.0,4/5,37.38%,CHI3L1;FGF9;FAM110C;CCL21
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.4000554384893032,-1.0593907035648302,0.37681159420289856,0.8524140653801602,1.0,4/5,37.38%,CHI3L1;FGF9;FAM110C;CCL21
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.33553982893934076,-1.0585627956422023,0.3675889328063241,0.8535797079016635,1.0,3/8,10.34%,MIF;CXCL8;INSM1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.2040557013860179,1.057948359716528,0.3801498127340824,0.999879884298595,1.0,15/28,36.78%,FOS;CITED2;DHX33;EGR1;JUN;SOX8;VEGFA;IER5;ZNF462;CAPN3;ABRA;TET1;ESRRG;ZIC2;NFIL3
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.7888446215139442,-1.0570223658948834,0.4139344262295082,0.856672891568928,1.0,1/1,21.47%,NANS
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.796812749003984,-1.0563946640654591,0.4066797642436149,0.8436410330552332,1.0,1/1,20.68%,ACADVL
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.796812749003984,-1.0563946640654591,0.4066797642436149,0.8436410330552332,1.0,1/1,20.68%,ACADVL
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.796812749003984,-1.0563946640654591,0.4066797642436149,0.8436410330552332,1.0,1/1,20.68%,ACADVL
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.796812749003984,-1.0563946640654591,0.4066797642436149,0.8436410330552332,1.0,1/1,20.68%,ACADVL
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.796812749003984,-1.0563946640654591,0.4066797642436149,0.8436410330552332,1.0,1/1,20.68%,ACADVL
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.796812749003984,-1.0563946640654591,0.4066797642436149,0.8436410330552332,1.0,1/1,20.68%,ACADVL
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.796812749003984,-1.0563946640654591,0.4066797642436149,0.8436410330552332,1.0,1/1,20.68%,ACADVL
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.796812749003984,-1.0563946640654591,0.4066797642436149,0.8436410330552332,1.0,1/1,20.68%,ACADVL
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.796812749003984,-1.0563946640654591,0.4066797642436149,0.8436410330552332,1.0,1/1,20.68%,ACADVL
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.796812749003984,-1.0563946640654591,0.4066797642436149,0.8436410330552332,1.0,1/1,20.68%,ACADVL
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),-0.796812749003984,-1.0563946640654591,0.4066797642436149,0.8436410330552332,1.0,1/1,20.68%,ACADVL
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.5084746678426033,-1.055846063516375,0.3956989247311828,0.8438247151966014,1.0,2/3,17.30%,CMPK2;NMNAT2
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.444156856436423,1.0555542960869566,0.3661417322834646,1.0,1.0,2/4,16.90%,DKK1;IFIT1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.6060224279214441,1.055329536207448,0.39105058365758755,1.0,1.0,1/2,4.37%,KANK1
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__nephron tubule formation (GO:0072079),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__ureter development (GO:0072189),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__metanephric nephron tubule morphogenesis (GO:0072282),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__positive regulation of kidney development (GO:0090184),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__regulation of kidney development (GO:0090183),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.7908366533864541,1.054569834908787,0.4165067178502879,0.9779436684762483,1.0,1/1,21.07%,SOX8
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.7868525896414342,-1.0537139577642924,0.4302788844621514,0.8462031755916487,1.0,1/1,21.67%,CNIH3
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.7868525896414342,-1.0537139577642924,0.4302788844621514,0.8462031755916487,1.0,1/1,21.67%,CNIH3
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.7868525896414342,-1.0537139577642924,0.4302788844621514,0.8462031755916487,1.0,1/1,21.67%,CNIH3
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.6129372266635932,1.0534235549778677,0.38779527559055116,0.9792557177368568,1.0,1/2,0.60%,COL2A1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.7888446215139441,1.0529354564239697,0.41904761904761906,0.9698574753696588,1.0,1/1,21.27%,ABHD17B
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.7888446215139441,1.0529354564239697,0.41904761904761906,0.9698574753696588,1.0,1/1,21.27%,ABHD17B
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.7888446215139441,1.0529354564239697,0.41904761904761906,0.9698574753696588,1.0,1/1,21.27%,ABHD17B
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.7888446215139441,1.0529354564239697,0.41904761904761906,0.9698574753696588,1.0,1/1,21.27%,ABHD17B
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.7888446215139441,1.0529354564239697,0.41904761904761906,0.9698574753696588,1.0,1/1,21.27%,ABHD17B
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.7888446215139441,1.0529354564239697,0.41904761904761906,0.9698574753696588,1.0,1/1,21.27%,ABHD17B
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.3853483356649851,1.0529120919617374,0.4,0.9680948241476257,1.0,2/6,9.74%,COL2A1;PLOD2
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.45325304046502946,-1.052203296711954,0.3952991452991453,0.849307389798248,1.0,3/4,24.25%,CORO1A;STMN1;KANK4
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.5868263473053892,-1.050896523517707,0.4015748031496063,0.8512860777107857,1.0,2/2,41.75%,PLPP3;MYH9
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.33045932290745506,-1.0502471698044975,0.4087136929460581,0.8516349336852006,1.0,5/8,22.47%,BDNF;CBLN1;CBLN2;DCTN1;PCDHB16
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.4428857715430861,-1.0501011774504128,0.3868312757201646,0.8507795773677199,1.0,4/4,56.26%,DTX3L;TOPORS;BMI1;PKIB
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.20833333333333334,-1.0498552976219542,0.4088888888888889,0.8500373202739113,1.0,23/23,80.32%,FABP3;CXCL8;INSM1;LIF;NUAK1;CDC7;FABP7;FGF9;TFAP2D;JUNB;NACC2;HSPA1A;HSPA1B;CYP27B1;STAT4;TET1;H2AC6;VIP;IER5;VEGFA;TOB1;JUN;GPNMB
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.4562085164575238,-1.0490767656621764,0.4219409282700422,0.8507106274317506,1.0,2/4,8.15%,CHI3L1;EN1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.5946782572596523,1.0481412915496777,0.41015625,0.9767088417396913,1.0,1/2,5.17%,RAD23B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5946782572596523,1.0481412915496777,0.41015625,0.9767088417396913,1.0,1/2,5.17%,RAD23B
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.5946782572596523,1.0481412915496777,0.41015625,0.9767088417396913,1.0,1/2,5.17%,RAD23B
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.5946782572596523,1.0481412915496777,0.41015625,0.9767088417396913,1.0,1/2,5.17%,RAD23B
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.403321702221781,1.0470718223430966,0.38645418326693226,0.9786056509821092,1.0,1/5,0.20%,DKK1
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.5848303393213572,-1.0470599399573994,0.3979591836734694,0.855273289755374,1.0,2/2,41.95%,TCIM;DTX1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.6063198902615728,1.0470050806459026,0.4015748031496063,0.976962694512663,1.0,1/2,4.37%,KANK1
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.514,-1.0462204792643335,0.4130879345603272,0.8560896560790734,1.0,3/3,49.11%,RPLP2;EIF4G1;EPRS1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.7948207171314741,-1.046216973578865,0.4351145038167939,0.8520563932502928,1.0,1/1,20.87%,PI4KA
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.7948207171314741,-1.046216973578865,0.4351145038167939,0.8520563932502928,1.0,1/1,20.87%,PI4KA
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.7948207171314741,-1.046216973578865,0.4351145038167939,0.8520563932502928,1.0,1/1,20.87%,PI4KA
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.36897623228552767,1.0458215980849128,0.41338582677165353,0.9792474345751928,1.0,4/6,33.80%,GPNMB;VEGFA;MYLK;ELP5
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.44488977955911846,1.0435102111732715,0.3812154696132597,0.9853946382823278,1.0,4/4,55.86%,HSPA1L;HSPA1B;HSPA1A;ABCB10
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.7808764940239044,1.042280442292188,0.42570281124497994,0.974785791928758,1.0,1/1,22.07%,RYR3
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.7808764940239044,1.042280442292188,0.42570281124497994,0.974785791928758,1.0,1/1,22.07%,RYR3
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.7808764940239044,1.042280442292188,0.42570281124497994,0.974785791928758,1.0,1/1,22.07%,RYR3
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.7808764940239044,1.042280442292188,0.42570281124497994,0.974785791928758,1.0,1/1,22.07%,RYR3
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.7808764940239044,1.042280442292188,0.42570281124497994,0.974785791928758,1.0,1/1,22.07%,RYR3
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.7808764940239044,1.042280442292188,0.42570281124497994,0.974785791928758,1.0,1/1,22.07%,RYR3
prerank,GO_Biological_Process_2021__cellular response to magnesium ion (GO:0071286),0.7808764940239044,1.042280442292188,0.42570281124497994,0.974785791928758,1.0,1/1,22.07%,RYR3
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.7808764940239044,1.042280442292188,0.42570281124497994,0.974785791928758,1.0,1/1,22.07%,RYR3
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.6067864271457085,-1.0413767340282438,0.41379310344827586,0.8649305577594187,1.0,2/2,39.76%,PTPN3;GPRC5A
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.7788844621513944,1.0410431104119722,0.4550898203592814,0.9758890447524954,1.0,1/1,22.27%,MYO3B
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),0.7788844621513944,1.0410431104119722,0.4550898203592814,0.9758890447524954,1.0,1/1,22.27%,MYO3B
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.5777700199076106,1.0409276503294316,0.40038684719535783,0.9745753888013104,1.0,1/2,1.39%,LTF
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.508,-1.0406336711370647,0.39574468085106385,0.8653903616840786,1.0,3/3,49.70%,STMN1;DCTN3;ANLN
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.488,-1.0394365631696314,0.42207792207792205,0.8659940762185461,1.0,3/3,51.69%,DCTN1;HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.488,-1.0394365631696314,0.42207792207792205,0.8659940762185461,1.0,3/3,51.69%,DCTN1;HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.598802395209581,1.0390823185633138,0.4294234592445328,0.9787148193094906,1.0,2/2,40.36%,CHMP4C;LIX1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.4969432260361477,1.0390743679875794,0.42193308550185876,0.9769499541048458,1.0,1/3,1.59%,OPHN1
prerank,GO_Biological_Process_2021__photoreceptor cell outer segment organization (GO:0035845),0.4408817635270542,1.0381805965306368,0.40236686390532544,0.9785093809555068,1.0,4/4,56.26%,CDHR1;PCARE;TOPORS;RP1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.488,-1.0369925323017517,0.41561181434599154,0.8701157921124913,1.0,3/3,51.69%,GPX1;HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.488,-1.0369925323017517,0.41561181434599154,0.8701157921124913,1.0,3/3,51.69%,GPX1;HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.488,-1.0350780402574753,0.41631799163179917,0.8716716725396272,1.0,3/3,51.69%,ABCB10;HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.488,-1.0350780402574753,0.41631799163179917,0.8716716725396272,1.0,3/3,51.69%,ABCB10;HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.488,-1.0350780402574753,0.41631799163179917,0.8716716725396272,1.0,3/3,51.69%,ABCB10;HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.7749003984063745,-1.0339975855217935,0.46435845213849286,0.8683133945354488,1.0,1/1,22.86%,PHACTR1
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),-0.7749003984063745,-1.0339975855217935,0.46435845213849286,0.8683133945354488,1.0,1/1,22.86%,PHACTR1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.7749003984063745,-1.0339975855217935,0.46435845213849286,0.8683133945354488,1.0,1/1,22.86%,PHACTR1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),-0.7749003984063745,-1.0339975855217935,0.46435845213849286,0.8683133945354488,1.0,1/1,22.86%,PHACTR1
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.7749003984063745,-1.0339975855217935,0.46435845213849286,0.8683133945354488,1.0,1/1,22.86%,PHACTR1
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.5948103792415169,-1.03389848139835,0.4175365344467641,0.8658919994892481,1.0,2/2,40.95%,PRPF8;PPP2R1A
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.5948103792415169,-1.03389848139835,0.4175365344467641,0.8658919994892481,1.0,2/2,40.95%,PRPF8;PPP2R1A
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.7868525896414342,1.0336487629519995,0.4585858585858586,0.9792819434264985,1.0,1/1,21.47%,RANBP2
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.7868525896414342,1.0336487629519995,0.4585858585858586,0.9792819434264985,1.0,1/1,21.47%,RANBP2
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.7868525896414342,1.0336487629519995,0.4585858585858586,0.9792819434264985,1.0,1/1,21.47%,RANBP2
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.7868525896414342,1.0336487629519995,0.4585858585858586,0.9792819434264985,1.0,1/1,21.47%,RANBP2
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.7868525896414342,1.0336487629519995,0.4585858585858586,0.9792819434264985,1.0,1/1,21.47%,RANBP2
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.7868525896414342,1.0336487629519995,0.4585858585858586,0.9792819434264985,1.0,1/1,21.47%,RANBP2
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.7868525896414342,1.0336487629519995,0.4585858585858586,0.9792819434264985,1.0,1/1,21.47%,RANBP2
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.7868525896414342,1.0336487629519995,0.4585858585858586,0.9792819434264985,1.0,1/1,21.47%,RANBP2
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.7729083665338644,1.0331155933909522,0.4491869918699187,0.9764328483232549,1.0,1/1,22.86%,EXOC8
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.7729083665338644,1.0331155933909522,0.4491869918699187,0.9764328483232549,1.0,1/1,22.86%,EXOC8
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.7729083665338644,1.0331155933909522,0.4491869918699187,0.9764328483232549,1.0,1/1,22.86%,EXOC8
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.3621730382293763,-1.0316195592754265,0.4017094017094017,0.8705756903884343,1.0,6/6,64.41%,PLPP3;PPP2R1A;SMPD4;HACD3;PLPP2;FA2H
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.7828685258964143,-1.0286380121617547,0.4725897920604915,0.8653493972100025,1.0,1/1,22.07%,SYT4
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),-0.7828685258964143,-1.0286380121617547,0.4725897920604915,0.8653493972100025,1.0,1/1,22.07%,SYT4
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.7828685258964143,-1.0286380121617547,0.4725897920604915,0.8653493972100025,1.0,1/1,22.07%,SYT4
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.7828685258964143,-1.0286380121617547,0.4725897920604915,0.8653493972100025,1.0,1/1,22.07%,SYT4
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.7828685258964143,-1.0286380121617547,0.4725897920604915,0.8653493972100025,1.0,1/1,22.07%,SYT4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.7828685258964143,-1.0286380121617547,0.4725897920604915,0.8653493972100025,1.0,1/1,22.07%,SYT4
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.7828685258964143,-1.0286380121617547,0.4725897920604915,0.8653493972100025,1.0,1/1,22.07%,SYT4
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),-0.7828685258964143,-1.0286380121617547,0.4725897920604915,0.8653493972100025,1.0,1/1,22.07%,SYT4
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.7828685258964143,-1.0286380121617547,0.4725897920604915,0.8653493972100025,1.0,1/1,22.07%,SYT4
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.7828685258964143,-1.0286380121617547,0.4725897920604915,0.8653493972100025,1.0,1/1,22.07%,SYT4
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.488,-1.0285202846775112,0.4166666666666667,0.8644214909075042,1.0,3/3,51.69%,ISG15;HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.7649402390438247,-1.0277078085642324,0.444022770398482,0.8636887172517607,1.0,1/1,23.86%,MICAL2
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.7649402390438247,-1.0277078085642324,0.444022770398482,0.8636887172517607,1.0,1/1,23.86%,MICAL2
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.4960000000000001,1.026023744151402,0.3920792079207921,0.9970422153788304,1.0,3/3,50.70%,KANK1;ADGRA2;ANLN
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.488,-1.0250230399723477,0.4288747346072187,0.8695251618712876,1.0,3/3,51.69%,PRPF8;HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.7689243027888446,-1.0243434903047093,0.4718162839248434,0.8674741423850852,1.0,1/1,23.46%,RPLP2
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7689243027888446,-1.0243434903047093,0.4718162839248434,0.8674741423850852,1.0,1/1,23.46%,RPLP2
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.7689243027888446,-1.0243434903047093,0.4718162839248434,0.8674741423850852,1.0,1/1,23.46%,RPLP2
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5788423153692615,-1.0238510699401415,0.4363256784968685,0.8676972052159996,1.0,2/2,42.54%,AP2M1;RAP1GAP2
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.7689243027888446,1.0235762073852814,0.4731800766283525,0.9961062695078805,1.0,1/1,23.26%,TOB1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.7689243027888446,1.0235762073852814,0.4731800766283525,0.9961062695078805,1.0,1/1,23.26%,TOB1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.7689243027888446,1.0235762073852814,0.4731800766283525,0.9961062695078805,1.0,1/1,23.26%,TOB1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.7689243027888446,1.0235762073852814,0.4731800766283525,0.9961062695078805,1.0,1/1,23.26%,TOB1
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.7689243027888446,1.0235762073852814,0.4731800766283525,0.9961062695078805,1.0,1/1,23.26%,TOB1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.495757917989081,1.0231114524152802,0.42857142857142855,0.9962260004210989,1.0,1/3,1.39%,LTF
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.5788423153692615,-1.0227109988419405,0.4105691056910569,0.8694594875371063,1.0,2/2,42.54%,CCL21;RAP1GAP2
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),0.7768924302788844,1.022705334734765,0.48466257668711654,0.983687032531461,1.0,1/1,22.47%,DSG2
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.7768924302788844,1.022705334734765,0.48466257668711654,0.983687032531461,1.0,1/1,22.47%,DSG2
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.7768924302788844,1.022705334734765,0.48466257668711654,0.983687032531461,1.0,1/1,22.47%,DSG2
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),0.7768924302788844,1.022705334734765,0.48466257668711654,0.983687032531461,1.0,1/1,22.47%,DSG2
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),0.7768924302788844,1.022705334734765,0.48466257668711654,0.983687032531461,1.0,1/1,22.47%,DSG2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.7768924302788844,1.022705334734765,0.48466257668711654,0.983687032531461,1.0,1/1,22.47%,DSG2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.7768924302788844,1.022705334734765,0.48466257668711654,0.983687032531461,1.0,1/1,22.47%,DSG2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.7768924302788844,1.022705334734765,0.48466257668711654,0.983687032531461,1.0,1/1,22.47%,DSG2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5039999999999998,1.0226006014700633,0.4226190476190476,0.9823132493759575,1.0,3/3,49.90%,LEMD3;HSPA1A;ZNF451
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.5814035350957447,-1.0215727265823857,0.44421906693711966,0.8709020173393927,1.0,1/2,3.18%,ISG15
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.42310801392978803,-1.0199107123626325,0.41995841995842,0.8741956771760067,1.0,3/4,34.00%,RAB3C;RAB15;ANK1
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.5748502994011978,1.0189933856784228,0.4079696394686907,0.9920143312131414,1.0,2/2,42.74%,IFIT1;IRAK3
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),-0.5828343313373253,-1.018777093487302,0.42034548944337813,0.8734863776888033,1.0,2/2,42.15%,PLIN2;OSBPL11
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.5828343313373253,-1.018777093487302,0.42034548944337813,0.8734863776888033,1.0,2/2,42.15%,PLIN2;OSBPL11
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.5828343313373253,-1.018777093487302,0.42034548944337813,0.8734863776888033,1.0,2/2,42.15%,PLIN2;OSBPL11
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__positive regulation of prostaglandin biosynthetic process (GO:0031394),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__positive regulation of heat generation (GO:0031652),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__positive regulation of fever generation (GO:0031622),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__regulation of fever generation (GO:0031620),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.7629482071713147,1.0185474249615016,0.466403162055336,0.9588243556923703,1.0,1/1,23.86%,PTGS2
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.488,-1.017382336308592,0.41422594142259417,0.8762771715449074,1.0,3/3,51.69%,NLRC5;HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.7669322709163346,-1.0170529437609843,0.49272349272349275,0.8701773135072561,1.0,1/1,23.66%,AQP9
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.7669322709163346,-1.0170529437609843,0.49272349272349275,0.8701773135072561,1.0,1/1,23.66%,AQP9
prerank,GO_Biological_Process_2021__glycerol transport (GO:0015793),-0.7669322709163346,-1.0170529437609843,0.49272349272349275,0.8701773135072561,1.0,1/1,23.66%,AQP9
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.7669322709163346,-1.0170529437609843,0.49272349272349275,0.8701773135072561,1.0,1/1,23.66%,AQP9
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.7669322709163346,-1.0170529437609843,0.49272349272349275,0.8701773135072561,1.0,1/1,23.66%,AQP9
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.7669322709163346,-1.0170529437609843,0.49272349272349275,0.8701773135072561,1.0,1/1,23.66%,AQP9
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.7589641434262948,-1.0166585642521482,0.4777327935222672,0.8687769021749241,1.0,1/1,24.45%,SMTNL2
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),-0.7589641434262948,-1.0166585642521482,0.4777327935222672,0.8687769021749241,1.0,1/1,24.45%,SMTNL2
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.5823085083536701,-1.0166152410173115,0.4383561643835616,0.8663428277259927,1.0,1/2,5.17%,MIF
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.5823085083536701,-1.0166152410173115,0.4383561643835616,0.8663428277259927,1.0,1/2,5.17%,MIF
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.5888223552894211,-1.015632496732219,0.47010309278350515,0.867673234864445,1.0,2/2,41.55%,ERC2;BSN
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.482,1.0143565443539118,0.4498069498069498,0.9705946658130775,1.0,3/3,52.09%,ZC3H7A;TDRD7;RBM4B
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.48165502664300397,1.014218221612236,0.43,0.9692936618169435,1.0,1/3,2.58%,CITED2
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.5868263473053892,-1.0141326535931814,0.4519230769230769,0.8702297344822943,1.0,2/2,41.75%,PLEKHM2;MYH9
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.47600000000000003,-1.0128938497229039,0.3975659229208925,0.8711227203984446,1.0,3/3,52.88%,CDC7;CAMK1G;TBK1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.47600000000000003,-1.0128938497229039,0.3975659229208925,0.8711227203984446,1.0,3/3,52.88%,CDC7;CAMK1G;TBK1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.5768463073852296,1.0120172592126258,0.45778611632270166,0.9660838841220358,1.0,2/2,42.54%,CENPC;ITGB3BP
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.5768463073852296,1.0120172592126258,0.45778611632270166,0.9660838841220358,1.0,2/2,42.54%,CENPC;ITGB3BP
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.5768463073852296,1.0120172592126258,0.45778611632270166,0.9660838841220358,1.0,2/2,42.54%,CENPC;ITGB3BP
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.5768463073852296,1.0120172592126258,0.45778611632270166,0.9660838841220358,1.0,2/2,42.54%,CENPC;ITGB3BP
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.5768463073852296,1.0120172592126258,0.45778611632270166,0.9660838841220358,1.0,2/2,42.54%,CENPC;ITGB3BP
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.5768463073852296,1.0120172592126258,0.45778611632270166,0.9660838841220358,1.0,2/2,42.54%,CENPC;ITGB3BP
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.5808401281960826,-1.011953447247158,0.44216417910447764,0.8679909553442952,1.0,1/2,5.17%,MIF
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.5808401281960826,-1.011953447247158,0.44216417910447764,0.8679909553442952,1.0,1/2,5.17%,MIF
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.5808401281960826,-1.011953447247158,0.44216417910447764,0.8679909553442952,1.0,1/2,5.17%,MIF
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.5808401281960826,-1.011953447247158,0.44216417910447764,0.8679909553442952,1.0,1/2,5.17%,MIF
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.7549800796812749,-1.009981578838432,0.4912621359223301,0.8650444149774112,1.0,1/1,24.85%,NPLOC4
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.7549800796812749,-1.009981578838432,0.4912621359223301,0.8650444149774112,1.0,1/1,24.85%,NPLOC4
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.7549800796812749,-1.009981578838432,0.4912621359223301,0.8650444149774112,1.0,1/1,24.85%,NPLOC4
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.7549800796812749,-1.009981578838432,0.4912621359223301,0.8650444149774112,1.0,1/1,24.85%,NPLOC4
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.7549800796812749,-1.009981578838432,0.4912621359223301,0.8650444149774112,1.0,1/1,24.85%,NPLOC4
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.7549800796812749,-1.009981578838432,0.4912621359223301,0.8650444149774112,1.0,1/1,24.85%,NPLOC4
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.7549800796812749,-1.009981578838432,0.4912621359223301,0.8650444149774112,1.0,1/1,24.85%,NPLOC4
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5740744614710261,1.009734045808637,0.43452380952380953,0.9709441218828564,1.0,1/2,6.56%,DDIT4
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.5708582834331338,1.0092992041281008,0.4635108481262327,0.970780974921142,1.0,2/2,43.14%,AANAT;RRH
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.4231418894884236,1.0092498106738321,0.4340344168260038,0.9677833274470851,1.0,1/4,0.40%,FOS
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.4231418894884236,1.0092498106738321,0.4340344168260038,0.9677833274470851,1.0,1/4,0.40%,FOS
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.749003984063745,1.0086804798255178,0.4695121951219512,0.9525480816145769,1.0,1/1,25.25%,CHMP4C
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.749003984063745,1.0086804798255178,0.4695121951219512,0.9525480816145769,1.0,1/1,25.25%,CHMP4C
prerank,GO_Biological_Process_2021__ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611),0.749003984063745,1.0086804798255178,0.4695121951219512,0.9525480816145769,1.0,1/1,25.25%,CHMP4C
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.749003984063745,1.0086804798255178,0.4695121951219512,0.9525480816145769,1.0,1/1,25.25%,CHMP4C
prerank,GO_Biological_Process_2021__negative regulation of cytokinesis (GO:0032466),0.749003984063745,1.0086804798255178,0.4695121951219512,0.9525480816145769,1.0,1/1,25.25%,CHMP4C
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.749003984063745,1.0086804798255178,0.4695121951219512,0.9525480816145769,1.0,1/1,25.25%,CHMP4C
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.749003984063745,1.0086804798255178,0.4695121951219512,0.9525480816145769,1.0,1/1,25.25%,CHMP4C
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.749003984063745,1.0086804798255178,0.4695121951219512,0.9525480816145769,1.0,1/1,25.25%,CHMP4C
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.749003984063745,1.0086804798255178,0.4695121951219512,0.9525480816145769,1.0,1/1,25.25%,CHMP4C
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.749003984063745,1.0086804798255178,0.4695121951219512,0.9525480816145769,1.0,1/1,25.25%,CHMP4C
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),0.749003984063745,1.0086804798255178,0.4695121951219512,0.9525480816145769,1.0,1/1,25.25%,CHMP4C
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.2969619782423484,1.0071487066379432,0.4230055658627087,0.9552580910187458,1.0,4/10,16.50%,OPHN1;DDIT4;SPOCK1;ANOS1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.7569721115537849,1.006761753267826,0.4859437751004016,0.9548870741889375,1.0,1/1,24.45%,SEC23B
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.4869426469020883,1.0050144131905419,0.43664717348927873,0.9580869537138196,1.0,1/3,1.59%,OPHN1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.340743741007441,1.0049420897478711,0.4405850091407678,0.9567129539806406,1.0,2/7,4.37%,OPHN1;KANK1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.5808383233532936,1.0038665273602885,0.4720616570327553,0.9587622391129567,1.0,2/2,42.15%,RYR3;CYP27B1
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.47200000000000003,-1.0037370345547807,0.4541577825159915,0.8793977519500525,1.0,3/3,53.28%,LIPG;PLBD2;SMPD4
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__vascular wound healing (GO:0061042),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of mast cell chemotaxis (GO:0060754),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of retinal ganglion cell axon guidance (GO:0090259),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.750996015936255,1.002103227238378,0.510934393638171,0.8543897148227412,1.0,1/1,25.05%,VEGFA
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.5594326180796668,1.0006354593169462,0.47036328871892924,0.8570767782413753,1.0,1/2,3.78%,CYP26B1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.2560638956763922,1.0005130599842291,0.44363636363636366,0.8560739686478825,1.0,3/13,9.74%,COL2A1;LTF;PLOD2
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.7450199203187251,-0.9999287768798791,0.48770491803278687,0.8848500268291716,1.0,1/1,25.84%,PRPF8
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.7450199203187251,-0.9999287768798791,0.48770491803278687,0.8848500268291716,1.0,1/1,25.84%,PRPF8
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.7450199203187251,-0.9999287768798791,0.48770491803278687,0.8848500268291716,1.0,1/1,25.84%,PRPF8
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.4800000000000001,0.9987207300121701,0.43106796116504853,0.8593065864931708,1.0,3/3,52.29%,RAD23B;RPA4;GTF2H4
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.5708582834331337,0.9986456250066159,0.4673076923076923,0.8583171252543481,1.0,2/2,43.14%,GNB1;RRH
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5756827710842318,0.9982519656665513,0.46122448979591835,0.8580725452297827,1.0,1/2,6.56%,DDIT4
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.39367778513096774,0.997949321274249,0.4706994328922495,0.8576747052876162,1.0,3/5,25.05%,PTER;SOX8;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.5628742514970061,0.9979104638625047,0.46942800788954636,0.8543185262881624,1.0,2/2,43.94%,IFIT1;HACD3
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.5628742514970061,0.9979104638625047,0.46942800788954636,0.8543185262881624,1.0,2/2,43.94%,IFIT1;HACD3
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.5628742514970061,0.9979104638625047,0.46942800788954636,0.8543185262881624,1.0,2/2,43.94%,IFIT1;HACD3
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.5691894882064575,-0.9977279952666316,0.47096774193548385,0.8875679860667028,1.0,1/2,2.78%,EDNRB
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.5691894882064575,-0.9977279952666316,0.47096774193548385,0.8875679860667028,1.0,1/2,2.78%,EDNRB
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.750996015936255,-0.9972258064516122,0.5040650406504065,0.8881090154218583,1.0,1/1,25.25%,EIF4A1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.25839678261347415,-0.997113235257097,0.4476987447698745,0.8871730889936132,1.0,4/12,12.13%,MIF;RBPMS2;INSM1;LIF
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.7529880478087649,-0.9966327213640808,0.5155038759689923,0.8855959237980966,1.0,1/1,25.05%,PLEKHM2
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.7529880478087649,-0.9966327213640808,0.5155038759689923,0.8855959237980966,1.0,1/1,25.05%,PLEKHM2
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.1560827445404958,0.9963491721217924,0.46853146853146854,0.8565969690199443,1.0,29/50,46.12%,FOS;CITED2;NKX2-3;EGR1;ID3;EFEMP1;SPIN4;ZNF217;EPC2;ZNF420;JUN;ZNF521;SOX8;ZNF397;VEGFA;ZNF232;MAMLD1;ZNF813;CAPN3;ESRRG;ZIC2;STAT4;NFIL3;ZNF146;ZNF528;ZNF816;ZNF468;ZNF222;ZNF850
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.41709309588308474,-0.9960368037024353,0.44742268041237115,0.8860407403286708,1.0,2/4,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.5700615058501657,-0.9954694739691242,0.4589178356713427,0.8860481650265727,1.0,1/2,4.57%,SDC1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.56686626746507,0.9952880964742964,0.4689922480620155,0.8569819356357222,1.0,2/2,43.54%,RYR3;HCN1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.56686626746507,0.9952880964742964,0.4689922480620155,0.8569819356357222,1.0,2/2,43.54%,RYR3;HCN1
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.562874251497006,0.9924352110929104,0.49306930693069306,0.8622420541401146,1.0,2/2,43.94%,TECRL;HACD3
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.562874251497006,0.9924352110929104,0.49306930693069306,0.8622420541401146,1.0,2/2,43.94%,TECRL;HACD3
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.2926952545975188,0.9917724570789679,0.47093023255813954,0.8624892266979531,1.0,2/9,6.56%,DKK1;DDIT4
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.5571618402886765,-0.9906379980719651,0.481335952848723,0.8967697509595565,1.0,1/2,5.96%,NLRC5
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.38240140806334,-0.9898160285832276,0.4670781893004115,0.8977147329300272,1.0,3/5,19.09%,PSMB9;PSMB8;LGALS1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.5688622754491017,-0.9897772742335348,0.4832347140039448,0.8965139541812934,1.0,2/2,43.54%,CFC1B;WLS
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.4750231110238107,-0.9892287943342281,0.4570815450643777,0.8969063384559325,1.0,2/3,27.04%,EDNRB;HMGCR
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),-0.5548902195608783,-0.9891213865852381,0.4779270633397313,0.89345055203329,1.0,2/2,44.93%,RP1;TOPORS
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),-0.5548902195608783,-0.9891213865852381,0.4779270633397313,0.89345055203329,1.0,2/2,44.93%,RP1;TOPORS
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),-0.5548902195608783,-0.9891213865852381,0.4779270633397313,0.89345055203329,1.0,2/2,44.93%,RP1;TOPORS
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.5657111501559396,-0.9888154555007606,0.4914933837429111,0.8916625407906333,1.0,1/2,5.17%,MIF
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.5657111501559396,-0.9888154555007606,0.4914933837429111,0.8916625407906333,1.0,1/2,5.17%,MIF
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.47537209972909533,0.9884744627625477,0.4540229885057471,0.8688759589546105,1.0,2/3,25.05%,GPNMB;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.47537209972909533,0.9884744627625477,0.4540229885057471,0.8688759589546105,1.0,2/3,25.05%,GPNMB;VEGFA
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.7430278884462151,0.987966708069259,0.5250501002004008,0.8667323018302291,1.0,1/1,25.84%,LUM
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.7430278884462151,0.987966708069259,0.5250501002004008,0.8667323018302291,1.0,1/1,25.84%,LUM
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.7430278884462151,0.987966708069259,0.5250501002004008,0.8667323018302291,1.0,1/1,25.84%,LUM
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.5688622754491017,-0.9875444276555649,0.4820717131474104,0.8929411813403546,1.0,2/2,43.54%,PLPP3;WLS
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.34129904778675635,0.9863693565691571,0.45714285714285713,0.8693720355684577,1.0,1/6,0.20%,DKK1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.3871183131393112,0.9856344477577307,0.4603174603174603,0.870189520418595,1.0,4/5,43.54%,EGR1;RYR3;AANAT;HCN1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.7410358565737052,-0.9846364019616733,0.5262096774193549,0.8969961526061908,1.0,1/1,26.24%,LYAR
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.7410358565737052,-0.9846364019616733,0.5262096774193549,0.8969961526061908,1.0,1/1,26.24%,LYAR
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.7410358565737052,-0.9846364019616733,0.5262096774193549,0.8969961526061908,1.0,1/1,26.24%,LYAR
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__negative regulation of lipid transport (GO:0032369),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.7470119521912351,-0.9843749999999992,0.5575396825396826,0.8677256809949325,1.0,1/1,25.65%,FIS1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.4228456913827655,-0.9842669076163553,0.4575569358178054,0.8668702700658129,1.0,4/4,58.25%,CXCL8;GGT5;IRAK3;CYP27B1
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.3496396950861645,0.983439041513485,0.48044692737430167,0.8746499460294463,1.0,1/6,0.20%,DKK1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.37489963598207715,-0.9808623253003371,0.46887966804979253,0.8748934177689085,1.0,3/5,14.71%,SHISA2;PSMB9;PSMB8
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.38242925747453266,0.9808507211892461,0.45955882352941174,0.8798890408816681,1.0,1/5,0.40%,FOS
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.5548902195608783,-0.98033573931296,0.47808764940239046,0.8747989034281974,1.0,2/2,44.93%,PHB2;TOPORS
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.5548902195608783,-0.9794956099284431,0.5099601593625498,0.8755730380806896,1.0,2/2,44.93%,DTX1;TOPORS
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.560878243512974,0.9794635372302815,0.49242424242424243,0.8823081728624953,1.0,2/2,44.14%,IRAK3;PKIB
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.7310756972111554,-0.9785843137461142,0.5187376725838264,0.8734595169465357,1.0,1/1,27.24%,FGF9
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.7310756972111554,-0.9785843137461142,0.5187376725838264,0.8734595169465357,1.0,1/1,27.24%,FGF9
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.7310756972111554,-0.9785843137461142,0.5187376725838264,0.8734595169465357,1.0,1/1,27.24%,FGF9
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.7310756972111554,-0.9785843137461142,0.5187376725838264,0.8734595169465357,1.0,1/1,27.24%,FGF9
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.4088176352705411,0.9781175244485278,0.49710982658959535,0.8844410911673746,1.0,4/4,59.44%,TMEM237;CDKN2AIP;DTX1;PPP2R1A
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.5588822355289421,-0.9780791503117797,0.5116772823779193,0.8723769096619481,1.0,2/2,44.53%,LYAR;ABCB10
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.5588822355289421,-0.9780791503117797,0.5116772823779193,0.8723769096619481,1.0,2/2,44.53%,LYAR;ABCB10
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.5461425844702241,-0.9777038995874191,0.5009823182711198,0.8719735568117499,1.0,1/2,3.18%,ISG15
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.35304597351519085,0.9766214084392097,0.4863883847549909,0.8872525683404545,1.0,2/6,9.15%,LRP2;LRP1B
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.4594003455830832,0.9764089512127261,0.49616858237547895,0.8865072715008887,1.0,1/3,1.39%,LTF
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.468,-0.9761988277674128,0.4686868686868687,0.874404429746583,1.0,3/3,53.68%,DTX3L;TOPORS;BMI1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.557219445423655,-0.9761897561756758,0.49173553719008267,0.8732654213819999,1.0,1/2,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.5386854825478677,-0.9745596881437145,0.4959183673469388,0.8761281217085196,1.0,1/2,7.75%,GPX1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.5528942115768463,-0.9743109753672714,0.4879032258064516,0.8754730521398774,1.0,2/2,45.13%,PHB2;EIF4G1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.26415271395296636,-0.9742382827127268,0.47890295358649787,0.8744713750786832,1.0,6/11,27.24%,BDNF;ATP6V0D1;AP2M1;STMN1;IRS4;FGF9
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.5508982035928143,-0.9740067979945226,0.5300970873786408,0.8739847998670165,1.0,2/2,45.33%,COPE;COG3
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.7330677290836654,-0.9727531516876785,0.5365384615384615,0.8693797277268559,1.0,1/1,27.04%,HMGCR
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),-0.7330677290836654,-0.9727531516876785,0.5365384615384615,0.8693797277268559,1.0,1/1,27.04%,HMGCR
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.7330677290836654,-0.9727531516876785,0.5365384615384615,0.8693797277268559,1.0,1/1,27.04%,HMGCR
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.7330677290836654,-0.9727531516876785,0.5365384615384615,0.8693797277268559,1.0,1/1,27.04%,HMGCR
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.7330677290836654,-0.9727531516876785,0.5365384615384615,0.8693797277268559,1.0,1/1,27.04%,HMGCR
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.7330677290836654,-0.9727531516876785,0.5365384615384615,0.8693797277268559,1.0,1/1,27.04%,HMGCR
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.7330677290836654,-0.9727531516876785,0.5365384615384615,0.8693797277268559,1.0,1/1,27.04%,HMGCR
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.3420523138832998,-0.9725690879671581,0.4536290322580645,0.8687417741037324,1.0,6/6,66.40%,RAB3C;RAB15;ANK1;NLGN1;LIN7C;CAPN3
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3440643863179075,0.9720904676695111,0.4949290060851927,0.8943733890698987,1.0,6/6,66.00%,FCGR3A;VIP;GNB1;MYH9;GGT5;ADCY3
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3440643863179075,0.9720904676695111,0.4949290060851927,0.8943733890698987,1.0,6/6,66.00%,FCGR3A;VIP;GNB1;MYH9;GGT5;ADCY3
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.47000000000000014,0.9719191741714492,0.48940269749518306,0.8935543835973178,1.0,3/3,53.28%,CHMP4C;CENPC;PSRC1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.38001103296284267,-0.9714555542881795,0.48577680525164113,0.8700293692955788,1.0,2/5,7.95%,RIT2;BDNF
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.7290836653386454,-0.9710891005380494,0.5378486055776892,0.8697251292499306,1.0,1/1,27.44%,ERC2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.5588822355289421,-0.9704954439281986,0.5125,0.8705382356775099,1.0,2/2,44.53%,FIS1;ABCB10
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.5449101796407185,-0.9684545072069024,0.49696969696969695,0.8741782819687738,1.0,2/2,45.92%,EGR2;XPO4
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.5489021956087824,-0.967955061829912,0.494949494949495,0.8741440879158485,1.0,2/2,45.53%,FIS1;TMEM33
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.7250996015936255,0.9669951071193222,0.537109375,0.9023871839373264,1.0,1/1,27.63%,LPAR1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.7250996015936255,0.9669951071193222,0.537109375,0.9023871839373264,1.0,1/1,27.63%,LPAR1
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.7250996015936255,0.9669951071193222,0.537109375,0.9023871839373264,1.0,1/1,27.63%,LPAR1
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.7270916334661355,0.9667045024593272,0.5436507936507936,0.9018342177451972,1.0,1/1,27.44%,CKB
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.3531518370177156,0.9665403449272564,0.5137254901960784,0.9011428001074041,1.0,2/6,6.56%,RELN;DDIT4
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.7310756972111554,0.9649996376774086,0.5708661417322834,0.9025331191363481,1.0,1/1,27.04%,MTFR1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.7310756972111554,0.9649996376774086,0.5708661417322834,0.9025331191363481,1.0,1/1,27.04%,MTFR1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.5528942115768463,-0.9633303482116178,0.5276190476190477,0.8838258785193905,1.0,2/2,45.13%,PTPN3;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.5536351758284213,-0.9631730186221923,0.524008350730689,0.8820618366060697,1.0,1/2,4.57%,SDC1
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.5536351758284213,-0.9631730186221923,0.524008350730689,0.8820618366060697,1.0,1/2,4.57%,SDC1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.36144578313253006,-0.9610077218576989,0.5031315240083507,0.8855614456905624,1.0,5/5,64.41%,PLPP3;SMPD4;HACD3;PLPP2;FA2H
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.37747705488347694,-0.960846438458378,0.49190283400809715,0.8848500617435474,1.0,4/5,41.75%,VWF;SYT4;RIMS3;MYH9
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.5449101796407185,0.9608010425241779,0.52,0.9122363470137619,1.0,2/2,45.73%,VEGFA;CAPN7
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.3469448200362862,0.9607882569220484,0.4896810506566604,0.9110482920069092,1.0,3/6,21.47%,PLOD2;METTL21C;RANBP2
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.46128288091997305,-0.9606955393932757,0.4885654885654886,0.8842920800435876,1.0,1/3,2.39%,PCSK1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.20949111787071747,0.9595502888544188,0.48638132295719844,0.9131292408381565,1.0,6/19,16.70%,MAN2A1;PLOD2;KBTBD7;DNAJC3;FCGR3A;LHPP
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.4072867312187114,-0.9591228484098152,0.5080971659919028,0.8865617313162477,1.0,2/4,14.71%,EGR2;PSMB8
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.37349397590361455,0.9582811016132902,0.5088757396449705,0.9150399143295685,1.0,5/5,63.02%,CEP120;NLGN1;PLPPR5;ANLN;CCL21
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.7171314741035857,0.9579617263478687,0.5621052631578948,0.909777735433397,1.0,1/1,28.43%,PEX6
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.7171314741035857,0.9579617263478687,0.5621052631578948,0.909777735433397,1.0,1/1,28.43%,PEX6
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.7171314741035857,0.9579617263478687,0.5621052631578948,0.909777735433397,1.0,1/1,28.43%,PEX6
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.7171314741035857,0.9579617263478687,0.5621052631578948,0.909777735433397,1.0,1/1,28.43%,PEX6
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.7171314741035857,0.9579617263478687,0.5621052631578948,0.909777735433397,1.0,1/1,28.43%,PEX6
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.45602659561267056,-0.9576379081832378,0.5136842105263157,0.8891099686130883,1.0,1/3,2.98%,AHNAK2
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.5528942115768463,-0.9571822217404057,0.5411522633744856,0.8891902374156558,1.0,2/2,45.13%,EIF4A1;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.5409181636726547,-0.9570088813852059,0.5082644628099173,0.8882931244884116,1.0,2/2,46.32%,FIS1;NACC2
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.3447698906605812,-0.9567243564224815,0.5,0.8879210108040718,1.0,5/6,45.13%,RPLP2;DTX1;NXF1;TOPORS;EIF4G1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.5416101832279617,0.9558936013154816,0.5585412667946257,0.9122436424999129,1.0,1/2,4.37%,KANK1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.5416101832279617,0.9558936013154816,0.5585412667946257,0.9122436424999129,1.0,1/2,4.37%,KANK1
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.7111553784860558,0.955784520525718,0.5616161616161616,0.8971475011903922,1.0,1/1,29.03%,VIP
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.7111553784860558,0.955784520525718,0.5616161616161616,0.8971475011903922,1.0,1/1,29.03%,VIP
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.7111553784860558,0.955784520525718,0.5616161616161616,0.8971475011903922,1.0,1/1,29.03%,VIP
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.7111553784860558,0.955784520525718,0.5616161616161616,0.8971475011903922,1.0,1/1,29.03%,VIP
prerank,GO_Biological_Process_2021__regulation of epinephrine secretion (GO:0014060),0.7111553784860558,0.955784520525718,0.5616161616161616,0.8971475011903922,1.0,1/1,29.03%,VIP
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.7111553784860558,0.955784520525718,0.5616161616161616,0.8971475011903922,1.0,1/1,29.03%,VIP
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),0.7111553784860558,0.955784520525718,0.5616161616161616,0.8971475011903922,1.0,1/1,29.03%,VIP
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.7111553784860558,0.955784520525718,0.5616161616161616,0.8971475011903922,1.0,1/1,29.03%,VIP
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.7111553784860558,0.955784520525718,0.5616161616161616,0.8971475011903922,1.0,1/1,29.03%,VIP
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.7111553784860558,0.955784520525718,0.5616161616161616,0.8971475011903922,1.0,1/1,29.03%,VIP
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.7111553784860558,0.955784520525718,0.5616161616161616,0.8971475011903922,1.0,1/1,29.03%,VIP
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.7111553784860558,0.955784520525718,0.5616161616161616,0.8971475011903922,1.0,1/1,29.03%,VIP
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.7111553784860558,0.955784520525718,0.5616161616161616,0.8971475011903922,1.0,1/1,29.03%,VIP
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.4544901066270752,-0.954799017159569,0.49369747899159666,0.8909304843414739,1.0,1/3,0.60%,CHI3L1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.7091633466135459,0.9541953547692834,0.5557620817843866,0.8974725940965784,1.0,1/1,29.22%,CCNA2
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.7091633466135459,0.9541953547692834,0.5557620817843866,0.8974725940965784,1.0,1/1,29.22%,CCNA2
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.7091633466135459,0.9541953547692834,0.5557620817843866,0.8974725940965784,1.0,1/1,29.22%,CCNA2
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.25609756097560976,-0.9537735783723005,0.4989429175475687,0.8919391693229338,1.0,11/11,75.15%,PHB2;MICAL2;NPLOC4;PLEKHM2;CNTNAP1;ANK1;COG3;SMPD4;PEX6;MTFR1;CHMP4C
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.33491582612600335,-0.9533387606807883,0.5227272727272727,0.8916357074877281,1.0,5/6,47.91%,CHSY3;DSEL;GGT5;SLC26A2;CHST9
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.25151188849342354,-0.9530591965444275,0.48043478260869565,0.8910076161826289,1.0,3/12,10.34%,FABP3;CXCL8;INSM1
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.4630760737515981,0.9527241564765044,0.5091649694501018,0.9002586129392793,1.0,1/3,2.58%,CITED2
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.36144578313253006,-0.9525755912619704,0.5210084033613446,0.8910438601002911,1.0,5/5,64.41%,PLPP3;PPP2R1A;SMPD4;PLPP2;FA2H
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.5369261477045908,-0.9519695352195048,0.5426829268292683,0.8912525244184463,1.0,2/2,46.72%,AP2M1;GDI1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.5389221556886227,-0.9504304551801925,0.53276955602537,0.8920863816265453,1.0,2/2,46.52%,CCL21;RASSF2
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.5389221556886227,-0.9504304551801925,0.53276955602537,0.8920863816265453,1.0,2/2,46.52%,CCL21;RASSF2
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.7211155378486056,0.9504067608784583,0.5798816568047337,0.904148839302441,1.0,1/1,28.03%,ZNRF3
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.4665803955044995,0.9497679973411217,0.5117647058823529,0.904610273892056,1.0,2/3,21.07%,RELN;SOX8
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.5449101796407186,0.9490612790893082,0.5291828793774319,0.9050592553709214,1.0,2/2,45.73%,CAPN3;CAPN7
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.3747838422676943,-0.947986513268357,0.498,0.8965234108408171,1.0,2/5,6.76%,MIF;CXCL8
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.5289051024909945,-0.947708602889663,0.5195071868583162,0.8960693920925641,1.0,1/2,7.75%,GPX1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.7151394422310757,0.9475846415348204,0.5680933852140078,0.9040136865014406,1.0,1/1,28.63%,TAF11
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.7151394422310757,0.9475846415348204,0.5680933852140078,0.9040136865014406,1.0,1/1,28.63%,TAF11
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.7151394422310757,0.9475846415348204,0.5680933852140078,0.9040136865014406,1.0,1/1,28.63%,TAF11
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.7151394422310757,0.9475846415348204,0.5680933852140078,0.9040136865014406,1.0,1/1,28.63%,TAF11
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.40622180916670375,0.9474291629431539,0.5029940119760479,0.903178641125903,1.0,1/4,1.19%,HSD17B2
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.7211155378486056,-0.9473339875695128,0.592741935483871,0.8959923970762035,1.0,1/1,28.23%,PCP4
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),-0.7091633466135459,-0.9467681418947741,0.5971943887775552,0.8916650631742856,1.0,1/1,29.42%,DSEL
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),-0.7091633466135459,-0.9467681418947741,0.5971943887775552,0.8916650631742856,1.0,1/1,29.42%,DSEL
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.7091633466135459,-0.9467681418947741,0.5971943887775552,0.8916650631742856,1.0,1/1,29.42%,DSEL
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.7091633466135459,-0.9467681418947741,0.5971943887775552,0.8916650631742856,1.0,1/1,29.42%,DSEL
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),-0.7091633466135459,-0.9467681418947741,0.5971943887775552,0.8916650631742856,1.0,1/1,29.42%,DSEL
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.5553344117521924,0.9467483194602917,0.56,0.9022399013242128,1.0,1/2,1.79%,DEFA4
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.5553344117521924,0.9467483194602917,0.56,0.9022399013242128,1.0,1/2,1.79%,DEFA4
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.36144578313253006,-0.946392587375303,0.5096359743040685,0.8914239075544519,1.0,5/5,64.41%,PCSK1;PLPP3;HACD3;PLPP2;FA2H
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.2834803088885012,0.9449040006173717,0.5418250950570342,0.9055725100999875,1.0,4/9,25.84%,COL2A1;PLOD2;EXOC8;LUM
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.45199999999999996,0.9449008390762499,0.5225048923679061,0.9044289032552798,1.0,3/3,55.07%,PLOD2;TET1;COG3
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.5329341317365269,-0.9444472453851367,0.5309168443496801,0.893640505163045,1.0,2/2,47.12%,DCTN1;PSRC1
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.5329341317365269,-0.9444472453851367,0.5309168443496801,0.893640505163045,1.0,2/2,47.12%,DCTN1;PSRC1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.703187250996016,-0.9406307977736548,0.6094674556213018,0.8989250117180467,1.0,1/1,30.02%,RIMS3
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.703187250996016,-0.9406307977736548,0.6094674556213018,0.8989250117180467,1.0,1/1,30.02%,RIMS3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.703187250996016,-0.9406307977736548,0.6094674556213018,0.8989250117180467,1.0,1/1,30.02%,RIMS3
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.3130688441351287,-0.9394983443820232,0.5222672064777328,0.9005298159146083,1.0,3/7,14.71%,PSMB9;RSPO2;PSMB8
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.39180686426750644,-0.9383159258781726,0.5306122448979592,0.9018732520253466,1.0,2/4,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.5345760715205785,-0.9375547496855727,0.5526881720430108,0.9023421746301994,1.0,1/2,7.75%,GPX1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.5275378339930624,-0.93734678082898,0.546875,0.9015994503152699,1.0,1/2,4.57%,SDC1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.7071713147410359,0.9369585364870853,0.5916030534351145,0.9175834255932251,1.0,1/1,29.42%,AK3
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7071713147410359,0.9369585364870853,0.5916030534351145,0.9175834255932251,1.0,1/1,29.42%,AK3
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.7071713147410359,0.9369585364870853,0.5916030534351145,0.9175834255932251,1.0,1/1,29.42%,AK3
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.7071713147410359,0.9369585364870853,0.5916030534351145,0.9175834255932251,1.0,1/1,29.42%,AK3
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.7071713147410359,0.9369585364870853,0.5916030534351145,0.9175834255932251,1.0,1/1,29.42%,AK3
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.5369261477045908,-0.9360937971917442,0.5392156862745098,0.9040958871920451,1.0,2/2,46.72%,FIS1;GDI1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.45216312470973585,0.9357437739158858,0.5359848484848485,0.9192305131985099,1.0,2/3,23.86%,S100A12;PTGS2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.703187250996016,0.933636983031025,0.5943204868154158,0.907911812837654,1.0,1/1,29.82%,GPAM
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.5309381237524953,0.9328188364711104,0.5858778625954199,0.9087852561603511,1.0,2/2,47.12%,FA2H;SMPD4
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.45527506332832834,0.9319859652825527,0.5742574257425742,0.9093312569375961,1.0,2/3,27.63%,SPOCK1;LPAR1
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.365614104611347,0.9319210659331914,0.5224171539961013,0.9083669629903914,1.0,3/5,25.05%,EFNA1;GPNMB;VEGFA
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.5329341317365269,-0.9308473685881298,0.5814432989690722,0.9153214146102346,1.0,2/2,47.12%,RP1;PSRC1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.28085118538629084,0.9305352352387029,0.5328330206378987,0.9103940003088641,1.0,8/9,55.47%,FANCL;UBA1;SMC5;XRCC2;CDKN2AIP;GTF2H4;EID3;TOPORS
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.5337810773226662,-0.929985815982074,0.5847107438016529,0.9157642424283652,1.0,1/2,5.77%,IRX3
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.31257489499135227,0.9297406919133754,0.533457249070632,0.9108724030087744,1.0,5/7,43.54%,EGR1;RYR3;GNB1;AANAT;HCN1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.4439999999999999,0.9296777239588057,0.5533980582524272,0.9099217525072656,1.0,3/3,55.86%,VIP;EIF4G1;ABCB10
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.452,-0.9293178315911513,0.5793650793650794,0.916233287221622,1.0,3/3,55.27%,EIF4G1;CDKN2AIP;TAF9B
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.43463853383426254,-0.9289544984939961,0.5110663983903421,0.9163542483157915,1.0,2/3,25.65%,GPX1;FIS1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.36615728135484316,0.9286884354024283,0.5437616387337058,0.9111156246598927,1.0,2/5,12.52%,PLOD2;DNAJC3
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.39982736781386174,-0.9270787034246745,0.5403726708074534,0.9181861395889687,1.0,1/4,1.19%,FABP5
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.39982736781386174,-0.9270787034246745,0.5403726708074534,0.9181861395889687,1.0,1/4,1.19%,FABP5
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.5374142397630828,-0.9266655556570463,0.5687022900763359,0.9156935008798015,1.0,1/2,5.17%,MIF
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.5374142397630828,-0.9266655556570463,0.5687022900763359,0.9156935008798015,1.0,1/2,5.17%,MIF
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.5374142397630828,-0.9266655556570463,0.5687022900763359,0.9156935008798015,1.0,1/2,5.17%,MIF
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.701195219123506,0.9261828445677661,0.6404040404040404,0.9159674324862392,1.0,1/1,30.02%,UBA1
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.4407723736617428,0.9258152696323099,0.5445736434108527,0.9156041331000601,1.0,1/3,2.98%,LRP2
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.3408808764203819,0.9250176573637436,0.5444444444444444,0.9167044008475022,1.0,5/6,49.30%,RMI1;ZFYVE26;RPA4;SMC5;XRCC2
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.6932270916334662,0.924632233815048,0.6016260162601627,0.9152467156337784,1.0,1/1,30.82%,SLC40A1
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.6932270916334662,0.924632233815048,0.6016260162601627,0.9152467156337784,1.0,1/1,30.82%,SLC40A1
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.701195219123506,-0.9241352673142258,0.6242544731610338,0.9201455357287014,1.0,1/1,30.22%,FAM110C
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.5249500998003992,-0.9225426988419418,0.5894308943089431,0.9216372640390884,1.0,2/2,47.91%,CHSY3;CHST9
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.5249500998003992,-0.9225426988419418,0.5894308943089431,0.9216372640390884,1.0,2/2,47.91%,CHSY3;CHST9
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3858304221209117,-0.9224226458999097,0.5608695652173913,0.918761297413508,1.0,3/4,32.60%,AP2M1;DCTN1;DCTN3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.3858304221209117,-0.9224226458999097,0.5608695652173913,0.918761297413508,1.0,3/4,32.60%,AP2M1;DCTN1;DCTN3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.3858304221209117,-0.9224226458999097,0.5608695652173913,0.918761297413508,1.0,3/4,32.60%,AP2M1;DCTN1;DCTN3
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.30535717062026213,-0.9223605856278129,0.5313725490196078,0.9177245871585771,1.0,2/7,5.17%,ISG15;MIF
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.4432253595419965,0.9216559178977553,0.5747126436781609,0.9204955706625269,1.0,2/3,25.05%,LRP2;VEGFA
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.22061104976275864,0.9204116002361975,0.549718574108818,0.9220511710092688,1.0,13/16,59.44%,BBS5;EXOC8;MAK;TMEM237;CEP19;EXOC5;EXOC6;SSX2IP;RAB3IP;DYNLRB2;RP1;OFD1;PPP2R1A
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.5282535802407118,0.9203267911668132,0.594488188976378,0.9210902300851149,1.0,1/2,1.59%,OPHN1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.5271756691780277,0.9193914727978061,0.5737704918032787,0.9220148035752298,1.0,1/2,1.39%,LTF
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.19522922867289597,0.9185563367306565,0.5338208409506399,0.9225514968452707,1.0,8/22,25.05%,DKK1;CITED2;ID3;EFNA1;ZNF217;JUN;SOX8;VEGFA
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.4441651481587307,-0.9182307945737943,0.5613682092555332,0.9255049542099406,1.0,2/3,26.44%,SDC1;SDC3
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.32420829605608187,0.9179588893937161,0.5674157303370787,0.9217540608180256,1.0,2/6,8.75%,RAD23B;OTUD1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.32420829605608187,0.9179588893937161,0.5674157303370787,0.9217540608180256,1.0,2/6,8.75%,RAD23B;OTUD1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.38637802449922687,0.917935862359723,0.5477099236641222,0.9206660666736642,1.0,1/4,1.39%,LTF
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.43999999999999995,0.9174919526859452,0.5731225296442688,0.9206684934829692,1.0,3/3,56.26%,VEGFA;TOPORS;RP1
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.43999999999999984,0.9168855681941718,0.5850202429149798,0.920895504770328,1.0,3/3,56.26%,SOX8;TOPORS;RP1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.5289421157684631,-0.916576302606449,0.5484536082474227,0.9270493448836157,1.0,2/2,47.51%,PI4KA;IMPA1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.5289421157684631,-0.916576302606449,0.5484536082474227,0.9270493448836157,1.0,2/2,47.51%,PI4KA;IMPA1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.5240671334772706,0.9153273824936333,0.6080808080808081,0.9230962314610232,1.0,1/2,3.58%,LAMP5
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.6832669322709163,-0.9138812999245443,0.623046875,0.930895500111727,1.0,1/1,32.01%,BLVRB
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.6832669322709163,-0.9138812999245443,0.623046875,0.930895500111727,1.0,1/1,32.01%,BLVRB
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.428,-0.9131062816452146,0.5687103594080338,0.9320599131098948,1.0,3/3,57.65%,FNDC4;LYAR;IRAK3
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.6832669322709164,0.9127135348226013,0.6419753086419753,0.9277105140407178,1.0,1/1,31.81%,UBR3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.6872509960159362,-0.9126799108047845,0.6340996168582376,0.9244142993898545,1.0,1/1,31.61%,PTPN3
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.6872509960159362,-0.9126799108047845,0.6340996168582376,0.9244142993898545,1.0,1/1,31.61%,PTPN3
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.6872509960159362,-0.9126799108047845,0.6340996168582376,0.9244142993898545,1.0,1/1,31.61%,PTPN3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.6872509960159362,-0.9126799108047845,0.6340996168582376,0.9244142993898545,1.0,1/1,31.61%,PTPN3
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.6872509960159362,-0.9126799108047845,0.6340996168582376,0.9244142993898545,1.0,1/1,31.61%,PTPN3
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.6872509960159362,-0.9126799108047845,0.6340996168582376,0.9244142993898545,1.0,1/1,31.61%,PTPN3
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.6872509960159362,-0.9126799108047845,0.6340996168582376,0.9244142993898545,1.0,1/1,31.61%,PTPN3
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.6872509960159362,-0.9126799108047845,0.6340996168582376,0.9244142993898545,1.0,1/1,31.61%,PTPN3
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.3795903955153194,-0.9125757859619017,0.5543933054393305,0.9234828023590184,1.0,2/4,11.53%,BDNF;CLSTN2
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.3927855711422845,-0.9121139815212391,0.5488565488565489,0.9232054046081122,1.0,4/4,61.23%,GAP43;CCL21;PLPPR5;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.43735788429125944,0.9117971094973614,0.5874524714828897,0.9287496109703516,1.0,2/3,25.05%,LTF;VEGFA
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.34864142387766744,0.910913843110024,0.549407114624506,0.9296528169434739,1.0,2/5,12.13%,RAD23B;KBTBD7
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6713147410358566,0.909986035043314,0.6282828282828283,0.9305386722493906,1.0,1/1,33.00%,CORO2B
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),0.6872509960159363,0.9097326758370095,0.6437007874015748,0.9201532674252091,1.0,1/1,31.41%,GNB1
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),0.6872509960159363,0.9097326758370095,0.6437007874015748,0.9201532674252091,1.0,1/1,31.41%,GNB1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.6872509960159363,0.9097326758370095,0.6437007874015748,0.9201532674252091,1.0,1/1,31.41%,GNB1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6872509960159363,0.9097326758370095,0.6437007874015748,0.9201532674252091,1.0,1/1,31.41%,GNB1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6872509960159363,0.9097326758370095,0.6437007874015748,0.9201532674252091,1.0,1/1,31.41%,GNB1
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),0.6872509960159363,0.9097326758370095,0.6437007874015748,0.9201532674252091,1.0,1/1,31.41%,GNB1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.6872509960159363,0.9097326758370095,0.6437007874015748,0.9201532674252091,1.0,1/1,31.41%,GNB1
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),0.6872509960159363,0.9097326758370095,0.6437007874015748,0.9201532674252091,1.0,1/1,31.41%,GNB1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),0.6872509960159363,0.9097326758370095,0.6437007874015748,0.9201532674252091,1.0,1/1,31.41%,GNB1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.6872509960159363,0.9097326758370095,0.6437007874015748,0.9201532674252091,1.0,1/1,31.41%,GNB1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.5205459354450523,-0.9082276013128598,0.611439842209073,0.9304515759154418,1.0,1/2,8.95%,PHB2
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.4373526448740749,0.9076431548225479,0.5764023210831721,0.9236646679516464,1.0,2/3,26.64%,FOLH1;FOLH1B
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.434,-0.9074865900316944,0.5426695842450766,0.9311948513061437,1.0,3/3,57.06%,SLC10A4;SLC16A14;SLC16A9
prerank,GO_Biological_Process_2021__tonic smooth muscle contraction (GO:0014820),0.6812749003984064,0.9071714869747601,0.635814889336016,0.9140418900626809,1.0,1/1,32.01%,MYLK
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.6812749003984064,0.9071714869747601,0.635814889336016,0.9140418900626809,1.0,1/1,32.01%,MYLK
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.6812749003984064,0.9071714869747601,0.635814889336016,0.9140418900626809,1.0,1/1,32.01%,MYLK
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.6812749003984064,0.9071714869747601,0.635814889336016,0.9140418900626809,1.0,1/1,32.01%,MYLK
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.6812749003984064,0.9071714869747601,0.635814889336016,0.9140418900626809,1.0,1/1,32.01%,MYLK
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.6812749003984064,0.9071714869747601,0.635814889336016,0.9140418900626809,1.0,1/1,32.01%,MYLK
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.6812749003984064,0.9071714869747601,0.635814889336016,0.9140418900626809,1.0,1/1,32.01%,MYLK
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.6812749003984064,0.9071714869747601,0.635814889336016,0.9140418900626809,1.0,1/1,32.01%,MYLK
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.6812749003984064,0.9071714869747601,0.635814889336016,0.9140418900626809,1.0,1/1,32.01%,MYLK
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.6812749003984064,0.9071714869747601,0.635814889336016,0.9140418900626809,1.0,1/1,32.01%,MYLK
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070426),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.5129740518962076,0.9054668265832131,0.6015625,0.9007433436177843,1.0,2/2,48.91%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.689243027888446,0.9046274032151366,0.6526104417670683,0.8993312222078476,1.0,1/1,31.21%,LEMD3
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.689243027888446,0.9046274032151366,0.6526104417670683,0.8993312222078476,1.0,1/1,31.21%,LEMD3
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.689243027888446,0.9046274032151366,0.6526104417670683,0.8993312222078476,1.0,1/1,31.21%,LEMD3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.517971363171462,-0.9045588154875843,0.5849056603773585,0.9352418383730683,1.0,1/2,5.77%,IRX3
prerank,GO_Biological_Process_2021__His-Purkinje system development (GO:0003164),-0.517971363171462,-0.9045588154875843,0.5849056603773585,0.9352418383730683,1.0,1/2,5.77%,IRX3
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.6752988047808764,-0.9043244430398043,0.6365461847389559,0.9336246521094287,1.0,1/1,32.80%,RNF165
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.6752988047808764,-0.9043244430398043,0.6365461847389559,0.9336246521094287,1.0,1/1,32.80%,RNF165
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.34681777002045905,0.9027621115534527,0.5803212851405622,0.9010115982970722,1.0,3/5,25.05%,RELN;EFNA1;VEGFA
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.34681777002045905,0.9027621115534527,0.5803212851405622,0.9010115982970722,1.0,3/5,25.05%,RELN;EFNA1;VEGFA
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.32192811765331425,0.9016937619940344,0.5716945996275605,0.9023948191914011,1.0,5/6,50.70%,CASQ1;IMMP2L;CENPC;HSPA1A;ANLN
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.6713147410358565,-0.9011159525677214,0.6295503211991434,0.938976853087947,1.0,1/1,33.20%,CDH8
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.6713147410358565,-0.9011159525677214,0.6295503211991434,0.938976853087947,1.0,1/1,33.20%,CDH8
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.38026712100338445,-0.900551334453213,0.5788336933045356,0.9390424839475578,1.0,2/4,7.75%,HBA1;GPX1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.3773241790102522,-0.8984370391245,0.5892116182572614,0.9426566247118272,1.0,2/4,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.4310137182091517,0.8983305075511099,0.5962264150943396,0.9071474601466243,1.0,1/3,4.77%,RELN
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.4310137182091517,0.8983305075511099,0.5962264150943396,0.9071474601466243,1.0,1/3,4.77%,RELN
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.428,-0.8973314435697498,0.57,0.9439305110799906,1.0,3/3,57.65%,HMGCR;PTPN3;IRAK3
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.4329060282871613,0.897101965739847,0.580896686159844,0.908322925039526,1.0,2/3,27.63%,VEGFA;LPAR1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.3124975892111568,0.896637677114903,0.5762081784386617,0.9072166537974719,1.0,1/6,0.60%,COL2A1
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.3124975892111568,0.896637677114903,0.5762081784386617,0.9072166537974719,1.0,1/6,0.60%,COL2A1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.5249500998003992,-0.8964226122306487,0.6333333333333333,0.9451376354946032,1.0,2/2,47.91%,COG3;CHST9
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.38136166091394225,-0.8963372606535914,0.5836909871244635,0.9441937160261786,1.0,2/4,11.93%,RIT2;RAB3C
prerank,GO_Biological_Process_2021__nodal signaling pathway (GO:0038092),-0.6733067729083665,-0.8961040298169393,0.6679611650485436,0.942596219643359,1.0,1/1,33.00%,CFC1B
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),-0.6733067729083665,-0.8961040298169393,0.6679611650485436,0.942596219643359,1.0,1/1,33.00%,CFC1B
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.42646009159070863,0.8949019865112349,0.5929549902152642,0.9100168773349571,1.0,1/3,3.18%,CEACAM8
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.38005575056576635,0.8946728778865789,0.5538160469667319,0.9094785224144423,1.0,1/4,1.59%,OPHN1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.24448630576091812,-0.8937224894887585,0.6031434184675835,0.9464988790658974,1.0,2/11,5.17%,FABP5;MIF
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.3408383574638237,-0.8931308986019375,0.5836909871244635,0.9470569429713062,1.0,2/5,12.13%,RIT2;LIF
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.5089820359281436,-0.8926838118303159,0.6150627615062761,0.9468039571972193,1.0,2/2,49.50%,SMPX;KCNH2
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.6593625498007968,-0.891973394358064,0.6507936507936508,0.9387277702866041,1.0,1/1,34.39%,ADCY3
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.6593625498007968,-0.891973394358064,0.6507936507936508,0.9387277702866041,1.0,1/1,34.39%,ADCY3
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),-0.6593625498007968,-0.891973394358064,0.6507936507936508,0.9387277702866041,1.0,1/1,34.39%,ADCY3
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.6593625498007968,-0.891973394358064,0.6507936507936508,0.9387277702866041,1.0,1/1,34.39%,ADCY3
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.6593625498007968,-0.891973394358064,0.6507936507936508,0.9387277702866041,1.0,1/1,34.39%,ADCY3
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.6593625498007968,-0.891973394358064,0.6507936507936508,0.9387277702866041,1.0,1/1,34.39%,ADCY3
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.6593625498007968,-0.891973394358064,0.6507936507936508,0.9387277702866041,1.0,1/1,34.39%,ADCY3
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.6593625498007968,-0.891973394358064,0.6507936507936508,0.9387277702866041,1.0,1/1,34.39%,ADCY3
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.6593625498007968,-0.891973394358064,0.6507936507936508,0.9387277702866041,1.0,1/1,34.39%,ADCY3
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.4239253749604486,0.8918223552270557,0.6146616541353384,0.9142927979467478,1.0,1/3,4.37%,KANK1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.4270057025955441,0.8917027553472162,0.5987654320987654,0.9136264854401936,1.0,1/3,1.39%,LTF
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.5129740518962076,-0.89147513324634,0.6142857142857143,0.9388166321829803,1.0,2/2,49.11%,RAB15;EPRS1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.4347120498055672,0.8912724219017942,0.6210720887245841,0.9136003746889888,1.0,1/3,1.79%,DEFA4
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.5138393548476237,-0.8906434367297669,0.6150870406189555,0.939912395565982,1.0,1/2,8.95%,PHB2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.5144149275853436,-0.8906316804152918,0.6288659793814433,0.9388907243585923,1.0,1/2,6.96%,RBPMS2
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.5109780439121756,-0.8889254376099521,0.6234309623430963,0.9414813265795797,1.0,2/2,49.30%,DCTN1;FIGNL1
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),0.43225040344774696,0.8887702074042746,0.5945945945945946,0.91692665727211,1.0,1/3,1.59%,OPHN1
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.43225040344774696,0.8887702074042746,0.5945945945945946,0.91692665727211,1.0,1/3,1.59%,OPHN1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.5085747242928145,-0.8884923240622002,0.6124497991967871,0.940164724968093,1.0,1/2,6.76%,CXCL8
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.5085747242928145,-0.8884923240622002,0.6124497991967871,0.940164724968093,1.0,1/2,6.76%,CXCL8
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.37860773709413237,0.8880281267661081,0.5708812260536399,0.9177197630853341,1.0,1/4,1.59%,OPHN1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.5067390631249286,-0.8880228779869296,0.650103519668737,0.9398445724683328,1.0,1/2,6.16%,CORO1A
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.5049900199600799,0.8879296173570618,0.6516634050880626,0.9169023155599887,1.0,2/2,49.70%,IER5;CDKN2AIP
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.5169660678642715,-0.8866396322783642,0.6354166666666666,0.9416189611238341,1.0,2/2,48.71%,CCL21;ITGB6
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.34248835537289923,0.8850432160685601,0.6060037523452158,0.9220216072459634,1.0,2/5,12.33%,OPHN1;SPOCK1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.5069860279441117,-0.8845013547008722,0.6447638603696099,0.9453911314466205,1.0,2/2,49.70%,STMN1;ANLN
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.6613545816733069,0.8843356213502714,0.6578947368421053,0.9142138850610788,1.0,1/1,34.00%,CAPN3
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.6613545816733069,0.8843356213502714,0.6578947368421053,0.9142138850610788,1.0,1/1,34.00%,CAPN3
prerank,GO_Biological_Process_2021__response to salt stress (GO:0009651),0.6613545816733069,0.8843356213502714,0.6578947368421053,0.9142138850610788,1.0,1/1,34.00%,CAPN3
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),0.6613545816733069,0.8843356213502714,0.6578947368421053,0.9142138850610788,1.0,1/1,34.00%,CAPN3
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.6613545816733069,0.8843356213502714,0.6578947368421053,0.9142138850610788,1.0,1/1,34.00%,CAPN3
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.6613545816733069,0.8843356213502714,0.6578947368421053,0.9142138850610788,1.0,1/1,34.00%,CAPN3
prerank,GO_Biological_Process_2021__negative regulation of protein sumoylation (GO:0033234),0.6613545816733069,0.8843356213502714,0.6578947368421053,0.9142138850610788,1.0,1/1,34.00%,CAPN3
prerank,GO_Biological_Process_2021__cellular response to salt stress (GO:0071472),0.6613545816733069,0.8843356213502714,0.6578947368421053,0.9142138850610788,1.0,1/1,34.00%,CAPN3
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.6613545816733069,0.8843356213502714,0.6578947368421053,0.9142138850610788,1.0,1/1,34.00%,CAPN3
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.1984787896466778,0.8839060955584742,0.5766283524904214,0.9141259343466034,1.0,10/20,34.99%,FOS;CITED2;EGR1;JUN;SOX8;VEGFA;IER5;ZNF462;ABRA;TET1
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.6653386454183267,-0.8837546708974392,0.6568047337278107,0.9387551395183762,1.0,1/1,33.80%,CNTNAP1
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.6653386454183267,-0.8837546708974392,0.6568047337278107,0.9387551395183762,1.0,1/1,33.80%,CNTNAP1
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.6653386454183267,-0.8837546708974392,0.6568047337278107,0.9387551395183762,1.0,1/1,33.80%,CNTNAP1
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),-0.6653386454183267,-0.8837546708974392,0.6568047337278107,0.9387551395183762,1.0,1/1,33.80%,CNTNAP1
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.6653386454183267,-0.8837546708974392,0.6568047337278107,0.9387551395183762,1.0,1/1,33.80%,CNTNAP1
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.6653386454183267,-0.8837546708974392,0.6568047337278107,0.9387551395183762,1.0,1/1,33.80%,CNTNAP1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.6653386454183267,-0.8837546708974392,0.6568047337278107,0.9387551395183762,1.0,1/1,33.80%,CNTNAP1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.6653386454183267,-0.8837546708974392,0.6568047337278107,0.9387551395183762,1.0,1/1,33.80%,CNTNAP1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.24060848497416032,-0.8830057236196743,0.5859872611464968,0.9392702687992474,1.0,9/11,55.27%,PHB2;PLPP3;GAPDH;CCT7;COG3;RASSF2;HSPA1A;HSPA1B;TAF9B
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.3439184891931635,0.8827573810397581,0.5865209471766849,0.9153967287140707,1.0,3/5,31.21%,LRP2;CHMP4C;LEMD3
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.34136546184738953,-0.8822023908772315,0.5711340206185567,0.9399093188732836,1.0,5/5,66.40%,AP2M1;CNIH3;PPP2R1A;EPRS1;CAPN3
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),-0.6573705179282868,-0.8820723958978889,0.6834677419354839,0.9380305058333879,1.0,1/1,34.59%,ASRGL1
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.6573705179282868,-0.8820723958978889,0.6834677419354839,0.9380305058333879,1.0,1/1,34.59%,ASRGL1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.370825994354474,-0.880725856461548,0.5974304068522484,0.939953849215428,1.0,2/4,21.07%,EDNRB;GAPDH
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),-0.6693227091633466,-0.8806046818815588,0.678,0.9370683266273295,1.0,1/1,33.40%,TNFRSF12A
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.6693227091633466,-0.8806046818815588,0.678,0.9370683266273295,1.0,1/1,33.40%,TNFRSF12A
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.6693227091633466,-0.8806046818815588,0.678,0.9370683266273295,1.0,1/1,33.40%,TNFRSF12A
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.2962242641874408,0.8797081845445031,0.599609375,0.9207455974630039,1.0,6/7,55.27%,HSPA1L;RANBP2;CORO2B;HSPA1B;HSPA1A;EIF4G1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.2769103538496963,0.87932911021543,0.5764705882352941,0.9204492489483629,1.0,7/8,59.44%,OPHN1;CAPN3;NLGN1;EPRS1;RP1;BSN;PPP2R1A
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.3755486427461171,0.878794111484616,0.6385767790262172,0.9205162881563257,1.0,1/4,2.39%,SLC6A6
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.33734939759036153,0.8783566677390016,0.6078431372549019,0.9203509396577448,1.0,5/5,66.60%,RAB20;CAPN3;COG3;WLS;CNTNAP1
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.6553784860557769,-0.8772606541335083,0.6970873786407767,0.9375802764528006,1.0,1/1,34.79%,GAP43
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.6553784860557769,-0.8772606541335083,0.6970873786407767,0.9375802764528006,1.0,1/1,34.79%,GAP43
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.6553784860557769,-0.8772606541335083,0.6970873786407767,0.9375802764528006,1.0,1/1,34.79%,GAP43
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.6553784860557769,-0.8772606541335083,0.6970873786407767,0.9375802764528006,1.0,1/1,34.79%,GAP43
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.6553784860557769,-0.8772606541335083,0.6970873786407767,0.9375802764528006,1.0,1/1,34.79%,GAP43
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.6553784860557769,-0.8772606541335083,0.6970873786407767,0.9375802764528006,1.0,1/1,34.79%,GAP43
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.649402390438247,-0.8770800014976543,0.6819085487077535,0.9308306884783081,1.0,1/1,35.39%,ALDH1A1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),-0.649402390438247,-0.8770800014976543,0.6819085487077535,0.9308306884783081,1.0,1/1,35.39%,ALDH1A1
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.649402390438247,-0.8770800014976543,0.6819085487077535,0.9308306884783081,1.0,1/1,35.39%,ALDH1A1
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.649402390438247,-0.8770800014976543,0.6819085487077535,0.9308306884783081,1.0,1/1,35.39%,ALDH1A1
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.649402390438247,-0.8770800014976543,0.6819085487077535,0.9308306884783081,1.0,1/1,35.39%,ALDH1A1
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.649402390438247,-0.8770800014976543,0.6819085487077535,0.9308306884783081,1.0,1/1,35.39%,ALDH1A1
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.649402390438247,-0.8770800014976543,0.6819085487077535,0.9308306884783081,1.0,1/1,35.39%,ALDH1A1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.5029940119760479,-0.876081703904058,0.641851106639839,0.9317764285929776,1.0,2/2,50.10%,LSM7;PAN2
prerank,GO_Biological_Process_2021__cytolysis in other organism involved in symbiotic interaction (GO:0051801),0.6573705179282869,0.8746852114111893,0.683991683991684,0.9261697314908709,1.0,1/1,34.39%,CFHR1
prerank,GO_Biological_Process_2021__cytolysis by host of symbiont cells (GO:0051838),0.6573705179282869,0.8746852114111893,0.683991683991684,0.9261697314908709,1.0,1/1,34.39%,CFHR1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.25686533000460376,0.8732027793756386,0.6081081081081081,0.9285996556833345,1.0,4/10,21.07%,RELN;DDIT4;SPOCK1;SOX8
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.4160000000000001,0.872978737101108,0.6279527559055118,0.9280311859016546,1.0,3/3,58.65%,VEGFA;ADGRA2;MYH9
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.4269140067588375,0.8727570785743398,0.622093023255814,0.9276350483136153,1.0,2/3,32.01%,KANK1;MYLK
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),-0.6673306772908366,-0.8723594121821893,0.7274549098196392,0.9382662294678445,1.0,1/1,33.60%,THAP4
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.3625555456749663,-0.8720747172735086,0.6029411764705882,0.9377746367112315,1.0,1/4,2.39%,PCSK1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.3688310058393006,0.871649169245028,0.6118143459915611,0.9280435909610859,1.0,3/4,39.17%,RYR3;CAPN3;NLGN1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.3688310058393006,0.871649169245028,0.6118143459915611,0.9280435909610859,1.0,3/4,39.17%,RYR3;CAPN3;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.36833202569841506,-0.8714185013664915,0.5991983967935872,0.9370183423402443,1.0,2/4,11.13%,ISG15;IFITM3
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.36833202569841506,-0.8714185013664915,0.5991983967935872,0.9370183423402443,1.0,2/4,11.13%,ISG15;IFITM3
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.2927780237620184,-0.8705041611139771,0.615546218487395,0.9377984954739976,1.0,4/7,27.24%,KNDC1;INSM1;PLPP3;FGF9
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.3408679391439611,-0.8680768910920982,0.6177685950413223,0.9420267371235245,1.0,3/5,27.63%,ISG15;GAPDH;DDX41
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.4177249524884171,-0.8672560464325224,0.6121593291404612,0.942803100343537,1.0,2/3,27.24%,GPX1;FGF9
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3149967418482356,0.8671831790790423,0.6245421245421245,0.9356882736727002,1.0,3/6,25.05%,LTF;S100A12;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.4903089696365897,-0.8656417652959536,0.6610878661087866,0.9450552746316412,1.0,1/2,7.75%,GPX1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.33333333333333337,0.8650223763684024,0.6428571428571429,0.938232675916618,1.0,5/5,67.00%,JUN;ARHGEF18;ITGB3BP;RASSF2;TNFRSF12A
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.33333333333333337,0.8650223763684024,0.6428571428571429,0.938232675916618,1.0,5/5,67.00%,JUN;ARHGEF18;ITGB3BP;RASSF2;TNFRSF12A
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.4910179640718564,0.8648350469525263,0.6727642276422764,0.9375624617032348,1.0,2/2,51.09%,RRH;FIGNL1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.4930139720558885,0.8646681092530704,0.6705426356589147,0.9369594947016376,1.0,2/2,50.89%,SLC40A1;KCNH2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.3607214428857715,-0.8644323254857538,0.6359832635983264,0.9470063096382405,1.0,4/4,64.41%,PLPP3;HACD3;PLPP2;FA2H
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.6513944223107571,0.8641857960726567,0.7151767151767152,0.9329656573814626,1.0,1/1,34.99%,TET1
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.6513944223107571,0.8641857960726567,0.7151767151767152,0.9329656573814626,1.0,1/1,34.99%,TET1
prerank,GO_Biological_Process_2021__negative regulation of heterochromatin assembly (GO:0031452),0.6513944223107571,0.8641857960726567,0.7151767151767152,0.9329656573814626,1.0,1/1,34.99%,TET1
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6513944223107571,0.8641857960726567,0.7151767151767152,0.9329656573814626,1.0,1/1,34.99%,TET1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.6513944223107571,0.8641857960726567,0.7151767151767152,0.9329656573814626,1.0,1/1,34.99%,TET1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.3629429762119857,-0.8638591714998916,0.6158536585365854,0.9468131991006178,1.0,3/4,27.83%,CETP;HMGCR;MSMO1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.49301397205588837,0.8621536562872671,0.6921606118546845,0.9330718225932969,1.0,2/2,50.89%,GNB1;KCNH2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.49301397205588837,0.8621536562872671,0.6921606118546845,0.9330718225932969,1.0,2/2,50.89%,GNB1;KCNH2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.49301397205588837,0.8621536562872671,0.6921606118546845,0.9330718225932969,1.0,2/2,50.89%,GNB1;KCNH2
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.49301397205588837,0.8621536562872671,0.6921606118546845,0.9330718225932969,1.0,2/2,50.89%,GNB1;KCNH2
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.651394422310757,-0.8613869502724383,0.7302904564315352,0.949986389833344,1.0,1/1,35.19%,PLD3
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.651394422310757,-0.8613869502724383,0.7302904564315352,0.949986389833344,1.0,1/1,35.19%,PLD3
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.4930139720558881,0.8610836443348985,0.6859344894026975,0.9342512028089573,1.0,2/2,50.89%,DSG2;KCNH2
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.49068383391033676,0.8607313225691171,0.6912621359223301,0.9328698345745998,1.0,1/2,10.34%,DHX33
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.49068383391033676,0.8607313225691171,0.6912621359223301,0.9328698345745998,1.0,1/2,10.34%,DHX33
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.3294637403425491,-0.8604559963936892,0.5979591836734693,0.9508895752701537,1.0,2/5,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.4827111344783246,-0.8593352471334387,0.6821862348178138,0.9520395020832897,1.0,1/2,8.15%,EN1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.48502994011976064,0.8592794557440483,0.6796875,0.9344171473808222,1.0,2/2,51.69%,PTGS2;ITGB6
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.4930139720558882,0.8584442326171051,0.6843100189035917,0.9353903946514586,1.0,2/2,50.89%,CYP27B1;KCNH2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.4930139720558882,0.856451674210951,0.693516699410609,0.9370396380214234,1.0,2/2,50.89%,VIP;KCNH2
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.4930139720558882,0.856451674210951,0.693516699410609,0.9370396380214234,1.0,2/2,50.89%,VIP;KCNH2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.6434262948207171,-0.8552043686910475,0.734375,0.9534387542824846,1.0,1/1,35.98%,CCT7
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.6434262948207171,-0.8552043686910475,0.734375,0.9534387542824846,1.0,1/1,35.98%,CCT7
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.6434262948207171,-0.8552043686910475,0.734375,0.9534387542824846,1.0,1/1,35.98%,CCT7
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.6434262948207171,-0.8552043686910475,0.734375,0.9534387542824846,1.0,1/1,35.98%,CCT7
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.6434262948207171,-0.8552043686910475,0.734375,0.9534387542824846,1.0,1/1,35.98%,CCT7
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.6434262948207171,-0.8552043686910475,0.734375,0.9534387542824846,1.0,1/1,35.98%,CCT7
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.6434262948207171,-0.8552043686910475,0.734375,0.9534387542824846,1.0,1/1,35.98%,CCT7
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.6354581673306773,0.8548152809460119,0.7084148727984344,0.932906268998148,1.0,1/1,36.58%,STAT4
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.6354581673306773,0.8548152809460119,0.7084148727984344,0.932906268998148,1.0,1/1,36.58%,STAT4
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.6354581673306773,0.8548152809460119,0.7084148727984344,0.932906268998148,1.0,1/1,36.58%,STAT4
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.6354581673306773,0.8548152809460119,0.7084148727984344,0.932906268998148,1.0,1/1,36.58%,STAT4
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.6354581673306773,0.8548152809460119,0.7084148727984344,0.932906268998148,1.0,1/1,36.58%,STAT4
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.6354581673306773,0.8548152809460119,0.7084148727984344,0.932906268998148,1.0,1/1,36.58%,STAT4
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.6354581673306773,0.8548152809460119,0.7084148727984344,0.932906268998148,1.0,1/1,36.58%,STAT4
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.6354581673306773,0.8548152809460119,0.7084148727984344,0.932906268998148,1.0,1/1,36.58%,STAT4
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.6414342629482072,0.8544839870587803,0.735812133072407,0.927588818512903,1.0,1/1,35.98%,FA2H
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.6414342629482072,0.8544839870587803,0.735812133072407,0.927588818512903,1.0,1/1,35.98%,FA2H
prerank,GO_Biological_Process_2021__glucosylceramide metabolic process (GO:0006678),0.6414342629482072,0.8544839870587803,0.735812133072407,0.927588818512903,1.0,1/1,35.98%,FA2H
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.6414342629482072,0.8544839870587803,0.735812133072407,0.927588818512903,1.0,1/1,35.98%,FA2H
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.6414342629482072,0.8544839870587803,0.735812133072407,0.927588818512903,1.0,1/1,35.98%,FA2H
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.6414342629482072,0.8544839870587803,0.735812133072407,0.927588818512903,1.0,1/1,35.98%,FA2H
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.6454183266932271,0.8543962130586786,0.7254098360655737,0.9238929099514374,1.0,1/1,35.59%,PUDP
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.6454183266932271,0.8543962130586786,0.7254098360655737,0.9238929099514374,1.0,1/1,35.59%,PUDP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.6454183266932271,0.8543962130586786,0.7254098360655737,0.9238929099514374,1.0,1/1,35.59%,PUDP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.6454183266932271,0.8543962130586786,0.7254098360655737,0.9238929099514374,1.0,1/1,35.59%,PUDP
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.20404890373258788,0.8539743349202884,0.6363636363636364,0.9237372610742757,1.0,12/16,53.88%,OPHN1;DDIT4;RMI1;ARHGAP11B;VEGFA;TAF11;CAPN3;NLGN1;ARHGEF18;TAF9B;ARHGAP5;RASSF2
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.41283599132357207,0.8536445633984879,0.6382575757575758,0.9233837905976437,1.0,2/3,25.05%,LRP2;VEGFA
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.4867404059494331,0.8530256492321805,0.6944444444444444,0.9239962681384221,1.0,1/2,12.52%,DNAJC3
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.414,0.8523272730426084,0.6745562130177515,0.9243811982775927,1.0,3/3,58.85%,NLGN1;ARHGEF18;BSN
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.6533864541832669,-0.8504174917828631,0.7322834645669292,0.9618481653855623,1.0,1/1,34.99%,GUK1
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.4897234698345552,-0.8484443705064734,0.6913827655310621,0.9638727240273974,1.0,1/2,8.95%,PHB2
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.4897234698345552,-0.8484443705064734,0.6913827655310621,0.9638727240273974,1.0,1/2,8.95%,PHB2
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.40138202134073697,0.8475914902635051,0.6522593320235757,0.9306765989231798,1.0,1/3,4.77%,RELN
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.40138202134073697,0.8475914902635051,0.6522593320235757,0.9306765989231798,1.0,1/3,4.77%,RELN
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.40138202134073697,0.8475914902635051,0.6522593320235757,0.9306765989231798,1.0,1/3,4.77%,RELN
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.26262626262626265,0.8473872533555195,0.6565464895635673,0.9300156587014565,1.0,8/8,74.16%,FCGR3A;VIP;GNB1;IRAK3;MYH9;GGT5;ADCY3;LYAR
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.48302132429115185,-0.8473162856972883,0.6809815950920245,0.9631724788209584,1.0,1/2,7.75%,GPX1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.48302132429115185,-0.8473162856972883,0.6809815950920245,0.9631724788209584,1.0,1/2,7.75%,GPX1
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.48302132429115185,-0.8473162856972883,0.6809815950920245,0.9631724788209584,1.0,1/2,7.75%,GPX1
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.6374501992031872,0.8470338086688612,0.7254098360655737,0.9241010071907693,1.0,1/1,36.38%,CA2
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),0.6374501992031872,0.8470338086688612,0.7254098360655737,0.9241010071907693,1.0,1/1,36.38%,CA2
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.6374501992031872,0.8470338086688612,0.7254098360655737,0.9241010071907693,1.0,1/1,36.38%,CA2
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.6374501992031872,0.8470338086688612,0.7254098360655737,0.9241010071907693,1.0,1/1,36.38%,CA2
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.6374501992031872,0.8470338086688612,0.7254098360655737,0.9241010071907693,1.0,1/1,36.38%,CA2
prerank,GO_Biological_Process_2021__carbon dioxide transport (GO:0015670),0.6374501992031872,0.8470338086688612,0.7254098360655737,0.9241010071907693,1.0,1/1,36.38%,CA2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.6374501992031872,0.8470338086688612,0.7254098360655737,0.9241010071907693,1.0,1/1,36.38%,CA2
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.40799999999999986,0.8456189502415045,0.6877551020408164,0.9258521753202259,1.0,3/3,59.44%,CAPN3;EPRS1;PPP2R1A
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.408091077613883,-0.8432671133551852,0.6652631578947369,0.9700882019616189,1.0,2/3,21.07%,SERPINH1;GAPDH
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.6254980079681275,0.8428827336155746,0.7214428857715431,0.9282931876835286,1.0,1/1,37.57%,IQGAP2
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6254980079681275,0.8428827336155746,0.7214428857715431,0.9282931876835286,1.0,1/1,37.57%,IQGAP2
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.6254980079681275,0.8428827336155746,0.7214428857715431,0.9282931876835286,1.0,1/1,37.57%,IQGAP2
prerank,GO_Biological_Process_2021__indolalkylamine metabolic process (GO:0006586),0.6314741035856574,0.8419475814590918,0.746,0.9243748523779817,1.0,1/1,36.98%,AANAT
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.6314741035856574,0.8419475814590918,0.746,0.9243748523779817,1.0,1/1,36.98%,AANAT
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.6314741035856574,0.8419475814590918,0.746,0.9243748523779817,1.0,1/1,36.98%,AANAT
prerank,GO_Biological_Process_2021__indole-containing compound biosynthetic process (GO:0042435),0.6314741035856574,0.8419475814590918,0.746,0.9243748523779817,1.0,1/1,36.98%,AANAT
prerank,GO_Biological_Process_2021__indolalkylamine biosynthetic process (GO:0046219),0.6314741035856574,0.8419475814590918,0.746,0.9243748523779817,1.0,1/1,36.98%,AANAT
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.6314741035856574,0.8419475814590918,0.746,0.9243748523779817,1.0,1/1,36.98%,AANAT
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.4009589932427781,0.8415782755798676,0.6673228346456693,0.9242246646110696,1.0,2/3,29.03%,VEGFA;VIP
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.6334661354581673,0.8411327641269631,0.7515400410677618,0.9222262195583459,1.0,1/1,36.78%,NFIL3
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.6334661354581673,0.8411327641269631,0.7515400410677618,0.9222262195583459,1.0,1/1,36.78%,NFIL3
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.6334661354581673,0.8411327641269631,0.7515400410677618,0.9222262195583459,1.0,1/1,36.78%,NFIL3
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.35503585505629387,-0.8405849426280929,0.6437007874015748,0.9742260150764284,1.0,2/4,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.6274900398406374,0.8397396156230624,0.7189922480620154,0.9193379026361596,1.0,1/1,37.38%,NDUFB6
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.6274900398406374,0.8397396156230624,0.7189922480620154,0.9193379026361596,1.0,1/1,37.38%,NDUFB6
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.6274900398406374,0.8397396156230624,0.7189922480620154,0.9193379026361596,1.0,1/1,37.38%,NDUFB6
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.6274900398406374,0.8397396156230624,0.7189922480620154,0.9193379026361596,1.0,1/1,37.38%,NDUFB6
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.6274900398406374,0.8397396156230624,0.7189922480620154,0.9193379026361596,1.0,1/1,37.38%,NDUFB6
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.6274900398406374,0.8397396156230624,0.7189922480620154,0.9193379026361596,1.0,1/1,37.38%,NDUFB6
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.4770459081836327,-0.8393519424245267,0.6931106471816284,0.9755311651311506,1.0,2/2,52.68%,FIS1;RAB3IP
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.17683724727789626,-0.8376075697919055,0.6551724137931034,0.977601743046744,1.0,5/20,15.31%,CHI3L1;SDC1;CXCL8;LIF;PLP2
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.6354581673306773,-0.8365771760313879,0.7450980392156863,0.9745371886063946,1.0,1/1,36.78%,COL4A2
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.6354581673306773,-0.8365771760313879,0.7450980392156863,0.9745371886063946,1.0,1/1,36.78%,COL4A2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.6354581673306773,-0.8365771760313879,0.7450980392156863,0.9745371886063946,1.0,1/1,36.78%,COL4A2
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.6354581673306773,-0.8365771760313879,0.7450980392156863,0.9745371886063946,1.0,1/1,36.78%,COL4A2
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.6354581673306773,-0.8365771760313879,0.7450980392156863,0.9745371886063946,1.0,1/1,36.78%,COL4A2
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__response to prostaglandin (GO:0034694),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell antigen processing and presentation (GO:0002606),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__regulation of dendritic cell antigen processing and presentation (GO:0002604),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__negative regulation of dendritic cell apoptotic process (GO:2000669),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__negative regulation of cellular extravasation (GO:0002692),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__establishment of T cell polarity (GO:0001768),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of antigen processing and presentation (GO:0002579),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein metabolic process (GO:1903020),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__establishment of lymphocyte polarity (GO:0001767),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__eosinophil migration (GO:0072677),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__eosinophil chemotaxis (GO:0048245),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.6294820717131474,-0.836050472375158,0.742914979757085,0.9336714018348937,1.0,1/1,37.38%,CCL21
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.4710578842315369,-0.8359589668059685,0.7016806722689075,0.9329711623184762,1.0,2/2,53.28%,TMEM33;SMPD4
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.35428254363353806,0.8350221550879219,0.6725838264299803,0.926917817597155,1.0,2/4,25.05%,CITED2;VEGFA
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.15900003056920087,-0.8338734431441545,0.7068965517241379,0.9361264085335269,1.0,6/25,12.52%,EDNRB;IRX3;EN1;PHB2;INSM1;EOMES
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.6215139442231076,-0.832508366453465,0.7478991596638656,0.937131378726203,1.0,1/1,38.17%,HR
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.6215139442231076,-0.832508366453465,0.7478991596638656,0.937131378726203,1.0,1/1,38.17%,HR
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.1742705697618805,-0.8322190886431057,0.6868475991649269,0.936659750281865,1.0,9/21,27.04%,EDNRB;BDNF;EGR2;CNTN6;CBLN1;DCTN1;PCDHB16;FABP7;HMGCR
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.46963855544987837,0.8320992126221298,0.7197452229299363,0.9287399698644243,1.0,1/2,4.17%,TNFSF13B
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.46963855544987837,0.8320992126221298,0.7197452229299363,0.9287399698644243,1.0,1/2,4.17%,TNFSF13B
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.46963855544987837,0.8320992126221298,0.7197452229299363,0.9287399698644243,1.0,1/2,4.17%,TNFSF13B
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.46963855544987837,0.8320992126221298,0.7197452229299363,0.9287399698644243,1.0,1/2,4.17%,TNFSF13B
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.3986056963748656,-0.8318344073625561,0.682,0.9365789395785162,1.0,2/3,27.24%,RBPMS2;FGF9
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.39844085689980746,0.8316787393839283,0.6973180076628352,0.9286602935186593,1.0,2/3,32.01%,KANK1;MYLK
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),-0.6314741035856574,-0.8305016160243212,0.7564356435643564,0.9297442576382373,1.0,1/1,37.18%,ABCB1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.6314741035856574,-0.8305016160243212,0.7564356435643564,0.9297442576382373,1.0,1/1,37.18%,ABCB1
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.6314741035856574,-0.8305016160243212,0.7564356435643564,0.9297442576382373,1.0,1/1,37.18%,ABCB1
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.6314741035856574,-0.8305016160243212,0.7564356435643564,0.9297442576382373,1.0,1/1,37.18%,ABCB1
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.6314741035856574,-0.8305016160243212,0.7564356435643564,0.9297442576382373,1.0,1/1,37.18%,ABCB1
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.6314741035856574,-0.8305016160243212,0.7564356435643564,0.9297442576382373,1.0,1/1,37.18%,ABCB1
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),-0.6314741035856574,-0.8305016160243212,0.7564356435643564,0.9297442576382373,1.0,1/1,37.18%,ABCB1
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.6314741035856574,-0.8305016160243212,0.7564356435643564,0.9297442576382373,1.0,1/1,37.18%,ABCB1
prerank,GO_Biological_Process_2021__positive regulation of anion transmembrane transport (GO:1903961),-0.6314741035856574,-0.8305016160243212,0.7564356435643564,0.9297442576382373,1.0,1/1,37.18%,ABCB1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.6314741035856574,-0.8305016160243212,0.7564356435643564,0.9297442576382373,1.0,1/1,37.18%,ABCB1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.6215139442231076,0.8299663299663304,0.768762677484787,0.9305466318926316,1.0,1/1,37.97%,ADGRA2
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.6454183266932271,-0.8299633978381684,0.7824267782426778,0.9256104462634609,1.0,1/1,35.79%,TRAK2
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.6454183266932271,-0.8299633978381684,0.7824267782426778,0.9256104462634609,1.0,1/1,35.79%,TRAK2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.6454183266932271,-0.8299633978381684,0.7824267782426778,0.9256104462634609,1.0,1/1,35.79%,TRAK2
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.6454183266932271,-0.8299633978381684,0.7824267782426778,0.9256104462634609,1.0,1/1,35.79%,TRAK2
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.6454183266932271,-0.8299633978381684,0.7824267782426778,0.9256104462634609,1.0,1/1,35.79%,TRAK2
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.6454183266932271,-0.8299633978381684,0.7824267782426778,0.9256104462634609,1.0,1/1,35.79%,TRAK2
prerank,GO_Biological_Process_2021__glutathione catabolic process (GO:0006751),-0.6235059760956175,-0.8287559730720984,0.7522603978300181,0.9207424975293685,1.0,1/1,37.97%,GGT5
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.6235059760956175,-0.8287559730720984,0.7522603978300181,0.9207424975293685,1.0,1/1,37.97%,GGT5
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.6235059760956175,-0.8287559730720984,0.7522603978300181,0.9207424975293685,1.0,1/1,37.97%,GGT5
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.6235059760956175,-0.8287559730720984,0.7522603978300181,0.9207424975293685,1.0,1/1,37.97%,GGT5
prerank,GO_Biological_Process_2021__leukotriene D4 biosynthetic process (GO:1901750),-0.6235059760956175,-0.8287559730720984,0.7522603978300181,0.9207424975293685,1.0,1/1,37.97%,GGT5
prerank,GO_Biological_Process_2021__leukotriene D4 metabolic process (GO:1901748),-0.6235059760956175,-0.8287559730720984,0.7522603978300181,0.9207424975293685,1.0,1/1,37.97%,GGT5
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.6235059760956175,-0.8287559730720984,0.7522603978300181,0.9207424975293685,1.0,1/1,37.97%,GGT5
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),-0.6235059760956175,-0.8287559730720984,0.7522603978300181,0.9207424975293685,1.0,1/1,37.97%,GGT5
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.4074012927847098,0.8287505183441991,0.6801541425818882,0.932056009638117,1.0,2/3,25.05%,SOX8;VEGFA
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.29979879275653926,-0.8280642684836131,0.6949891067538126,0.9211757361066087,1.0,6/6,70.58%,PLPP3;LIPG;PLBD2;PLPPR5;PLPP2;GPAM
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.46798904562785226,0.8276631018693626,0.7076023391812866,0.9331269313924394,1.0,1/2,12.72%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.467065868263473,-0.8275106813737506,0.7239263803680982,0.9203307364120017,1.0,2/2,53.68%,TOPORS;BMI1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.467065868263473,-0.8275106813737506,0.7239263803680982,0.9203307364120017,1.0,2/2,53.68%,TOPORS;BMI1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.6155378486055777,0.8272934479148498,0.7535641547861507,0.9308147931680845,1.0,1/1,38.57%,ZC3H7A
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.6155378486055777,0.8272934479148498,0.7535641547861507,0.9308147931680845,1.0,1/1,38.57%,ZC3H7A
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.6155378486055777,0.8272934479148498,0.7535641547861507,0.9308147931680845,1.0,1/1,38.57%,ZC3H7A
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.6175298804780877,0.8267425350774426,0.7611336032388664,0.9309109886347847,1.0,1/1,38.37%,ZFYVE26
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.6235059760956175,0.8263136559412214,0.7581573896353166,0.9307996045534036,1.0,1/1,37.77%,LMBRD2
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.39072741885250284,0.8257696296395637,0.671875,0.9307643112875097,1.0,1/3,4.77%,RELN
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.4650698602794411,0.8246603220935672,0.746031746031746,0.9318067279223231,1.0,2/2,53.68%,CHODL;GDI1
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.6095617529880477,0.8238585261584102,0.7592190889370932,0.9144636886314439,1.0,1/1,39.17%,NLGN1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.46753430387585393,0.8227003233904581,0.726890756302521,0.91564896771159,1.0,1/2,4.37%,KANK1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.467065868263473,-0.8222568130764097,0.7224669603524229,0.9275838821742998,1.0,2/2,53.68%,CDC7;BMI1
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.467065868263473,-0.8222568130764097,0.7224669603524229,0.9275838821742998,1.0,2/2,53.68%,CDC7;BMI1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.46763486056200465,-0.8218659900276207,0.73125,0.9273382702699143,1.0,1/2,6.76%,CXCL8
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.4710578842315369,-0.8218450002195615,0.7239915074309978,0.9264799348063347,1.0,2/2,53.28%,CETP;SMPD4
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.46906187624750484,0.8217389323075442,0.731610337972167,0.9164927816050947,1.0,2/2,53.28%,CHMP4C;PSRC1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.4728471394392797,-0.8213780749651889,0.7253668763102725,0.926374958284256,1.0,1/2,7.95%,BDNF
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.6135458167330677,0.8212360016590619,0.75,0.9136037778076472,1.0,1/1,38.77%,LIN7C
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.6135458167330677,0.8212360016590619,0.75,0.9136037778076472,1.0,1/1,38.77%,LIN7C
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.6135458167330677,0.8212360016590619,0.75,0.9136037778076472,1.0,1/1,38.77%,LIN7C
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.6135458167330677,0.8212360016590619,0.75,0.9136037778076472,1.0,1/1,38.77%,LIN7C
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.2747020663333488,0.8201578672643675,0.6902985074626866,0.914586366812106,1.0,6/7,53.48%,RAD23B;FANCL;RPA4;XRCC2;GTF2H4;EID3
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.2973069964790007,-0.8190333088114355,0.704312114989733,0.9296978617888609,1.0,2/6,9.54%,MIF;KNDC1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.394,-0.8175609074985343,0.6901408450704225,0.9315552078756326,1.0,3/3,61.03%,PLPP3;PPP2R1A;PLPP2
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.394,-0.8175462381938252,0.7039337474120083,0.929779719684384,1.0,3/3,61.03%,PLPP3;PLPPR5;PLPP2
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.394,-0.8175462381938252,0.7039337474120083,0.929779719684384,1.0,3/3,61.03%,PLPP3;PLPPR5;PLPP2
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.28772635814889336,-0.8164934696738935,0.696969696969697,0.9308383828840668,1.0,6/6,71.77%,IRF9;DTX1;TOPORS;GTF2H4;TAF9B;TAF11
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.392,-0.8163210011214662,0.6854838709677419,0.9301305573032382,1.0,3/3,61.23%,PCDHB16;CDH8;NLGN1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.46180666529117853,-0.8161716807288845,0.7382413087934561,0.9296024241621038,1.0,1/2,6.96%,RBPMS2
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.34625482255681994,-0.8151635218426491,0.6756756756756757,0.9304066306637112,1.0,1/4,3.18%,ISG15
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.46107784431137744,0.815007563056208,0.7433962264150943,0.9226719483479103,1.0,2/2,54.08%,GPNMB;NACC2
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.2603370103377984,0.8142546382839725,0.6920152091254753,0.9232777764931763,1.0,6/8,45.73%,CNDP1;TRHDE;FOLH1;CAPN3;ADAMTS3;CAPN7
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.38952977374925374,0.8132632386746829,0.7209302325581395,0.9244895562522064,1.0,1/3,4.37%,KANK1
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.3141522796088901,-0.812299840065909,0.6876310272536688,0.9347231757896686,1.0,3/5,25.05%,GPX1;DCTN1;PLEKHM2
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.384,-0.810543651885981,0.6991525423728814,0.9368135712253411,1.0,3/3,62.03%,INSM1;INSM2;ZFYVE26
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.6075697211155379,-0.8103651476304689,0.7821011673151751,0.9361375805387482,1.0,1/1,39.56%,RUNDC3A
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.38914153135270657,-0.8098878036521256,0.721030042918455,0.9360986965227146,1.0,2/3,27.24%,CXCL8;FGF9
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.3846143564730712,0.809399769705198,0.6876267748478702,0.9302451853623019,1.0,2/3,33.00%,CEP120;CORO2B
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.2939740902348984,0.8090561149708254,0.6990825688073394,0.9299142472110612,1.0,5/6,53.48%,FANCL;RPA4;XRCC2;GTF2H4;EID3
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.4550898203592816,0.8081066820152016,0.7264150943396226,0.930756143329394,1.0,2/2,54.67%,SSX2IP;DYNLRB2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.46906187624750495,0.8076547625878194,0.7743785850860421,0.9308385600490231,1.0,2/2,53.28%,CCNA2;PSRC1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.45965305946041835,0.8062500279152055,0.7602339181286549,0.9314247127906989,1.0,1/2,6.56%,DDIT4
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.45965305946041835,0.8062500279152055,0.7602339181286549,0.9314247127906989,1.0,1/2,6.56%,DDIT4
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.6115537848605578,0.8055388917000099,0.7813121272365805,0.9291298631044517,1.0,1/1,38.97%,RPA4
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.6115537848605578,0.8055388917000099,0.7813121272365805,0.9291298631044517,1.0,1/1,38.97%,RPA4
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.6115537848605578,0.8055388917000099,0.7813121272365805,0.9291298631044517,1.0,1/1,38.97%,RPA4
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),0.6115537848605578,0.8055388917000099,0.7813121272365805,0.9291298631044517,1.0,1/1,38.97%,RPA4
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.46295307752363796,0.8049883338885019,0.7452107279693486,0.9283869380842283,1.0,1/2,13.72%,ARHGAP11B
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.46295307752363796,0.8049883338885019,0.7452107279693486,0.9283869380842283,1.0,1/2,13.72%,ARHGAP11B
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.393295481439219,0.8048506521491753,0.7092337917485265,0.9277558325373869,1.0,2/3,23.66%,RANBP2;KPNA5
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.28772635814889336,-0.8046084153996347,0.7055084745762712,0.9443516982537913,1.0,6/6,71.77%,IRF9;DTX1;GTF2H4;TAF9B;ESRRG;TAF11
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.3397772408632569,0.8031780358416865,0.7288801571709234,0.929633732931113,1.0,1/4,2.58%,CITED2
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.45480449210396257,-0.802823903717746,0.75,0.946768525076223,1.0,1/2,6.16%,CORO1A
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.392,-0.8026039173725139,0.7037037037037037,0.9461702266784628,1.0,3/3,61.23%,CCL21;PLPPR5;NLGN1
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.30194994619005266,0.8004643567635299,0.6947162426614482,0.9335860138872951,1.0,1/5,1.59%,OPHN1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.603585657370518,0.7997882268303441,0.7850287907869482,0.9340333983941527,1.0,1/1,39.76%,ARHGEF18
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.6055776892430279,-0.7981686379244572,0.7954110898661568,0.9504908244505981,1.0,1/1,39.76%,GPRC5A
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.6055776892430279,-0.7981686379244572,0.7954110898661568,0.9504908244505981,1.0,1/1,39.76%,GPRC5A
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.6055776892430279,-0.7981686379244572,0.7954110898661568,0.9504908244505981,1.0,1/1,39.76%,GPRC5A
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.6055776892430279,-0.7981686379244572,0.7954110898661568,0.9504908244505981,1.0,1/1,39.76%,GPRC5A
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.45304519269932636,-0.7973268370906695,0.751984126984127,0.9508992946730482,1.0,1/2,8.95%,PHB2
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.392,-0.7966634779458509,0.71484375,0.9510884796078336,1.0,3/3,61.23%,SYT4;RAB15;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.38492914582389864,0.7955044480931277,0.7389705882352942,0.9404283327784906,1.0,1/3,2.98%,LRP2
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.376257353473867,-0.7940420193396627,0.7222222222222222,0.9546774543406314,1.0,1/3,4.77%,DTX3L
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.3005386722530576,0.7910063984734387,0.7340619307832422,0.9471521835637725,1.0,1/5,1.59%,OPHN1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.599601593625498,-0.7907328566536681,0.8132295719844358,0.9581193249881359,1.0,1/1,40.36%,LSM7
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.599601593625498,-0.7907328566536681,0.8132295719844358,0.9581193249881359,1.0,1/1,40.36%,LSM7
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.3337518431719061,0.7905930997335698,0.7330827067669173,0.9470827678658855,1.0,3/4,43.94%,TECRL;PTGS2;HACD3
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4491017964071857,0.7904709547384262,0.7775590551181102,0.9463558613471023,1.0,2/2,55.27%,GPNMB;EIF4G1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.26299272254892586,-0.7872153811521236,0.7364185110663984,0.9631700478441005,1.0,2/7,9.34%,PHB2;EGR2
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.5936254980079682,0.7860158774402018,0.821917808219178,0.9506040312576766,1.0,1/1,40.76%,CENPC
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.5936254980079682,0.7860158774402018,0.821917808219178,0.9506040312576766,1.0,1/1,40.76%,CENPC
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.5936254980079682,0.7860158774402018,0.821917808219178,0.9506040312576766,1.0,1/1,40.76%,CENPC
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),0.5936254980079682,0.7860158774402018,0.821917808219178,0.9506040312576766,1.0,1/1,40.76%,CENPC
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.5976095617529881,0.7854664610639938,0.8548057259713702,0.9497698441549925,1.0,1/1,40.36%,LIX1
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.5976095617529881,0.7854664610639938,0.8548057259713702,0.9497698441549925,1.0,1/1,40.36%,LIX1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.37023620805239066,0.7849377910455905,0.7472118959107806,0.9498216199397124,1.0,1/3,4.37%,KANK1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.44487005723197837,0.784856251521784,0.7771084337349398,0.9482263539728445,1.0,1/2,10.14%,RAB20
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.44487005723197837,0.784856251521784,0.7771084337349398,0.9482263539728445,1.0,1/2,10.14%,RAB20
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.4451097804391217,-0.7848128557749369,0.768762677484787,0.9659680198012756,1.0,2/2,55.86%,NPLOC4;SEL1L2
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.4451097804391217,-0.7848128557749369,0.768762677484787,0.9659680198012756,1.0,2/2,55.86%,NPLOC4;SEL1L2
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.25924845937648655,0.784543906784531,0.7129455909943715,0.9477718130261383,1.0,4/7,35.98%,CYP26B1;CKB;GPAM;FA2H
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.4411177644710578,-0.7837293388292141,0.754,0.964051124163775,1.0,2/2,56.26%,CCT7;PKIB
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.4411177644710578,-0.7837293388292141,0.754,0.964051124163775,1.0,2/2,56.26%,CCT7;PKIB
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.4411177644710578,-0.7837293388292141,0.754,0.964051124163775,1.0,2/2,56.26%,CCT7;PKIB
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.4411177644710578,-0.7837293388292141,0.754,0.964051124163775,1.0,2/2,56.26%,CCT7;PKIB
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.3772930452640059,-0.7832477919015383,0.7510729613733905,0.9621508045133847,1.0,2/3,23.86%,EOMES;MICAL2
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.3772930452640059,-0.7832477919015383,0.7510729613733905,0.9621508045133847,1.0,2/3,23.86%,EOMES;MICAL2
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.3772930452640059,-0.7832477919015383,0.7510729613733905,0.9621508045133847,1.0,2/3,23.86%,EOMES;MICAL2
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.4491017964071857,0.7823629668452202,0.780439121756487,0.9491105469914145,1.0,2/2,55.27%,RANBP2;EIF4G1
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.4491017964071857,0.7823629668452202,0.780439121756487,0.9491105469914145,1.0,2/2,55.27%,RANBP2;EIF4G1
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.4491017964071857,0.7823629668452202,0.780439121756487,0.9491105469914145,1.0,2/2,55.27%,RANBP2;EIF4G1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.3724953213821717,-0.7801165539657058,0.7383720930232558,0.966739289856397,1.0,1/3,4.77%,DTX3L
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.36744446753087473,-0.7791870833149687,0.77079107505071,0.965733944535186,1.0,1/3,6.16%,CORO1A
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.36744446753087473,-0.7791870833149687,0.77079107505071,0.965733944535186,1.0,1/3,6.16%,CORO1A
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.36744446753087473,-0.7791870833149687,0.77079107505071,0.965733944535186,1.0,1/3,6.16%,CORO1A
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.5936254980079682,-0.7783198737972608,0.848,0.9642407801862926,1.0,1/1,40.95%,PPP2R1A
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5936254980079682,-0.7783198737972608,0.848,0.9642407801862926,1.0,1/1,40.95%,PPP2R1A
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.5936254980079682,-0.7783198737972608,0.848,0.9642407801862926,1.0,1/1,40.95%,PPP2R1A
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.4369140915496399,-0.7781410222814032,0.8024948024948025,0.9636118694235767,1.0,1/2,8.95%,PHB2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.44910179640718567,0.7777051499781684,0.8032454361054767,0.9565622211232888,1.0,2/2,55.27%,CAPN3;EIF4G1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.5776892430278884,0.7776461934151019,0.8482490272373541,0.9548454404510651,1.0,1/1,42.35%,LRIF1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.5776892430278884,0.7776461934151019,0.8482490272373541,0.9548454404510651,1.0,1/1,42.35%,LRIF1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5776892430278885,-0.7775366703528284,0.8268482490272373,0.9636982643870299,1.0,1/1,42.54%,RAP1GAP2
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.5836653386454184,-0.7766349457140338,0.8254901960784313,0.9646200433055396,1.0,1/1,41.95%,DTX1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5816733067729083,0.7761680857372814,0.8446215139442231,0.9559807581144409,1.0,1/1,41.95%,ADAMTS3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.5816733067729083,0.7761680857372814,0.8446215139442231,0.9559807581144409,1.0,1/1,41.95%,ADAMTS3
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.4461298720454381,0.7758488231287559,0.806,0.9555246359583205,1.0,1/2,14.91%,SLC1A3
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.44510978043912164,0.7731311062033723,0.7928286852589641,0.9564325186051098,1.0,2/2,55.67%,RANBP2;NXF1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.44510978043912164,0.7731311062033723,0.7928286852589641,0.9564325186051098,1.0,2/2,55.67%,RANBP2;NXF1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.44510978043912164,0.7731311062033723,0.7928286852589641,0.9564325186051098,1.0,2/2,55.67%,RANBP2;NXF1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.44510978043912164,0.7731311062033723,0.7928286852589641,0.9564325186051098,1.0,2/2,55.67%,RANBP2;NXF1
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),0.5836653386454183,0.7723940763371737,0.8611670020120724,0.9565089845975685,1.0,1/1,41.75%,SLIRP
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.5856573705179283,-0.7713925529625187,0.857421875,0.9668318645479892,1.0,1/1,41.75%,MYH9
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.5856573705179283,-0.7713925529625187,0.857421875,0.9668318645479892,1.0,1/1,41.75%,MYH9
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.5856573705179283,-0.7713925529625187,0.857421875,0.9668318645479892,1.0,1/1,41.75%,MYH9
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.5856573705179283,-0.7713925529625187,0.857421875,0.9668318645479892,1.0,1/1,41.75%,MYH9
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.5856573705179283,-0.7713925529625187,0.857421875,0.9668318645479892,1.0,1/1,41.75%,MYH9
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),-0.5856573705179283,-0.7713925529625187,0.857421875,0.9668318645479892,1.0,1/1,41.75%,MYH9
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.5856573705179283,-0.7713925529625187,0.857421875,0.9668318645479892,1.0,1/1,41.75%,MYH9
prerank,GO_Biological_Process_2021__vitamin D3 metabolic process (GO:0070640),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__regulation of calcidiol 1-monooxygenase activity (GO:0060558),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__negative regulation of vitamin D biosynthetic process (GO:0010957),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__regulation of vitamin D receptor signaling pathway (GO:0070562),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.5796812749003983,0.7684509265301787,0.867816091954023,0.947467041953731,1.0,1/1,42.15%,CYP27B1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.32320371512345203,-0.7676272150184512,0.7645875251509054,0.9720769301188804,1.0,2/4,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.3720000000000001,0.7661183126374206,0.7815442561205274,0.9501501669630104,1.0,3/3,63.02%,VEGFA;RASSF2;CCL21
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.3699999999999999,0.7656097252562677,0.80083857442348,0.950365922542154,1.0,3/3,63.22%,CORO2B;EIF4G1;ABCB1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.29289213769080946,0.7647648471022278,0.7652859960552268,0.9507986572818419,1.0,1/5,1.59%,OPHN1
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.2743407190396383,0.7642093321117136,0.7392120075046904,0.9507900572253021,1.0,5/6,49.30%,RMI1;ZFYVE26;RPA4;SMC5;XRCC2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__response to peptidoglycan (GO:0032494),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),0.5737051792828685,0.7640400724648908,0.8521400778210116,0.9333891662395182,1.0,1/1,42.74%,IRAK3
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.5657370517928286,-0.7639238117514466,0.8517786561264822,0.9750311270769428,1.0,1/1,43.74%,SLC26A2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.5657370517928286,-0.7639238117514466,0.8517786561264822,0.9750311270769428,1.0,1/1,43.74%,SLC26A2
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),-0.5657370517928286,-0.7639238117514466,0.8517786561264822,0.9750311270769428,1.0,1/1,43.74%,SLC26A2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.5657370517928286,-0.7639238117514466,0.8517786561264822,0.9750311270769428,1.0,1/1,43.74%,SLC26A2
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",0.4391217564870259,0.7637561835570854,0.8125,0.9330137698034794,1.0,2/2,56.26%,GNB1;RP1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.43837751902137606,-0.7607639679322704,0.8057259713701431,0.9791469887473215,1.0,1/2,10.34%,INSM1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.37,-0.760079678531215,0.796976241900648,0.9785151603928942,1.0,3/3,63.42%,AQP9;HCN1;AANAT
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.37,-0.760079678531215,0.796976241900648,0.9785151603928942,1.0,3/3,63.42%,AQP9;HCN1;AANAT
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.37199999999999994,0.7597458605807,0.7893700787401575,0.9385950342008668,1.0,3/3,63.02%,ARHGAP11B;RAP1GAP2;CCL21
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.433696154661637,-0.7584790189823083,0.7970085470085471,0.980510205769811,1.0,1/2,7.75%,GPX1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.5717131474103585,-0.7571386458682039,0.8617424242424242,0.9778893033201956,1.0,1/1,43.14%,OFD1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.5717131474103585,-0.7571386458682039,0.8617424242424242,0.9778893033201956,1.0,1/1,43.14%,OFD1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.5717131474103585,-0.7571386458682039,0.8617424242424242,0.9778893033201956,1.0,1/1,43.14%,OFD1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.5717131474103585,-0.7571386458682039,0.8617424242424242,0.9778893033201956,1.0,1/1,43.14%,OFD1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.5717131474103585,-0.7571386458682039,0.8617424242424242,0.9778893033201956,1.0,1/1,43.14%,OFD1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.4271457085828343,-0.7565867386874806,0.8029978586723768,0.9779572163952047,1.0,2/2,57.65%,LYAR;IRAK3
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.5677290836653386,0.7558411276304106,0.8732673267326733,0.943741298122087,1.0,1/1,43.34%,SLC16A9
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.4271457085828343,-0.7557377531519087,0.8072289156626506,0.9784947450654232,1.0,2/2,57.65%,HMGCR;IRAK3
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.36201102111143685,-0.7555316509281098,0.7951807228915663,0.9779010601277659,1.0,1/3,6.76%,CXCL8
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.5717131474103585,0.7549906123665728,0.8846918489065606,0.9369304311770223,1.0,1/1,42.94%,SMC5
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.5717131474103585,0.7549906123665728,0.8846918489065606,0.9369304311770223,1.0,1/1,42.94%,SMC5
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.5717131474103585,0.7549906123665728,0.8846918489065606,0.9369304311770223,1.0,1/1,42.94%,SMC5
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.5717131474103585,0.7549906123665728,0.8846918489065606,0.9369304311770223,1.0,1/1,42.94%,SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.5717131474103585,0.7549906123665728,0.8846918489065606,0.9369304311770223,1.0,1/1,42.94%,SMC5
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.5717131474103585,0.7549906123665728,0.8846918489065606,0.9369304311770223,1.0,1/1,42.94%,SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.5717131474103585,0.7549906123665728,0.8846918489065606,0.9369304311770223,1.0,1/1,42.94%,SMC5
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.5717131474103585,0.7549906123665728,0.8846918489065606,0.9369304311770223,1.0,1/1,42.94%,SMC5
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.5717131474103585,0.7549906123665728,0.8846918489065606,0.9369304311770223,1.0,1/1,42.94%,SMC5
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.5717131474103585,0.7549906123665728,0.8846918489065606,0.9369304311770223,1.0,1/1,42.94%,SMC5
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),-0.5677290836653386,-0.7530599800710901,0.8705440900562852,0.9812167744782231,1.0,1/1,43.54%,WLS
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.3257939068551483,0.7527316328939306,0.7752808988764045,0.9392180323720858,1.0,3/4,42.74%,S100A12;VEGFA;IRAK3
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.35908108807145683,0.7513976571643256,0.8065134099616859,0.9403899259072657,1.0,2/3,25.05%,GPNMB;VEGFA
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.5617529880478087,-0.7494640956968295,0.8762088974854932,0.9841127948886308,1.0,1/1,44.14%,RP1
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),-0.5617529880478087,-0.7494640956968295,0.8762088974854932,0.9841127948886308,1.0,1/1,44.14%,RP1
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.5617529880478087,-0.7494640956968295,0.8762088974854932,0.9841127948886308,1.0,1/1,44.14%,RP1
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.5617529880478087,0.7486306356762807,0.8881856540084389,0.9428021161143261,1.0,1/1,43.94%,HACD3
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.5617529880478087,0.7486306356762807,0.8881856540084389,0.9428021161143261,1.0,1/1,43.94%,HACD3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.5597609561752988,0.7479266239267076,0.8860510805500982,0.9381450248328728,1.0,1/1,44.14%,PKIB
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.5597609561752988,0.7479266239267076,0.8860510805500982,0.9381450248328728,1.0,1/1,44.14%,PKIB
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5597609561752988,0.7479266239267076,0.8860510805500982,0.9381450248328728,1.0,1/1,44.14%,PKIB
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.5597609561752988,0.7479266239267076,0.8860510805500982,0.9381450248328728,1.0,1/1,44.14%,PKIB
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.5597609561752988,0.7479266239267076,0.8860510805500982,0.9381450248328728,1.0,1/1,44.14%,PKIB
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.5597609561752988,0.7479266239267076,0.8860510805500982,0.9381450248328728,1.0,1/1,44.14%,PKIB
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.5597609561752988,0.7479266239267076,0.8860510805500982,0.9381450248328728,1.0,1/1,44.14%,PKIB
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.3650291820248231,0.7477154626574163,0.8084210526315789,0.9361398612082714,1.0,2/3,30.82%,LCN2;SLC40A1
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.3650291820248231,0.7477154626574163,0.8084210526315789,0.9361398612082714,1.0,2/3,30.82%,LCN2;SLC40A1
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.3650291820248231,0.7477154626574163,0.8084210526315789,0.9361398612082714,1.0,2/3,30.82%,LCN2;SLC40A1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.19996417476626804,0.7474605244338355,0.7559055118110236,0.9356376052807263,1.0,6/12,33.80%,CITED2;KANK1;GPNMB;VEGFA;MYLK;ELP5
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.2975148787831087,0.7468250719813478,0.7696737044145874,0.9361233474326044,1.0,1/5,1.79%,DEFA4
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.5537848605577689,-0.7458595150180302,0.8792756539235412,0.9875413792670993,1.0,1/1,44.93%,TOPORS
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.5537848605577689,-0.7458595150180302,0.8792756539235412,0.9875413792670993,1.0,1/1,44.93%,TOPORS
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.5537848605577689,-0.7458595150180302,0.8792756539235412,0.9875413792670993,1.0,1/1,44.93%,TOPORS
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.3149564932654406,-0.7457094211279018,0.7887596899224806,0.9868923624388994,1.0,2/4,21.07%,ATP6V0D1;GAPDH
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.4297716264176753,0.7448559951260403,0.8158415841584158,0.9381401944015817,1.0,1/2,15.71%,GUCY2F
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.41832956604596055,-0.7430867383602892,0.8258064516129032,0.9893075899452783,1.0,1/2,13.32%,STMN1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.41832956604596055,-0.7430867383602892,0.8258064516129032,0.9893075899452783,1.0,1/2,13.32%,STMN1
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.5577689243027888,-0.7428345115315136,0.8916155419222904,0.9862483993261687,1.0,1/1,44.53%,ABCB10
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.5577689243027888,-0.7428345115315136,0.8916155419222904,0.9862483993261687,1.0,1/1,44.53%,ABCB10
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.5577689243027888,-0.7428345115315136,0.8916155419222904,0.9862483993261687,1.0,1/1,44.53%,ABCB10
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.5577689243027888,-0.7428345115315136,0.8916155419222904,0.9862483993261687,1.0,1/1,44.53%,ABCB10
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.31816568451154725,-0.7427105962571496,0.78099173553719,0.9855689859834875,1.0,1/4,2.78%,EDNRB
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.5537848605577689,0.7419222521638449,0.9027237354085603,0.9396676050078314,1.0,1/1,44.73%,GPR37
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5537848605577689,0.7419222521638449,0.9027237354085603,0.9396676050078314,1.0,1/1,44.73%,GPR37
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.5537848605577689,0.7419222521638449,0.9027237354085603,0.9396676050078314,1.0,1/1,44.73%,GPR37
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.5537848605577689,0.7419222521638449,0.9027237354085603,0.9396676050078314,1.0,1/1,44.73%,GPR37
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.42947722270453303,-0.741622794972574,0.828,0.9861791395240536,1.0,1/2,10.74%,VWF
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.25012403442986614,0.7413208778338594,0.7855822550831792,0.9397297511725279,1.0,6/7,53.68%,JUN;CCNA2;GNB1;HACD3;ARHGAP5;GDI1
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.547808764940239,-0.7412607482105081,0.8789144050104384,0.981305232441341,1.0,1/1,45.53%,TMEM33
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),-0.547808764940239,-0.7412607482105081,0.8789144050104384,0.981305232441341,1.0,1/1,45.53%,TMEM33
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.547808764940239,-0.7412607482105081,0.8789144050104384,0.981305232441341,1.0,1/1,45.53%,TMEM33
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.547808764940239,-0.7412607482105081,0.8789144050104384,0.981305232441341,1.0,1/1,45.53%,TMEM33
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.547808764940239,-0.7412607482105081,0.8789144050104384,0.981305232441341,1.0,1/1,45.53%,TMEM33
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.547808764940239,-0.7412607482105081,0.8789144050104384,0.981305232441341,1.0,1/1,45.53%,TMEM33
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.4171656686626746,-0.7410281769420879,0.8073770491803278,0.979929791171,1.0,2/2,58.65%,FIS1;SLIRP
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.4171656686626746,-0.7410281769420879,0.8073770491803278,0.979929791171,1.0,2/2,58.65%,FIS1;SLIRP
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.3634727914848928,-0.7409926949674278,0.7933333333333333,0.9790999805778071,1.0,2/3,24.25%,CORO1A;KANK4
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.2842047317016668,-0.7406088365760473,0.7551867219917012,0.9788612756745069,1.0,2/5,15.90%,CXCL8;NUAK1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.285140562248996,-0.7400918063246488,0.7717171717171717,0.9792518633064622,1.0,5/5,71.97%,FIS1;TRAK2;RAB3IP;NLGN1;PEX6
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.4109875811951385,-0.7366120545272297,0.8352941176470589,0.9836138603616688,1.0,1/2,13.72%,SLC18A2
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.5557768924302788,-0.7357142484899966,0.9268774703557312,0.9832256905986356,1.0,1/1,44.73%,NXF1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.5557768924302788,-0.7357142484899966,0.9268774703557312,0.9832256905986356,1.0,1/1,44.73%,NXF1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.3164117329819207,-0.7354501779317353,0.7974137931034483,0.9828628511509494,1.0,3/4,35.39%,SDC1;SDC3;ALDH1A1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.4211576846307385,-0.734710107154907,0.8113948919449901,0.9833309528200358,1.0,2/2,58.25%,GGT5;CYP27B1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.41516966067864264,0.7344437385284233,0.8169014084507042,0.9470784042904404,1.0,2/2,58.65%,VEGFA;MYH9
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.41516966067864264,0.7344437385284233,0.8169014084507042,0.9470784042904404,1.0,2/2,58.65%,VEGFA;MYH9
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.41516966067864264,0.7344437385284233,0.8169014084507042,0.9470784042904404,1.0,2/2,58.65%,VEGFA;MYH9
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.41516966067864264,0.7344437385284233,0.8169014084507042,0.9470784042904404,1.0,2/2,58.65%,VEGFA;MYH9
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.4131736526946108,0.7312336720034758,0.8600823045267489,0.9501865977647047,1.0,2/2,58.85%,NLGN1;BSN
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.4131736526946108,0.7312336720034758,0.8600823045267489,0.9501865977647047,1.0,2/2,58.85%,NLGN1;BSN
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.24124707614045823,-0.7309956887004121,0.788135593220339,0.9882256041695958,1.0,3/7,20.87%,ALDOC;PLPP3;PI4KA
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.30967253402993156,-0.7304363075525376,0.7956777996070727,0.9882077432562076,1.0,2/4,21.07%,ATP6V0D1;GAPDH
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.5438247011952191,-0.727901767642693,0.9008097165991903,0.9897001939148302,1.0,1/1,45.92%,XPO4
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5438247011952191,-0.727901767642693,0.9008097165991903,0.9897001939148302,1.0,1/1,45.92%,XPO4
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.5438247011952191,-0.727901767642693,0.9008097165991903,0.9897001939148302,1.0,1/1,45.92%,XPO4
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.31114125551437216,0.7277152035628573,0.7974683544303798,0.9545623976415846,1.0,1/4,2.98%,LRP2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.5517928286852589,-0.7269485768073831,0.9103313840155945,0.9809817139894953,1.0,1/1,45.13%,EIF4G1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.5517928286852589,-0.7269485768073831,0.9103313840155945,0.9809817139894953,1.0,1/1,45.13%,EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),-0.5517928286852589,-0.7269485768073831,0.9103313840155945,0.9809817139894953,1.0,1/1,45.13%,EIF4G1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.5517928286852589,-0.7269485768073831,0.9103313840155945,0.9809817139894953,1.0,1/1,45.13%,EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),-0.5517928286852589,-0.7269485768073831,0.9103313840155945,0.9809817139894953,1.0,1/1,45.13%,EIF4G1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.5517928286852589,-0.7269485768073831,0.9103313840155945,0.9809817139894953,1.0,1/1,45.13%,EIF4G1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),-0.5517928286852589,-0.7269485768073831,0.9103313840155945,0.9809817139894953,1.0,1/1,45.13%,EIF4G1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.5517928286852589,-0.7269485768073831,0.9103313840155945,0.9809817139894953,1.0,1/1,45.13%,EIF4G1
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.5517928286852589,-0.7269485768073831,0.9103313840155945,0.9809817139894953,1.0,1/1,45.13%,EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.5517928286852589,-0.7269485768073831,0.9103313840155945,0.9809817139894953,1.0,1/1,45.13%,EIF4G1
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),-0.5517928286852589,-0.7269485768073831,0.9103313840155945,0.9809817139894953,1.0,1/1,45.13%,EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.5517928286852589,-0.7269485768073831,0.9103313840155945,0.9809817139894953,1.0,1/1,45.13%,EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4093405807535523,0.7257019799232283,0.8249027237354085,0.953991433345261,1.0,1/2,12.72%,EFNA1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.4093405807535523,0.7257019799232283,0.8249027237354085,0.953991433345261,1.0,1/2,12.72%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.4093405807535523,0.7257019799232283,0.8249027237354085,0.953991433345261,1.0,1/2,12.72%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.4093405807535523,0.7257019799232283,0.8249027237354085,0.953991433345261,1.0,1/2,12.72%,EFNA1
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.27939204903793124,0.7236133948747534,0.8082191780821918,0.9561032686663103,1.0,2/5,17.69%,RAD23B;NAP1L3
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.5517928286852589,0.7230729315584925,0.922920892494929,0.9562283190544127,1.0,1/1,44.93%,PCARE
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.23991935483870966,-0.722998129429606,0.7978947368421052,0.985871764234653,1.0,7/7,76.54%,GPX1;LIPG;MSMO1;GGT5;FA2H;GPAM;PTGS2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.5438247011952191,0.7221659208905657,0.9096267190569745,0.9566357515885892,1.0,1/1,45.73%,CAPN7
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.5398406374501992,-0.7216026085828242,0.9322033898305084,0.9857121177194016,1.0,1/1,46.32%,NACC2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5398406374501992,-0.7216026085828242,0.9322033898305084,0.9857121177194016,1.0,1/1,46.32%,NACC2
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.5398406374501992,-0.7216026085828242,0.9322033898305084,0.9857121177194016,1.0,1/1,46.32%,NACC2
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.3418663046764819,-0.7215456343313402,0.8382978723404255,0.9832179238583628,1.0,1/3,6.76%,CXCL8
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.3418663046764819,-0.7215456343313402,0.8382978723404255,0.9832179238583628,1.0,1/3,6.76%,CXCL8
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.3418663046764819,-0.7215456343313402,0.8382978723404255,0.9832179238583628,1.0,1/3,6.76%,CXCL8
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.34716235086090946,-0.7213795639523924,0.819327731092437,0.9826968694532789,1.0,1/3,6.76%,CXCL8
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.5358565737051793,-0.7205530020256864,0.927063339731286,0.9804391560853629,1.0,1/1,46.72%,GDI1
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.5358565737051793,-0.7205530020256864,0.927063339731286,0.9804391560853629,1.0,1/1,46.72%,GDI1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.5358565737051793,-0.7205530020256864,0.927063339731286,0.9804391560853629,1.0,1/1,46.72%,GDI1
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.5358565737051793,-0.7205530020256864,0.927063339731286,0.9804391560853629,1.0,1/1,46.72%,GDI1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.411109072656356,0.7204459193767137,0.85546875,0.958328496079069,1.0,1/2,12.72%,EFNA1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.277830183740348,-0.7199542397131269,0.806910569105691,0.980386340717218,1.0,4/5,49.11%,GAPDH;EIF4G1;RBM4B;EPRS1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.4070817741426513,-0.7192142636945997,0.8631790744466801,0.9811033140858213,1.0,1/2,12.13%,LIF
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.34199999999999997,0.7192046768429774,0.8480300187617261,0.9590230565178735,1.0,3/3,66.00%,LPAR1;GPR37;ADCY3
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3031955509835304,0.7189433129068065,0.8239700374531835,0.9584983039960757,1.0,3/4,42.54%,RANBP2;CENPC;ITGB3BP
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.4083084674500013,0.715536061638419,0.838150289017341,0.9620127639399547,1.0,1/2,17.50%,S100A12
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.4083084674500013,0.715536061638419,0.838150289017341,0.9620127639399547,1.0,1/2,17.50%,S100A12
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.40718562874251507,0.7146743295321657,0.8622754491017964,0.9608722659114419,1.0,2/2,59.44%,CHMP4C;PPP2R1A
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.40718562874251507,0.7146743295321657,0.8622754491017964,0.9608722659114419,1.0,2/2,59.44%,CHMP4C;PPP2R1A
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.40718562874251507,0.7146743295321657,0.8622754491017964,0.9608722659114419,1.0,2/2,59.44%,CHMP4C;PPP2R1A
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.3110430560998946,-0.7141982120668539,0.8229166666666666,0.9879066247149414,1.0,3/4,43.54%,RAB3C;RAB15;WLS
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.5318725099601593,-0.7139898076606935,0.9262295081967213,0.9866356851812159,1.0,1/1,47.12%,PSRC1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.5318725099601593,-0.7139898076606935,0.9262295081967213,0.9866356851812159,1.0,1/1,47.12%,PSRC1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.3420000000000002,0.7138022008141978,0.833969465648855,0.9609409410890898,1.0,3/3,66.00%,GUCY2F;SLC26A2;ADCY3
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.4089918296805055,-0.7135202471439488,0.870020964360587,0.9847626729323592,1.0,1/2,13.32%,STMN1
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.4089918296805055,-0.7135202471439488,0.870020964360587,0.9847626729323592,1.0,1/2,13.32%,STMN1
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.4089918296805055,-0.7135202471439488,0.870020964360587,0.9847626729323592,1.0,1/2,13.32%,STMN1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.4091816367265469,-0.7124258601394717,0.8574380165289256,0.98536805604594,1.0,2/2,59.44%,CNTNAP1;PLLP
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.3014825568789759,0.7112372409260052,0.8585657370517928,0.9637644876637048,1.0,1/4,3.58%,LAMP5
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5338645418326693,0.7104005343240586,0.9232283464566929,0.9617068402337438,1.0,1/1,46.72%,BMI1
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.5338645418326693,0.7104005343240586,0.9232283464566929,0.9617068402337438,1.0,1/1,46.72%,BMI1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.5338645418326693,0.7104005343240586,0.9232283464566929,0.9617068402337438,1.0,1/1,46.72%,BMI1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.5338645418326693,0.7104005343240586,0.9232283464566929,0.9617068402337438,1.0,1/1,46.72%,BMI1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.5258964143426295,0.7101365385270179,0.9388185654008439,0.9557531839474116,1.0,1/1,47.51%,TBK1
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5258964143426295,0.7101365385270179,0.9388185654008439,0.9557531839474116,1.0,1/1,47.51%,TBK1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5258964143426295,0.7101365385270179,0.9388185654008439,0.9557531839474116,1.0,1/1,47.51%,TBK1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.5258964143426295,0.7101365385270179,0.9388185654008439,0.9557531839474116,1.0,1/1,47.51%,TBK1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.5258964143426295,0.7101365385270179,0.9388185654008439,0.9557531839474116,1.0,1/1,47.51%,TBK1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.5258964143426295,0.7101365385270179,0.9388185654008439,0.9557531839474116,1.0,1/1,47.51%,TBK1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.5258964143426295,0.7101365385270179,0.9388185654008439,0.9557531839474116,1.0,1/1,47.51%,TBK1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.5258964143426295,0.7101365385270179,0.9388185654008439,0.9557531839474116,1.0,1/1,47.51%,TBK1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.19931962450851448,-0.7075927941500131,0.8131212723658051,0.9917827738408773,1.0,3/10,14.71%,DTX3L;PSMB9;PSMB8
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.2707448109382873,-0.7056870866630762,0.8025210084033614,0.993916577633616,1.0,4/5,49.11%,IRF9;GAPDH;CCL21;EPRS1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.39836740810101606,-0.7049423250891854,0.8598726114649682,0.9941332264389505,1.0,1/2,13.12%,AP2M1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.2971827375010957,0.7044741705070243,0.8438735177865613,0.9629025556645255,1.0,1/4,5.96%,CASQ1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.5298804780876494,0.7026441243129183,0.9428007889546351,0.9604551536063722,1.0,1/1,47.12%,SMPD4
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.5298804780876494,0.7026441243129183,0.9428007889546351,0.9604551536063722,1.0,1/1,47.12%,SMPD4
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.5298804780876494,0.7026441243129183,0.9428007889546351,0.9604551536063722,1.0,1/1,47.12%,SMPD4
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.5298804780876494,0.7026441243129183,0.9428007889546351,0.9604551536063722,1.0,1/1,47.12%,SMPD4
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.5298804780876494,0.7026441243129183,0.9428007889546351,0.9604551536063722,1.0,1/1,47.12%,SMPD4
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.5298804780876494,0.7026441243129183,0.9428007889546351,0.9604551536063722,1.0,1/1,47.12%,SMPD4
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.5278884462151394,-0.7013934934075372,0.9363449691991786,0.9938386225411909,1.0,1/1,47.51%,IMPA1
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.5278884462151394,-0.7013934934075372,0.9363449691991786,0.9938386225411909,1.0,1/1,47.51%,IMPA1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.5278884462151394,-0.7013934934075372,0.9363449691991786,0.9938386225411909,1.0,1/1,47.51%,IMPA1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.5278884462151394,-0.7013934934075372,0.9363449691991786,0.9938386225411909,1.0,1/1,47.51%,IMPA1
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.5278884462151394,-0.7013934934075372,0.9363449691991786,0.9938386225411909,1.0,1/1,47.51%,IMPA1
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.5278884462151394,-0.7013934934075372,0.9363449691991786,0.9938386225411909,1.0,1/1,47.51%,IMPA1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.4071856287425152,0.7000187546326465,0.8768939393939394,0.963332221223442,1.0,2/2,59.44%,CCNA2;PPP2R1A
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.5199203187250996,-0.6983965934181472,0.9666011787819253,0.9953273482077158,1.0,1/1,48.31%,RBM4B
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.5199203187250996,-0.6983965934181472,0.9666011787819253,0.9953273482077158,1.0,1/1,48.31%,RBM4B
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.5199203187250996,-0.6983965934181472,0.9666011787819253,0.9953273482077158,1.0,1/1,48.31%,RBM4B
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.297322790619002,-0.6981316674374152,0.8374485596707819,0.9947834014774521,1.0,1/4,5.17%,MIF
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.2358805628357865,0.6971492193876179,0.8122676579925651,0.9667291895367223,1.0,5/7,43.94%,JUN;CCNA2;GNB1;ARHGEF18;HACD3
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.5239043824701195,-0.6970275527743182,0.9514563106796117,0.9937985100167588,1.0,1/1,47.91%,CHST9
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.5239043824701195,-0.6970275527743182,0.9514563106796117,0.9937985100167588,1.0,1/1,47.91%,CHST9
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.5239043824701195,-0.6970275527743182,0.9514563106796117,0.9937985100167588,1.0,1/1,47.91%,CHST9
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.388291056364205,-0.695871269435736,0.8599605522682445,0.9943799297332495,1.0,1/2,10.54%,IRF9
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.2953232356635792,0.6954064970638559,0.8413001912045889,0.9684553048276667,1.0,3/4,45.13%,RMI1;TAF11;TAF9B
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.4032109179904274,0.6947740380063876,0.888,0.9684060638707785,1.0,1/2,16.50%,ANOS1
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),-0.33846178876698907,-0.694378616843215,0.8517034068136272,0.9956830529147201,1.0,1/3,7.75%,GPX1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta activation (GO:1901388),-0.5159362549800797,-0.6926332017178188,0.9647058823529412,0.9973505940102602,1.0,1/1,48.71%,ITGB6
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.2932926889917579,0.6924449153944234,0.8402366863905325,0.9704552455416718,1.0,1/4,4.77%,RELN
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.5239043824701195,0.6910968883338535,0.9603960396039604,0.9717449664126755,1.0,1/1,47.71%,RAB3IP
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.2474849094567403,0.6900919438675102,0.8406374501992032,0.972156591874283,1.0,6/6,75.55%,EXOC8;LEMD3;SMPD4;COG3;PLEKHM2;NPLOC4
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.24302548083603984,-0.6896771807282048,0.8450980392156863,1.0,1.0,5/6,57.65%,NUAK1;PI4KA;MAP3K9;TBK1;IRAK3
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.2627388943715103,-0.6893048193134924,0.8546637744034707,1.0,1.0,4/5,51.69%,DCTN1;PSRC1;HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.332,-0.6874661112312469,0.8603238866396761,1.0,1.0,3/3,67.20%,PHACTR1;MYH9;THSD7B
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.2608682634934791,0.6872585893097297,0.8626692456479691,0.975032441226038,1.0,1/5,2.98%,LRP2
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.39321357285429137,-0.6870886481389299,0.8859470468431772,1.0,1.0,2/2,61.03%,PLPP3;PLPP2
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.39321357285429137,-0.6870886481389299,0.8859470468431772,1.0,1.0,2/2,61.03%,PLPP3;PLPP2
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.39321357285429137,-0.6870886481389299,0.8859470468431772,1.0,1.0,2/2,61.03%,PLPP3;PLPP2
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.5219123505976095,-0.6866261068236682,0.960552268244576,0.9882765054555619,1.0,1/1,48.11%,GTF2H4
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.338,-0.6863295439112791,0.8336798336798337,0.9878846361435472,1.0,3/3,66.60%,ANKRD16;TRMT13;ELP5
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.39121756487025944,-0.6858716369419007,0.8783783783783784,0.9876278659125686,1.0,2/2,61.23%,RIMS3;NLGN1
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.38722554890219557,-0.6830212235328714,0.8850325379609545,0.9900208983526514,1.0,2/2,61.63%,ANK1;LIN7C
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.38722554890219557,-0.6830212235328714,0.8850325379609545,0.9900208983526514,1.0,2/2,61.63%,ANK1;LIN7C
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.39121756487025944,-0.6823328818113747,0.8828125,0.9903414114893532,1.0,2/2,61.23%,CCL21;NLGN1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5119521912350598,-0.6816976127320956,0.9771428571428571,0.9896133772080868,1.0,1/1,49.11%,EPRS1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.5119521912350598,-0.6816976127320956,0.9771428571428571,0.9896133772080868,1.0,1/1,49.11%,EPRS1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.5119521912350598,0.6800949012071993,0.9797160243407708,0.9775409554892267,1.0,1/1,48.91%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5119521912350598,0.6800949012071993,0.9797160243407708,0.9775409554892267,1.0,1/1,48.91%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.5119521912350598,0.6800949012071993,0.9797160243407708,0.9775409554892267,1.0,1/1,48.91%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5119521912350598,0.6800949012071993,0.9797160243407708,0.9775409554892267,1.0,1/1,48.91%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5119521912350598,0.6800949012071993,0.9797160243407708,0.9775409554892267,1.0,1/1,48.91%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5119521912350598,0.6800949012071993,0.9797160243407708,0.9775409554892267,1.0,1/1,48.91%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5119521912350598,0.6800949012071993,0.9797160243407708,0.9775409554892267,1.0,1/1,48.91%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.5119521912350598,0.6800949012071993,0.9797160243407708,0.9775409554892267,1.0,1/1,48.91%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5119521912350598,0.6800949012071993,0.9797160243407708,0.9775409554892267,1.0,1/1,48.91%,HSPA1A
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.5159362549800797,0.6799471642037481,0.9685534591194969,0.976129769993005,1.0,1/1,48.51%,TRMT13
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.5159362549800797,0.6799471642037481,0.9685534591194969,0.976129769993005,1.0,1/1,48.51%,TRMT13
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.5099601593625498,-0.6779086794801802,0.9788053949903661,0.990600843423562,1.0,1/1,49.30%,FIGNL1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.5099601593625498,-0.6779086794801802,0.9788053949903661,0.990600843423562,1.0,1/1,49.30%,FIGNL1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.5099601593625498,-0.6779086794801802,0.9788053949903661,0.990600843423562,1.0,1/1,49.30%,FIGNL1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.5099601593625498,-0.6779086794801802,0.9788053949903661,0.990600843423562,1.0,1/1,49.30%,FIGNL1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.5099601593625498,-0.6779086794801802,0.9788053949903661,0.990600843423562,1.0,1/1,49.30%,FIGNL1
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.3892215568862275,-0.6765545727290669,0.8950749464668094,0.9917099501296301,1.0,2/2,61.43%,CDC7;RPA4
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.5079681274900398,-0.6748910289995195,0.9816326530612245,0.9745534956603125,1.0,1/1,49.50%,KCNH2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.5039840637450199,-0.6742190370179475,0.9897119341563786,0.9747424362651715,1.0,1/1,49.90%,ARHGAP5
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.50199203187251,-0.6737647487754489,0.9940711462450593,0.974476024140341,1.0,1/1,50.10%,PAN2
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.50199203187251,0.6728295033116185,1.0,0.9824216411497421,1.0,1/1,49.90%,ZNF451
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.50199203187251,0.6728295033116185,1.0,0.9824216411497421,1.0,1/1,49.90%,ZNF451
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.50199203187251,0.6728295033116185,1.0,0.9824216411497421,1.0,1/1,49.90%,ZNF451
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.37724550898203596,0.6726745360780538,0.9008264462809917,0.9818732296377028,1.0,2/2,62.43%,LUM;GGT5
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.5099601593625498,0.6707754107469651,0.9863813229571985,0.9831714389885898,1.0,1/1,49.11%,HELZ
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.5079681274900398,0.6703832245729248,0.9822134387351779,0.9827181511881923,1.0,1/1,49.30%,XRCC2
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.5059760956175299,0.6676821689436137,0.9879275653923542,0.9844961436262003,1.0,1/1,49.50%,TDRD7
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.32615675274342787,-0.6657966494089342,0.8958333333333334,0.982017954656614,1.0,1/3,7.95%,BDNF
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.3772455089820359,0.6650447908013066,0.9061224489795918,0.9855352329561873,1.0,2/2,62.43%,TRHDE;GGT5
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.22228411316717714,-0.6604182982339564,0.8665207877461707,0.9857170325178152,1.0,5/7,45.13%,CDC7;RPLP2;DTX1;TOPORS;EIF4G1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3875992710810502,-0.6571643938818812,0.8964803312629399,0.9868434525385288,1.0,1/2,12.33%,CNTN6
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.37125748502994016,0.6565672756337662,0.9044834307992202,0.9874430297696956,1.0,2/2,63.02%,RYR3;CCL21
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.37125748502994016,0.6565672756337662,0.9044834307992202,0.9874430297696956,1.0,2/2,63.02%,RYR3;CCL21
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.37125748502994016,0.6565672756337662,0.9044834307992202,0.9874430297696956,1.0,2/2,63.02%,RYR3;CCL21
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.37924151696606784,-0.6546680167494837,0.9037656903765691,0.9871633016854703,1.0,2/2,62.43%,CCL21;ADGRA2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2069484797117093,0.653678144443389,0.8867562380038387,0.9878164965389674,1.0,1/8,1.39%,LTF
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.2560927434822397,-0.6535228453787504,0.8832997987927566,0.9868165890757905,1.0,1/5,3.18%,ISG15
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.31400000000000006,0.6516001948913862,0.905241935483871,0.9878882194657302,1.0,3/3,68.79%,LHPP;PPP2R1A;PTPN3
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),0.37125748502994016,0.6510026698460079,0.9176029962546817,0.9873184426719803,1.0,2/2,63.02%,GNB1;CCL21
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.3692614770459082,0.6505937725187115,0.9090909090909091,0.9867044884026382,1.0,2/2,63.22%,CA2;ABCB1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.1782953074783023,0.6475331225963513,0.8873517786561265,0.9871129204595811,1.0,8/11,51.29%,CITED2;GPNMB;TOB1;VEGFA;BMI1;HSPA1B;HSPA1A;EPRS1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.3712574850299402,0.6391922591926863,0.9310344827586207,0.987291715322832,1.0,2/2,63.02%,VEGFA;CCL21
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.3712574850299402,0.6391922591926863,0.9310344827586207,0.987291715322832,1.0,2/2,63.02%,VEGFA;CCL21
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.3712574850299402,0.6391922591926863,0.9310344827586207,0.987291715322832,1.0,2/2,63.02%,VEGFA;CCL21
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.3712574850299402,0.6391922591926863,0.9310344827586207,0.987291715322832,1.0,2/2,63.02%,VEGFA;CCL21
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.19028340080971662,0.6383151420489273,0.9104477611940298,0.9868468801013431,1.0,9/9,81.31%,LTF;S100A12;LPAR1;CAPN3;TBK1;WLS;CCL21;GAPDH;LGALS1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.35928143712574867,0.6339331862622577,0.9367588932806324,0.9878173246902557,1.0,2/2,64.21%,MAK;MAP3K9
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.20030560126580835,0.631228350160548,0.898,0.9880244687563162,1.0,2/8,12.13%,RAD23B;KBTBD7
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.354477211754492,0.6306459721934808,0.9386138613861386,0.9866694882915382,1.0,1/2,20.28%,JUN
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.354477211754492,0.6306459721934808,0.9386138613861386,0.9866694882915382,1.0,1/2,20.28%,JUN
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.17560815150167264,0.6242486748168152,0.9204545454545454,0.9881310281993756,1.0,9/11,64.21%,RELN;EFEMP1;MAK;CCNA2;IRAK3;TBK1;GTF2H4;CAMK1G;MAP3K9
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.298,-0.6201998780979175,0.9191919191919192,0.9986990142381864,1.0,3/3,70.58%,PI4KA;IMPA1;GPAM
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.34646172945037257,0.6189876196409313,0.9450980392156862,0.9891138028199334,1.0,1/2,20.68%,IMMP2L
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.2545090180360721,-0.6187362045200172,0.9209401709401709,0.9984442499902332,1.0,4/4,74.95%,TCIM;HSPA1A;HSPA1B;IER5
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),-0.28910067253458094,-0.6093159467253557,0.9313131313131313,1.0,1.0,1/3,9.54%,KNDC1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.2988447894569843,0.6086941081731743,0.9284403669724771,0.9917267165148749,1.0,2/3,38.97%,RMI1;RPA4
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.25519842707142776,-0.6084949970285782,0.9479392624728851,1.0,1.0,3/4,43.74%,GABRA2;GABRA4;SLC26A2
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.3413173652694612,0.6080450836699314,0.9454191033138402,0.9911450533282581,1.0,2/2,66.00%,LGR5;ADCY3
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.29141979597990125,0.6078366659197099,0.9489194499017681,0.9904298626279349,1.0,2/3,38.37%,CHMP4C;ZFYVE26
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),-0.343768239539591,-0.6072506918007047,0.9464668094218416,0.9988891992145988,1.0,1/2,17.10%,CMPK2
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.343768239539591,-0.6072506918007047,0.9464668094218416,0.9988891992145988,1.0,1/2,17.10%,CMPK2
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.341317365269461,0.6068196916226617,0.9595375722543352,0.9892019215523593,1.0,2/2,66.00%,UBR3;ADCY3
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.341317365269461,0.6068196916226617,0.9595375722543352,0.9892019215523593,1.0,2/2,66.00%,UBR3;ADCY3
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.29,-0.603552015815282,0.9396378269617707,0.9992419210083446,1.0,3/3,71.37%,HMGCR;IRAK3;VIP
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.3429271065538755,0.600238518151794,0.9471698113207547,0.9904357205534694,1.0,1/2,19.68%,CEP120
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.2348292345436373,0.5989722043887418,0.9318181818181818,0.9900381801744271,1.0,1/5,4.57%,PTER
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.34131736526946105,0.5984967723345423,0.9541108986615678,0.9885938120005943,1.0,2/2,66.00%,GNB1;ADCY3
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.34131736526946105,0.5984967723345423,0.9541108986615678,0.9885938120005943,1.0,2/2,66.00%,GNB1;ADCY3
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.3365684723070994,0.5942807729239139,0.9319066147859922,0.9890499085897761,1.0,1/2,21.47%,RANBP2
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.3393213572854291,-0.5942083685470197,0.9587628865979382,1.0,1.0,2/2,66.40%,AQP9;CAPN3
prerank,GO_Biological_Process_2021__killing by host of symbiont cells (GO:0051873),-0.343313373253493,-0.5941647462575218,0.9608247422680413,1.0,1.0,2/2,66.00%,GAPDH;CFHR1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.335097979859334,0.5907459754562211,0.9529190207156308,0.9893079844327217,1.0,1/2,19.88%,ZNF420
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.20724346076458755,-0.5892964042303839,0.9399141630901288,1.0,1.0,6/6,79.72%,PHB2;FIS1;TRAK2;SLIRP;MTFR1;IMMP2L
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.3414632978415934,-0.5889670488402639,0.9432048681541582,0.9995827421705825,1.0,1/2,17.89%,ANKRD16
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.3414632978415934,-0.5889670488402639,0.9432048681541582,0.9995827421705825,1.0,1/2,17.89%,ANKRD16
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.33825281742130753,0.5880895406054556,0.9649805447470817,0.9892357893369804,1.0,1/2,19.68%,CEP120
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.21369287364427292,-0.587413725867636,0.9387755102040817,0.999245074457568,1.0,2/6,14.71%,PSMB9;PSMB8
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.276,-0.5854627900967724,0.962882096069869,0.9989497103401453,1.0,3/3,72.76%,STMN1;ARHGEF18;LPAR1
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.286338773106808,-0.5832693719926132,0.9480249480249481,0.9987310653303137,1.0,1/3,8.95%,PHB2
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.193151632737867,0.5774848516432265,0.9457831325301205,0.9911304557493185,1.0,6/7,66.00%,FCGR3A;VIP;GNB1;MYH9;GGT5;ADCY3
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.32486140337018166,-0.5760339964740359,0.96,0.9997350887863679,1.0,1/2,17.30%,NMNAT2
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.3342528753423187,0.5757040115640665,0.9715909090909091,0.9908236828387371,1.0,1/2,22.47%,DSG2
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.20925553319919507,0.5745192153648104,0.9347826086956522,0.9903153013166465,1.0,6/6,79.32%,DDIT4;CAPN3;ZNF443;PPP2R1A;DDX41;GAPDH
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.214859437751004,-0.5719557620544822,0.9713114754098361,0.9999353137044229,1.0,5/5,78.93%,STMN1;OFD1;ITGB3BP;CENPC;RANBP2
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.3193612774451098,-0.5676403080342476,0.9748427672955975,1.0,1.0,2/2,68.39%,SMPX;MYLK
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.1943531217578527,-0.5670468072940583,0.9267782426778243,0.9995410585660148,1.0,4/7,33.20%,CNTN6;CBLN1;PCDHB16;CDH8
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.24176198363370105,0.5649729984501889,0.9619047619047619,0.9916924402241964,1.0,3/4,48.91%,HSPA1L;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.26815753481837945,0.5561260356295875,0.9694072657743786,0.9927156525896454,1.0,1/3,14.71%,HSPA1L
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.26896408291678053,0.5536298478085838,0.9730769230769231,0.9924611254349567,1.0,1/3,12.72%,EFNA1
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.19429925007250506,-0.5507645203312079,0.956989247311828,1.0,1.0,2/6,16.30%,SLC18A2;GABRA2
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.3101672482480673,-0.549941978464289,0.9740820734341252,1.0,1.0,1/2,19.48%,CDC7
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.19114688128772644,0.5424186500016734,0.9625468164794008,0.9938255990941186,1.0,6/6,81.11%,LHPP;PLPP2;PLPPR5;PPP2R1A;PTPN3;PLPP3
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),0.2599999999999999,0.5413707481783855,0.9830188679245283,0.9932428147227905,1.0,3/3,74.16%,VEGFA;ABCB10;LYAR
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.26232700538380843,-0.5399760210657218,0.9814432989690721,1.0,1.0,1/3,12.13%,LIF
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.30339321357285426,-0.5379791591854166,0.9936440677966102,1.0,1.0,2/2,69.98%,DCTN1;CEP19
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.30339321357285426,-0.5379791591854166,0.9936440677966102,1.0,1.0,2/2,69.98%,DCTN1;CEP19
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.22393478418376483,-0.5301723454883411,0.9649484536082474,1.0,1.0,1/4,9.34%,EGR2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.252,-0.5279887242000746,0.9732739420935412,1.0,1.0,3/3,75.15%,CDC7;BMI1;CHMP4C
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.3034779812575544,-0.5275901966667293,0.9917355371900827,1.0,1.0,1/2,19.28%,PLPP3
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.29740518962075846,-0.5172496080651448,0.9878542510121457,1.0,1.0,2/2,70.58%,HMGCR;GPAM
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.2456238842152488,0.5142924572974323,0.9883720930232558,0.9965057194112995,1.0,1/3,14.91%,SLC1A3
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.24492875917446297,0.5135049919519038,0.9868173258003766,0.9950155223672594,1.0,1/3,14.91%,SLC1A3
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.24492875917446297,0.5135049919519038,0.9868173258003766,0.9950155223672594,1.0,1/3,14.91%,SLC1A3
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.2894211576846307,-0.5081973073235114,0.9903100775193798,1.0,1.0,2/2,71.37%,PLEKHM2;VIP
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.2834331337325349,-0.50571767032772,0.9941634241245136,1.0,1.0,2/2,71.97%,FIS1;PEX6
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.2834331337325349,-0.50571767032772,0.9941634241245136,1.0,1.0,2/2,71.97%,FIS1;PEX6
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.2834331337325349,-0.50571767032772,0.9941634241245136,1.0,1.0,2/2,71.97%,FIS1;PEX6
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.2734530938123752,-0.500168144737455,0.9979508196721312,1.0,1.0,2/2,72.96%,FGF9;CKB
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.27766195108234837,0.48952112316810326,0.9923076923076923,0.9967063103679722,1.0,1/2,24.45%,SEC23B
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.232,-0.4868699365350261,0.9894736842105263,0.9998551368737028,1.0,3/3,77.14%,GAPDH;EPRS1;TOB1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.232,-0.4868699365350261,0.9894736842105263,0.9998551368737028,1.0,3/3,77.14%,GAPDH;EPRS1;TOB1
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.27544910179640714,-0.486718276969576,0.99800796812749,0.9983176560615349,1.0,2/2,72.76%,FIS1;LPAR1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.27544910179640714,-0.486718276969576,0.99800796812749,0.9983176560615349,1.0,2/2,72.76%,FIS1;LPAR1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.26946107784431134,-0.47717276264950603,1.0,0.9976239452120842,1.0,2/2,73.36%,FIS1;MTFR1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.26946107784431134,-0.47717276264950603,1.0,0.9976239452120842,1.0,2/2,73.36%,FIS1;MTFR1
